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Résumé 
Un papier bioactif est obtenu par la modification d’un papier en y immobilisant une ou 
plusieurs biomolécules. La recherche et le développement de papiers bioactifs est en plein 
essor car le papier est un substrat peu dispendieux qui est déjà d’usage très répandu à 
travers le monde. Bien que les papiers bioactifs n’aient pas connus de succès commercial 
depuis la mise en marche de bandelettes mesurant le taux de glucose dans les années 
cinquante, de nombreux groupes de recherche travaillent à immobiliser des biomolécules 
sur le papier pour obtenir un papier bioactif qui est abordable et possède une bonne durée 
de vie. Contrairement à la glucose oxidase, l’enzyme utilisée sur ces bandelettes, la 
majorité des biomolécules sont très fragiles et perdent leur activité très rapidement 
lorsqu’immobilisées sur des papiers. Le développement de nouveaux papiers bioactifs 
pouvant détecter des substances d’intérêt ou même désactiver des pathogènes dépend donc 
de découverte de nouvelles techniques d’immobilisation des biomolécules permettant de 
maintenir leur activité tout en étant applicable dans la chaîne de production actuelle des 
papiers fins. 
Le but de cette thèse est de développer une technique d’immobilisation efficace et 
versatile, permettant de protéger l’activité de biomolécules incorporées sur des papiers. La 
microencapsulation a été choisie comme technique d’immobilisation car elle permet 
d’enfermer de grandes quantités de biomolécules à l’intérieur d’une sphère poreuse 
permettant leur protection. Pour cette étude, le polymère poly(éthylènediimine) a été choisi 
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afin de générer la paroi des microcapsules. Les enzymes laccase et glucose oxidase, dont 
les propriétés sont bien établies, seront utilisées comme biomolécules test. Dans un premier 
temps, deux procédures d’encapsulation ont été développées puis étudiées. La méthode par 
émulsion produit des microcapsules de plus petits diamètres que la méthode par 
encapsulation utilisant un encapsulateur, bien que cette dernière offre une meilleure 
efficacité d’encapsulation. Par la suite, l’effet de la procédure d’encapsulation sur l’activité 
enzymatique et la stabilité thermique des enzymes a été étudié à cause de l’importance du 
maintien de l’activité sur le développement d’une plateforme d’immobilisation. L’effet de 
la nature du polymère utilisé pour la fabrication des capsules sur la conformation de 
l’enzyme a été étudié pour la première fois. 
Finalement, l’applicabilité des microcapsules de poly(éthylèneimine) dans la confection 
de papiers bioactifs a été démontré par le biais de trois prototypes. Un papier réagissant au 
glucose a été obtenu en immobilisant des microcapsules contenant l’enzyme glucose 
oxidase. Un papier sensible à l’enzyme neuraminidase pour la détection de la vaginose 
bactérienne avec une plus grande stabilité durant l’entreposage a été fait en encapsulant les 
réactifs colorimétriques dans des capsules de poly(éthylèneimine). L’utilisation de 
microcapsules pour l’immobilisation d’anticorps a également été étudiée.  
Les avancées au niveau de la plateforme d’immobilisation de biomolécules par 
microencapsulation qui ont été réalisées lors de cette thèse permettront de mieux 
comprendre l’effet des réactifs impliqués dans la procédure de microencapsulation sur la 
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stabilité, l’activité et la conformation des biomolécules. Les résultats obtenus démontrent 
que la plateforme d’immobilisation développée peut être appliquée pour la confection de 
nouveaux papiers bioactifs. 
Mots-clés :  
Microencapsulation, microcapsules de poly (éthylèneimine), encapsulateur, buse 
vibrations, papiers bioactifs, conformation des enzymes, fluorescence, microscopie 
confocale à balayage laser (CLSM), biocapteur colorimétrique, microcapsules d'anticorps 
sensibilisés. 
  
  
vi
 
Abstract 
Biosensing paper attracts increasing attention due to its benefits of being simple, 
visible, portable and useful for detecting various contaminants, pathogens and toxins. While 
there has been no bioactive paper commercialized since glucose paper strips developed in 
the fifties, many research groups are working to immobilize biomolecules on paper to 
achieve a bioactive paper that is affordable and has good shelf life. The goal of this 
research is to develop some highly useful bioactive paper that could, for example, measure 
blood glucose, or immediately detect and simultaneously deactivate pathogens such as 
neuraminidase and E.coli. Previously, bioactive paper was produced either through 
physically absorbing biorecognition elements or printing bio-ink onto paper substrate. Our 
methodology for fabrication of bioactive paper strips is compatible with existing paper 
making process and includes three procedures: the fabrication of microcapsules, enzyme or 
antibody microencapsulation, immobilization of enzymes or antibody-entrapped 
microcapsules into paper pulp.  
The first step, in fabricating of bioactive paper strips is to produce biocompatible 
and inexpensive microcapsules with suitable parameters. To do so, two types of 
microencapsulation methods were compared; the emulsion method and the vibration nozzle 
method accomplished with an encapsulator. The parameters for producing optimal 
microcapsules with both methods were studied. Factors that affect their diameter, wall 
thickness, shell pore size, encapsulation efficiency and membrane compositions were also 
discussed. By comparison, microcapsules prepared with poly(ethyleneimine) (PEI) by the 
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emulsion method exhibit properties that were more suitable for enzyme encapsulation and 
paper making process, whereas the microcapsules prepared by the vibration nozzle method 
were too big to be immobilized within paper pulp, and had lower encapsulation efficiency, 
enzymatic activity and productivity. Thus the emulsion method was chosen for subsequent 
experiments such as enzyme and antibody microencapsulation and bacterial vaginosis (BV) 
paper preparation. Microcapsules made by the emulsion method were semi-permeable in 
that the diffusion of substrate and product molecules were allowed freely across the 
membranes but the encapsulated enzymes would be retained inside.  
Glucose oxidase from Aspergillus niger (GOx) and laccase from Trametes 
versicolor (TvL) microcapsules showed high encapsulation efficiency, but the 
encapsulation process caused a severe decrease in the specific activities of both enzymes. 
Results from circular dichroism (CD) studies, fluorescence properties, enzymatic activities 
of free enzymes and Michaelis-Menten behavior demonstrated that the Vmax decrease for 
GOx was due to the restriction of diffusion across microcapsule membranes with pore size 
less than 5 nm. The microencapsulation process improved the thermal stability of GOx but 
decreased that of laccase. 
Bioactive papers were fabricated either by incorporating microcapsules containing 
different enzymes or empty microcapsules soaked in substrate and enhancer solution into 
the paper pulp during the sheet making process. Both the GOx and the BV paper strips 
underwent a color change in the presence of glucose and potassium iodide, and sialidase 
from Clostridium perfringens respectively. Some preliminary studies on antibody 
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sensitized microcapsules, in which antibody was either encapsulated within the PEI 
microcapsules or conjugated to its membranes, were also performed.  
Our objective was to establish an enzyme immobilization platform based on 
microencapsulation techniques for paper based biosensors. Even though our current studies 
only focused on the microencapsulation of two enzymes, TvL and GOx, as well as the 
bioactive paper preparation, a similar approach can be applied to other enzymes. We 
believe that this immobilization method can potentially be employed for bioactive paper 
preparation on an industrial scale. 
Keywords  
Microencapsulation, microcapsules, poly(ethyleneimine), encapsulator, vibration 
nozzle, bioactive paper, enzymes conformation, fluorescence, confocal laser scanning 
microscope (CLSM), colorimetric biosensor, antibody sensitized microcapsules. 
  
  
ix
 
Contribution of co-author 
The present work has been supported financially by the Natural Sciences and 
Engineering Research Council of Canada (NSERC) through SENTINEL--- A Canadian 
bioactive paper network. The research has been supervised by Dr. Rochefort, Université de 
Montréal (Montréal, Canada). Dr. Rochefort is the co-author for the articles that have been 
published and will be co-author for the manuscripts that have been submitted or in 
preparation for publication. 
Parts of this work have been published or submitted 
1. Yufen Zhang, Dominic Rochefort, Comparison of emulsion and vibration nozzle 
methods for microencapsulation of laccase and glucose oxidase by interfacial reticulation 
of poly(ethyleneimine), Journal of Microencapsulation, 2010, 27(8), 703-713. (Chapter 4) 
2. Yufen Zhang, Dominic Rochefort, Activity, conformation and thermal stability of 
laccase and glucose oxidase in poly(ethyleneimine) microcapsules for immobilization in 
paper, Process Biochemistry, 2011, 46(4), 993-1000. (Chapter 5) 
3. Yufen Zhang, Dominic Rochefort, Characterization and applications of 
microcapsules obtained by interfacial polycondensation, Journal of Microencapsulation, 
2012, 29(7), 636-649. (Chapter 3) 
4. Yufen Zhang, Dominic Rochefort, Fast and Effective Bioactive Paper for Self-
Diagnosis of Bacterial Vaginosis, Lab on a Chip, in preparation. (Chapter 6) 
 
  
x
 
List of Abbreviations, initials and nomenclature 
Ab   Antibody 
ABTS  2,2’-azinobis(3-ethylbenzthiazoline-6-sulfonate) 
AFM  Atomic force microscope 
BCA  Bicinchoninic acid 
BCIN  5-Bromo-4-chloro-3-indolyl-α-D-N-acetylneuraminic acid 
BET  Brunauer-Emmett-Teller 
BSA  Bovine serum albumin 
BV   Bacterial vaginosis 
CD   Circular dichroism 
CDEMA 2-chloro-N-(2,6-diethylphenyl)-N-(methoxy methyl)acetamide 
CFU  Colony forming units 
CLSM  Confocal laser scanning microscope 
CV   Coefficient of variation 
DBS  Dibutyl sebacate 
DEG  Diethylene glycol 
DETA  Diethylene triamine  
DHEA  Dehydroepiandrosterone 
DSC  Differential scanning calorimetry 
EA   Elemental analysis 
E.Coli  Escherichia Coli 
  
xi
 
EDA  Ethylenediamine 
EGDE  Ethyleneglycol diglycidylether 
ELISA  Enzyme-Linked immunosorbent assay 
FITC  Fluorescein isothiocyanate 
GOx  Glucose oxidase from Aspergillus Niger 
HAD  1,6 Hexamethylenediamine 
HMDA  1,6-hexamethylenediamine  
HMW  High molecular weight 
LMW  Low molecular weight 
HPVA  Hydrolyzed polyvinyl alcohol 
HRP  Horseradish peroxidase 
IPDI  Isophorone diisocyanate 
L-B plot Lineweaver-Burk plot 
MCR  Monocrotophos 
MDI  Diphenylmethane-4,4'-diisocyanate 
MF  Melamine-formaldehyde resin 
NBT  Nitroblue tetrazolium 
NC   Negative control 
NMR  Nuclear magnetic resonance 
OES  Oligoethoxysiloxane 
OM  Optical microscope 
OPD  o-phenylenediamine 
  
xii
 
PBS  Phosphate-buffered saline 
PBST  phosphate-buffered saline with Tween 20 
PCM  Phase change material 
PEI  Poly(ethyleneimine) 
PPD  p-phenylenediamine 
PTFE  Polytetrafluoroethylene 
PU   Polyurethane 
PVA  Poly(vinyl alcohol) 
SC   Sebacoyl chloride 
SEM  Scanning electron microscope 
SMA  Styrene–maleic anhydride 
TBS  Tris-buffered saline 
TC   Trimesoyl chloride 
TCMP  (Trichloromethyl)pyridine 
TDC  Terephthaloyl dichloride 
TDI  Toluene-2,4-diisocyanate 
TDITC  Terephthaloyl diisothiocyanate 
TEM  Transmission electron microscope 
TEOHS Tetradecaethoxyhexasiloxane 
TGA  Thermogravimetric analysis 
TMB  3, 3’, 5, 5’ –Tetramethylbenzidine 
TMP  Trimethylolpropane 
  
xiii
 
TPC  Acid dichloride (or Terephthalic acid) 
TvL  Laccase from Trametes Versicolor 
UF   Urea-formaldehyde 
 
 
  
  
xiv
 
Table of Contents 
 
Résumé .................................................................................................................................. iii 
Abstract .................................................................................................................................. vi 
Contribution of co-author .................................................................................................... ix 
List of Abbreviations, initials and nomenclature ................................................................. x 
Table of Contents ................................................................................................................ xiv 
List of Tables ...................................................................................................................... xix 
List of Figures ..................................................................................................................... xx 
Acknowledgements ............................................................................................................ xxiv 
Chapter 1 Introduction ......................................................................................................... 1 
1.1 General introduction .................................................................................................... 1 
1.2 Rationale and objectives of the study ......................................................................... 7 
1.3 Structure of thesis ........................................................................................................ 8 
1.4 References ..................................................................................................................... 9 
Chapter 2 Instrumental and experimental methodologies ................................................ 16 
2.1 Oxygen electrode ........................................................................................................ 16 
2.2 Confocal laser scanning microscope (CLSM) and optical microscope .................. 19 
  
xv
 
2.3 Particle size analyzer .................................................................................................. 20 
2.4 Emulsion microencapsulation method ..................................................................... 23 
2.5 Encapsulator microencapsulation method ............................................................... 27 
2.6 Scheme of enzyme microcapsules ............................................................................. 29 
2.7 Preparation of paper strips ....................................................................................... 33 
2.8 References ................................................................................................................... 35 
Chapter 3  Characterization and applications of microcapsules obtained by interfacial 
polycondensation ................................................................................................................. 39 
3.1 Abstract ....................................................................................................................... 39 
3.2 Introduction ................................................................................................................ 40 
3.3 Classification, mechanism and characterization ..................................................... 41 
3.4 Applications ................................................................................................................ 55 
3.5 Microencapsulation for paper modification in our group ...................................... 66 
3.6 Conclusion ................................................................................................................... 68 
3.7 References ................................................................................................................... 70 
Chapter 4 Comparison of emulsion and vibration nozzle methods for microencapsulation 
of laccase and glucose oxidase by interfacial reticulation of poly(ethyleneimine) .......... 93 
4.1 Abstract ....................................................................................................................... 93 
4.2 Introduction ................................................................................................................ 94 
  
xvi
 
4.3 Materials and methods .............................................................................................. 96 
4.3.1. Materials .......................................................................................................................... 96 
4.3.2. Preparation methods of PEI microcapsules...................................................................... 97 
4.3.3. Characterization of microcapsules ................................................................................... 98 
4.4 Results and Discussion ............................................................................................. 101 
4.4.1 Microencapsulation with an encapsulation device ......................................................... 101 
4.4.2 Characterisation of microcapsules ................................................................................. 105 
4.4.3 Enzyme microcapsules .................................................................................................. 117 
4.5 Conclusions ............................................................................................................... 119 
4.6 References ................................................................................................................. 120 
Chapter 5  Activity, conformation and thermal stability of laccase and glucose oxidase in 
poly(ethyleneimine) microcapsules for immobilization in paper  ................................... 126 
5.1 Abstract ..................................................................................................................... 126 
5.2 Introduction .............................................................................................................. 127 
5.3 Materials and methods ............................................................................................ 130 
5.4 Results ....................................................................................................................... 134 
5.4.1 Enzymatic activity of microencapsulated enzymes ....................................................... 134 
5.4.2 Preliminary results on bioactive paper ........................................................................... 143 
5.5 Discussions ................................................................................................................ 145 
5.6 Conclusions ............................................................................................................... 150 
5.7 References ................................................................................................................. 152 
  
xvii
 
Chapter 6 Fast and effective bioactive paper for self-diagnosis of bacterial vaginosis . 159 
6.1 Abstract ..................................................................................................................... 159 
6.2 Introduction .............................................................................................................. 160 
6.3 Materials and methods ............................................................................................ 163 
6.3.1 Preparation of microcapsules ......................................................................................... 163 
6.3.2 Fabrication of bioactive paper ....................................................................................... 164 
6.3.3 Loading efficiency of BCIN .......................................................................................... 166 
6.4 Results and discussion .............................................................................................. 167 
6.4.1 Microcapsules in bioactive paper ................................................................................... 167 
6.4.2 Different kinds of paper ................................................................................................. 167 
6.4.3 The same paper with different amounts of sialidase ...................................................... 175 
6.4.4 Loading efficiency of BCIN .......................................................................................... 177 
6.5 Conclusions ............................................................................................................... 178 
6.6 References ................................................................................................................. 179 
Chapter 7 Antibody sensitized microcapsules for the detection and deactivation of 
pathogens ........................................................................................................................... 184 
7.1 Introduction .............................................................................................................. 184 
7.2 Materials and methods ............................................................................................ 186 
7.3 Results and discussions ............................................................................................ 191 
7.3.1 Activity of conjugated GOx microcapsules ................................................................... 191 
7.3.2 CLSM study of antibody-microcapsule conjugation ..................................................... 192 
7.3.3 Conventional and rapid ELISA ...................................................................................... 192 
  
xviii
 
7.3.4 Killing assay .................................................................................................................. 194 
7.3.5 Microencapsulation of Immunoglobulin G from human plasma ................................... 196 
7.4 References ................................................................................................................. 199 
Chapter 8 Conclusions and future work .......................................................................... 203 
8.1 Conclusions ............................................................................................................... 203 
8.2 Future work .............................................................................................................. 205 
Annexes .................................................................................................................................. I 
Annex  1. The procedure of antibody conjugation to microcapsules. ................................ I 
Annex  2. Confocal laser scanning microscope (CLSM) for the detection of conjugation.
 ....................................................................................................................................................... II 
Annex  3. Conventional ELISA for the detection of conjugation. ................................... III 
Annex  4. Rapid ELISA for the detection of conjugation. ................................................ IV 
 
 
  
  
xix
 
List of Tables 
Chapter 3 
Table 3-1 The core and shell phases and applications of microcapsules by interfacial 
polycondensation. ........................................................................................................ 44 
Chapter 4 
Table 4-1 Optimal reagent ratios and instrumental parameters for preparation of PEI 
microcapsules with the encapsulation device. ........................................................... 105 
Table 4-2 Results from the elemental analysis of the microcapsule membranes composition 
prepared by the emulsion method and the encapsulation device. .............................. 112 
Chapter 5 
Table 5-1 Decrease in laccase activity observed after the microencapsulation procedure..
 .................................................................................................................................... 134 
Table 5-2 Monitoring of TvL’s and GOx’s activities by the oxygen consumption method.
 .................................................................................................................................... 139 
Chapter 6 
Table 6-1 Materials used for the preparation of four kinds of paper ................................. 165 
Table 6-2.  Paper 1 components per square centimeter of paper. ...................................... 175 
Chapter 7 
Table 7-1 Killing capacity of GOx microcapsules with various dilutions ......................... 195 
Table 7-2 Killing capacity of GOx microcapsules and GOx microcapsules-Ab ............... 196 
  
xx
 
 
List of Figures 
Chapter 2 
Figure 2-1  Setup of the Perspex oxygen electrode from Rank Brothers ............................ 17 
Figure 2-2 Schematic illustration of the reaction of encapsulated TvL (a) and GOx (b) in 
oxygen cell. .................................................................................................................. 18 
Figure 2-3 Typical oxygen consumption curve measured with the oxygen electrode.. ....... 18 
Figure 2-4  The configuration scheme of Leica TCS SP5 ................................................... 21 
Figure 2-5  3-D image of the cross-sections of microcapsules prepared by the emulsion 
method.. ........................................................................................................................ 22 
Figure 2-6 Idealized laser diffraction setup (angle of scatter VS. particle size) . ................ 23 
Figure 2-7  Schematic illustration of the emulsion method. ................................................ 26 
Figure 2-8 Optical micrograph of microcapsules prepared by the emulsion method with 
pitched blade turbine (a)............................................................................................... 27 
Figure 2-9 Scheme of the encapsulator and vibration nozzle method. ................................ 31 
Figure 2-10 Optical micrograph of microcapsules prepared by an encapsulator equipped 
with a homemade nozzle with a diameter of 10 µm. ................................................... 32 
Figure 2-11 Scheme of the enzyme microcapsules formation. ............................................ 32 
Figure 2-12 Dry bleached hard wood pulp from Paprican. .................................................. 34 
  
xxi
 
Chapter 3 
Figure 3-1  Scheme of microcapsule formation by interfacial polycondensation. .............. 42 
Figure 3-2  (a) and (b) SEM cross-section micrographs and IFME® numerical results of 
(b).. ............................................................................................................................... 55 
Figure 3-3 Morphology of the capsules membrane in dependence on the amount of shell 
components. ................................................................................................................. 56 
Figure 3-4 TEM micrograph of the cross-section of microcapsules at ×14 000 
magnification.. ............................................................................................................. 57 
Figure 3-5 The autonomic healing concept.. ........................................................................ 64 
Figure 3-6 Zeta potential of empty (squares) and laccase (triangles) microcapsules at 
different pHs of the buffer solution. ............................................................................. 67 
Chapter 4 
Figure 4-1 Schematic diagrams of microcapsule formation with the encapsulation device 
(A) and by the emulsion method (B)............................................................................ 98 
Figure 4-2 Effect of the flow rate at the nozzle of the encapsulation device. .................... 104 
Figure 4-3 Micrographs of typical microcapsules prepared by the emulsion method ....... 107 
Figure 4-4 Size distribution of microcapsule prepared by emulsion method. ................... 108 
Figure 4-5 (A and B) Fluorescence intensity histograms calculated from the corresponding 
confocal micrographs of microcapsules (insets) ........................................................ 110 
Figure 4-6 TGA curves of microcapsules prepared by the mechanical method. ............... 113 
  
xxii
 
Figure 4-7 Confocal micrographs showing the combined signals of microcapsules 
membranes. ................................................................................................................ 116 
Figure 4-8 pH dependency of glucose oxidation by GOx either free in solution .............. 118 
Chapter 5 
Figure 5-1 Scheme of the cross-linking reaction during encapsulation showing several 
possible linkages between PEI chains. ....................................................................... 132 
Figure 5-2 Michaelis-Menten behavior for the oxidation of glucose ................................ 136 
Figure 5-3 Heat inactivation curves obtained by measuring the activity of GOx. ............. 138 
Figure 5-4 Lineweaver-Burk plot for the OPD oxidation by laccase in presence of PEI at 
different concentrations. ............................................................................................. 141 
Figure 5-5 Intrinsic fluorescence emission spectrum of laccase. ....................................... 142 
Figure 5-6 CD spectra showing the disruption of β-sheets arrangements in laccase ......... 143 
Figure 5-7 (A) Fluorescence micrograph of a 3 mm2 section of a bioactive paper ........... 145 
Chapter 6 
Figure 6-1 Microcapsules in wet (1(a)) and dried (1(b)) format and microcapsules paper 
(1(c)).. ......................................................................................................................... 168 
Figure 6-2. The color reaction of four kinds of paper in the presence of sialidase. ........... 169 
Figure 6-3 The color change of paper 1 and 5 with different lengths of reaction time in the 
presence of 15 µl (0.937 UN) sialidase. ..................................................................... 174 
Figure 6-4 The color change of papers 1 and 2 with different lengths of reaction time .... 176 
  
xxiii
 
Figure 6-5 Mean color intensity of paper 1 and 2 in the presence of sialidase at different 
time lengths. ............................................................................................................... 177 
Figure 6-6 Standard graph of BCIN.. ................................................................................. 178 
 
Chapter 7 
Figure 7-1 Plots of oxygen consumption speed as a function of enzymatic activity. ........ 191 
Figure 7-2 Confocal micrographs of Goat anti-E.Coli antibody-microcapsules. .............. 193 
Figure 7-3 Rapid ELISA result for GOx microcapsules and GOx microcapsules-Ab. ..... 195 
Figure 7-4 Multi-panel view of confocal images of IgG microcapsules. .......................... 198 
 
 
 
  
  
xxiv
 
Acknowledgements 
I gratefully acknowledge my supervisor Prof. Dominic Rochefort at Université de 
Montréal, for giving me the opportunity to pursue my doctorate study in his research group. 
His valuable scientific guidance, constant encouragement and financial support through my 
whole study were gratefully appreciated. Many of my success are directly attributed to his 
own zest for success and thirst for knowledge.  
Many thanks to Prof. Karen C. Waldron for the many times I stopped in. She never 
hesitated to stop what she was doing to help me out.  
Thanks to all of past and present group colleagues and Dr. Waldron’s group 
members, not only for the occasional assistance they provided on my projects but for their 
personal stories, group and birthday parties.  
Special thanks to Dr. Kevin J. Wilkinson, Dr. Pierre Lavallée, Dr. Julian X. Zhu, Dr. 
J. Pelletier and A. Schmitzer for the access to their instruments. 
I would like to thank my committee members: Prof. Gil Garnier, Julian X. Zhu, and 
Karen C. Waldron for your advice and support. 
I would like to thank my friends, Kayee Lok, Pei Tsu, Michelle Lin and Tina Lin for 
their encouragements, help and friendship.  
My deepest gratitude goes to parent, parent-in-law and my husband for their love, 
financial support, comprehension. 
 Chapter 1 Introduction 
1.1 General introduction 
The aim of this research is to construct an enzyme immobilization platform using 
microencapsulation methods to make paper-based biosensors. Biosensing paper strips 
have shown great promise and a vast market potential. They are increasingly gaining 
interest from researchers and industry due to their benefits of being inexpensive, 
portable, disposable, fast-responding and environmentally friendly. 
The first paper strip biosensor can be traced back to the first invention of paper-
based partition chromatography by Martin and Synge in 1941 [1, 2], for which they 
were awarded the Nobel Prize in Chemistry in 1952.  Both the EAWAG Company [3] 
and Stocker et al. [4] developed paper biosensors for the detection of arsenic in potable 
water. Stocker [4] devised a process in which sensor cells were dried on paper such that 
when it soaked in aqueous solution for 30 min a color change would take place. The 
paper strip sensor developed by the EAWAG team [3, 5]  used genetically modified 
bacteria that produced a blue coloration even at low arsenic concentrations. After 
incubation with an arsenite-containing water sample, the bacterial cells produce β-
galactosidase, whose activity can be visualized by its conversion of a substrate to a blue 
colored product. Similarly, Struss [6, 7] reported the development of a portable filter-
paper-based strip biosensor for the detection of the bacterial quorum by sensing 
signaling molecules called N-acylhomoserine lactones. Their bacterial cell-based 
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sensing system was designed using components of the N-acylhomoserine lactone-
mediated quorum signaling regulatory system as the recognition elements and β-
galactosidase as the reporter protein. These bacterial-sensing cells were then liquid-
dried on strips of filter paper. Using β-galactosidase as the reporter allows for visual 
monitoring of the analyte-induced signal when a colorimetric method of detection is 
used at the same time. Yu et al. [8] proposed a paper-based chemiluminescence 
analytical biosensor device as a point-of-care diagnostic method for the simultaneous 
quantification of glucose and uric acid in artificial urine. Wang et al. [9] impregnated 
nanotubes mixed with antibodies to detect microcystin-LR in the paper strip when it 
came into contact with water contaminated with microcystin-LR. In their method, the 
antibodies begin to squeeze themselves through the nanotubes to bind to the antigens, 
such that the spreading apart of the nanotubes changes their electrical conductivity: this 
change is measurable. Khan et al. [10] developed inexpensive, portable paper-based test 
strips for blood-typing by printing antibodies onto a thin piece of paper. Savolainen et 
al. [11] likewise fabricated bioactive paper using screen printing, flexo printing and rod 
coating methods to immobilize enzymes onto paper. Murray et al. [12] investigated the 
direct adsorption of pitch on pulp fibers as a papermaking strategy and investigated the 
potential of surface plasmon resonance to quantify the adsorption of polydisperse 
colloids at the solid-liquid interface. 
Some bioactive papers were produced either though physically absorbing 
biorecognition elements [13] or printing the bioink onto the paper [14]. In this project, 
the bioactive paper was prepared by incorporating microencapsulated enzymes into the 
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paper pulp. Given that the characteristics exhibited by poly(ethyleneimine) (PEI) 
microcapsules prepared by the emulsion method were confirmed to be suitable for the 
paper immobilization, we therefore continued to use this method to encapsulate 
enzymes [15]. The scheme of the membrane-forming reaction of PEI microcapsules is 
represented in Chapter 5. 
As far as the authors are aware, there are but few reports on biological 
encapsulation using the interfacial polycondensation methods, despite its advantage in 
providing a tight control of the mean diameter of the microcapsules in a fast 
preparation. Chapter 3 provides a literature review of microencapsulation technology 
by interfacial polycondensation, as well as the characterization and applications of 
produced microcapsules. To our knowledge, no publication so far has been devoted to 
the nature of the interactions between the microencapsulated enzymes and the 
membranes of PEI microcapsules. In this study, PEI microcapsules were prepared by a 
microemulsion method and vibration nozzle method to entrap two different enzymes, 
glucose oxidase (GOx) from Aspergillus Niger and laccase from Trametes versicolor 
(TvL), with a high entrapment efficiency [15]. The activities of both enzymes were 
investigated throughout the various steps of the encapsulation procedure to give insight 
that may explain the loss of any observed enzymatic activities.  
Immobilization of enzymes has invariably resulted in a loss of activity. The loss of 
enzymatic activity upon immobilization is due to the conformational changes in the 
enzyme resulting from several complex interactions between protein and 
polyelectrolytes, such as Lifshitz-van der Waals forces, dipolar or hydrogen bonding, 
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conformational entropy, electrostatic forces, Coulomb and hydrophobic dehydrations 
[16, 17]. Additionally, the diffusion limitation of substrate and product molecules for 
enzymes immobilized inside the microcapsules may be another factor in the apparent 
reduction of enzymatic activities. The determination of the exact cause of enzymatic 
activity decrease was therefore a key consideration in the development of our 
immobilization platform based on microencapsulation. 
Takashi et al [18] used polyamide microcapsules prepared by an interfacial 
polycondensation method to entrap trypsin (I).  They observed that the KM and Vmax 
values were considerably lower than those of free trypsin in solution. 
The layer-by-layer microencapsulation method has often been used to encapsulate 
enzymes [19-23], notwithstanding its drawbacks of time-consuming multiple deposition 
steps as well as the tedious cleansing of particles required after each deposition to 
remove the excess non-absorbed polyelectrolytes [24]. Another drawback is the 
necessity of working at very low particle concentrations due to a high tendency for 
polyelectrolyte-induced particle flocculation, leaving most enzymes and 
polyelectrolytes lost during the absorption and deposition procedures. Furthermore, this 
technique requires templates at all times whereby the template removal step results in a 
decrease in enzymatic activity.  
The preparation of bioactive paper requires a high quantity of microcapsules that 
are strong enough to withstand the mixing or coating process. Moreover, its 
components including polymers, crosslinker and membranes must be biocompatible 
with the encapsulated active agents, hence the microencapsulation procedure and the 
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properties of the materials of choice determine the activity of the encapsulated 
enzymes.  
PEI is a polymer often used to help in the immobilization of biomolecules. For 
example, it has been utilized to make self-assembled catalase/PEI-PEG (polyethylene 
glycol) complexes [25], and “nanozymes” to treat Parkinson’s disease by selectively 
delivering antioxidants to the substantia nigra pars compacta (SNpc) to attenuate the 
oxidative stress, thereby increasing the survival of dopaminergic neurons. In another 
example, the co-aggregation of glutaryl acylase with the PEI system favored the cross-
linking between the very reactive and abundant primary amino groups of the PEI and 
the primary amino groups on the enzyme surface and as such, PEI was used to prevent 
the release of enzymes from the aggregate [26]. PEI was also used to coat the anodic 
aluminum oxide (AAO) membrane by cross-flow filtration of the polymer solution 
through the membranes [27]. AAO–PEI–trypsin preparations with different porosities 
showed that the enzymatic activity increased with larger pore diameters. In addition, 
PEI has been used as an enzyme carrier [28], for the protection of oligonucleotides 
against enzymatic degradation [29], stabilization of electrostatically-immobilized 
enzymes against washing-off in low pH and/or ionic strength environments [30] and 
immobilization of enzymes on the surface of electrode [31]. As microcapsules, it is 
utilized for the extraction of metal [32, 33], trapping of magnetic PEI microcapsules 
[34-36] and the conversion of ammonia to glutamate by enzymes within lipid-
polyamide PEI microcapsules [37]. Our group has successfully immobilized 
microencapsulated enzymes on the surface of an electrode and investigated the 
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electrochemical behavior of microencapsulated laccase prepared with a non-conductive 
polymer (PEI) adsorbed on a glassy carbon electrode [38, 39]. Moreover, PEI 
microcapsules were incorporated into a paper substance [40] with the goal of 
developing stable bioactive papers with a high retention of proteins. Other strategies to 
immobilize biocatalysts on various supports using PEI are discussed in a review article 
by Bahulekar et al.[41] 
 In spite of apparent advantages of using PEI for enzyme immobilization, many 
authors reported a decrease of enzymatic activity in PEI-based immobilization systems. 
For instance, Matella et al [42] studied the immobilized-enzyme system using PEI, 
glutaraldehyde (GA), and cotton cloth and reported an enzyme inactivation between 50 
to 90% with the combination of PEI and GA.  
In this thesis, we have compared two simple and effective enzyme 
microencapsulation methods based on the interfacial polycondensation of PEI and 
evaluated the microcapsules' properties by several characterization methods. The 
enzymatic activities of free and encapsulated enzymes were investigated. PEI 
microcapsules prepared by the emulsion method were strong, intact and with 
controllable size and size distribution. This method was fast and mild with high 
productivity and encapsulation efficiency. Capsules prepared by the emulsion method 
were used for enzyme microencapsulation (Chapter 3 and 4), enzyme paper strip 
preparation (Chapter 4), bacterial vaginosis (BV) paper strip preparation (Chapter 5) 
and antibody encapsulation and conjugation (Chapter 6). 
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1.2 Rationale and objectives of the study 
The work reported in this thesis is part of Canada’s Sentinel Bioactive Paper 
Network. The goal of Sentinel is to develop technology platforms required for the 
production of bioactive paper that can detect, capture and deactivate water and airborne 
pathogens. The overall objective of this study was to make value-added bioactive paper 
strips that can provide a visible indication of the presence of pathogens or toxic 
compounds.  The specific objectives of the current thesis are:  
To fabricate microcapsules with two different technologies and determine the optimal 
parameters for both methods; 
To characterize the produced microcapsules and evaluate their properties, such as the 
membranes pore size, capsule size and size distribution, wall thickness and wall 
compositions, all of which are essential factors for future applications; 
To compare enzymatic activities and thermal stability, because after 
microencapsulation, some enzyme properties were modified; to study their new 
properties, compare the differences and find out the causes;  
To fabricate preliminary bioactive paper with enzymes; 
To incorporate microcapsules into paper and to examine whether the immobilization 
step affects the activities of encapsulated active ingredients; 
To make bacterial vaginosis (BV) paper that can detect sialidase (neuraminidase), 
which is related to bacterial vaginosis; 
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To find a preparation method for antibody microcapsules through microencapsulation 
or by conjugating antibodies to the outer membranes of microcapsules. 
1.3 Structure of thesis 
This thesis consists of eight chapters. Instrumental and experimental 
methodologies are explained in Chapter 2. The recent progress in characterization 
and applications of microcapsules prepared by this technology is reviewed in 
Chapter 3. Chapter 4 describes the fabrication, characterization of PEI 
microcapsules and comparison of two microencapsulation methods, in which the 
optimal parameters of fabrication are studied, and produced microcapsules are 
characterized. Physically, this microencapsulation method can be classified into two 
different techniques: the emulsion and the vibration nozzle microencapsulation 
methods. Changes in enzymatic activities, confirmations and thermal stabilities 
after microencapsulation were investigated. Chapter 5 is devoted to studying 
microencapsulated enzymes’ properties and discussing the factors that resulted in 
those changes. Preliminary GOx bioactive paper was fabricated, which can display 
a color change in the presence of glucose and potassium iodine. A simple, 
inexpensive and sensitive bioactive paper was fabricated for the self diagnosis of 
bacterial vaginosis; this is a one-step spot assay. Chapter 6 compares various BV 
paper strips and highlights the sensitivity and storage stability of this colorimetric 
biosensor. Moreover, attempts were made on antibody sensitized microcapsules for 
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the detection and deactivation of pathogens. Chapter 7 examines two types of 
antibody microcapsule preparation methods:  one method is to conjugate antibodies 
onto the surface of microcapsules and another is to microencapsulate antibodies. 
Some assays, such as the conjugation method, killing assay and rapid ELISA, will 
be depicted. Lastly, a brief conclusion and some suggestions for further studies are 
presented in Chapter 8.  
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 Chapter 2 Instrumental and experimental methodologies 
2.1 Oxygen electrode   
The most common technique used in enzyme kinetic characterization is 
spectrophotometry. Given that the enzymes were encapsulated into microcapsules 
in this work and its membranes were solid, a traditional spectrophotometer was not 
suitable for these measurements. Consequently, enzymatic activity measurements 
were conducted with an oxygen electrode [1-3]. The setup of the oxygen electrode 
from Rank Brothers is illustrated in Figure 2-1. It comprises a working (Platinum) 
and reference (silver) electrode. The small (2 mm in diameter) central platinum disc 
working electrode is the cathode, and O2 diffusing through the semi-permeable 
Teflon membrane is reduced on this electrode. Set in a well surrounding, this is a 
silver ring counter acting as a reference electrode. Conduction between the two 
electrodes is achieved by using a 3 M potassium chloride solution to saturate the 
paper tissue covering the two electrodes, and then two electrodes were connected by 
wet tissue paper. On top of this is the key gas-permeable and ion-impermeable 
Teflon membrane with thickness of 12.7 µm, sealed under a sample solution or 
suspension in an incubation chamber with a silicone rubber ring. The sample 
solution is sealed in the incubation chamber. 
The oxygen electrode is sensitive to oxygen concentration, whereby the oxygen 
consumption of enzyme catalyzed reactions can be recorded through it. The scheme 
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of reaction of encapsulated TvL and GOx is shown in Figure 2-2 and the typical 
measurement curve is shown in Figure 2-3. We took the slope (oxygen consumption 
speed) as relative enzymatic activity. Substrate molecules (p-phenylene diamine 
(PPD) or o-phenylenediamine (OPD) for TvL and glucose for GOx) passed through 
the membranes of microcapsules and were oxidized; this was catalyzed by 
encapsulated enzymes.  
 
Figure 2-  Setup of the Perspex oxygen electrode from Rank Brothers [4]. 
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Figure 2- Schematic illustration of the reaction of encapsulated TvL (a) and GOx (b) in 
oxygen cell. 
 
Figure 2- Typical oxygen consumption curve (on the left) measured with the 
oxygen electrode for a given substrate concentration. The slope of the oxygen 
consumption curve, representing enzymatic activity, is determined for each substrate 
concentration and plotted (on the right) to obtain the Michaelis-Menten parameters. 
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2.2 Confocal laser scanning microscope (CLSM) and optical 
microscope   
A confocal laser scanning microscope [5-7] is used for obtaining high resolution 
images and 3-D reconstruction. In contrast to wide-field microscopy, confocal 
microscopy is able to produce blur-free images of thick specimens at various 
depths, and eliminate image degradation of out-of-focus information or glare in 
specimens whose thickness exceeds the intermediate plane of focus. The principle 
of the CLSM was developed by Marvin Minsky in 1957 [8]. During the late 1970s 
and 1980s, advances in computer and laser technology, coupled to new algorithms 
for digital manipulation of images, led to a growing interest in confocal microscopy 
[9]. Practical CLSM designs were translated into working instruments by several 
investigators [10-13]. 
In CLSM, images are taken point-by-point [14]. Our measurements were 
conducted on a Leica TCS SP5 II CLSM equipped with three point laser sources: 
Argon ion (blue and green, 458/488/514 nm), Helium-Neon (red, 633 nm) and 
Diode-pumped solid-state (DPSS) (yellow, 561 nm), controlled by high-speed 
acousto-optic tunable filters that allow a very precise regulation of wavelength and 
excitation intensity. The configuration scheme of Leica TCS SP5 is shown in Figure 
2-4. 
In the specimen, the light is absorbed by fluorophores, which are artificially 
added to label molecules.  After absorption, fluorophores, for example, 
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fluorescamine labeled to PEI start to emit light in a random direction and with a 
wavelength longer than that of the excitation [6]. The objective focuses the laser 
light on a small spot in the specimen, whereby it collects the fluorescence emitted 
by the fluorophore within the specimen and relays the images of the specimen onto 
the detection pinhole. Regular fluorochrome dyes such as fluorescein isothiocyanate 
(FITC, Maximum Excitation: 490 nm, maximum Emission: 525 nm), 
sulforhodamine 101 acid chloride (Texas-red, Maximum Excitation: 596 nm, 
Maximum Emission: 615 nm) and fluorescamine (Maximum excitation: 390 nm, 
Maximum emission: 465 nm, 475 nm) were used to label poly(ethyleneimine) and 
enzymes. The 3-D image of half microcapsules prepared by the emulsion method is 
illustrated in Figure 2-5. The membranes of microcapsules were labeled by Texas-
red and the enzyme was labeled by FITC.  
2.3 Particle size analyzer  
The mean size and size distribution of microcapsules were measured by LA-950 
laser diffraction analyzer (Horiba). The measurements were made based on their 
static light scattering. The scheme is shown in Figure 2-6. For particles larger than 
the wavelength of light, the light scatters from the edge of the particle at an angle 
which is dependent on the size of the particle. Larger particles scatter light (green 
line) at relatively smaller angles than light scattered from smaller particles (red 
line). By observing the intensity of light scattered at different angles, we determined 
the relative amount of different particle sizes.  
  
21
 
 
 
Figure 2-  The configuration scheme of Leica TCS SP5 [15]. This system is 
composed of a regular florescence microscope and a confocal part, including a scan 
head and laser optics. 
The dynamic range of the Horiba LA-950 light scattering particle size analyzer  
is of 0.01 to 3000 µm, and the diameters of microcapsules prepared by either 
emulsion or the vibration nozzle method range from a few microns to several 
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hundred microns (up to 300 µm), which falls within the dynamic range of the 
instrument. A measurement result for the emulsion method is shown in Figure 2-8b.  
 
 
Figure 2-  3-D image of the cross-sections of microcapsules prepared by the 
emulsion method. Membranes of microcapsules were labeled by Texas-red and core 
phase was labeled by FITC. 
 
  
23
 
 
Figure 2- Idealized laser diffraction setup (angle of scatter VS. particle size) 
[16]. The angle of scatter is inversely proportional to the particle size; the amount of 
light is proportional to particle size. Large particles scatter more light than small 
particles. 
2.4 Emulsion microencapsulation method 
Poly(ethyleneimine) polymer was cross-linked by sebacoyl chloride to form the 
membranes of microcapsules. The external phase consists of the solvent 
cyclohexane, containing Span 85 (sorbitan trioleate) as an emulsifier to stabilize 
microdroplets. The core phase is hydrophilic and contains a buffer, PEI and 
encapsulated components. This technique, first described by D. Poncelet [17] 
includes two main steps: emulsification and the formation of membranes. The 
method involves the formation of a polymeric wall around the aqueous phase in 
order that it is encapsulated. Protein or enzymes are dissolved in emulsion droplets. 
This kind of microcapsule is obtained from a water-in-oil emulsion by interfacial 
polycondensation. The polycondensation reaction is rather quick and mild; the first 
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membrane is formed at the interface between water and oil. In our case, the organic 
solvent is cyclohexane. 
Our group updated this method by modifying some parameters, such as the 
agitator type, agitation speed, emulsification time etc. The initial emulsification step 
was crucial to overall process, as it dictated the final size and size distribution of 
microcapsules. The physicochemical properties of the two phases and the choice of 
surfactant were undoubtedly the key parameters in determining the equilibrium 
droplet size. However, only proper association between properties and operation 
parameters would allow a controllable size distribution [18].  
Agitation force and duration of agitation determine the emulsification quality 
and facilitate the diffusion of the crosslinker from the aqueous solution into the 
organic phase for the reaction process. A pitched blade turbine (four blades) with a 
45° angle offers a good balance between shear and pumping flow; this was adopted 
for the emulsion method. With sufficient agitation time (longer than 15 min), the 
mean size of droplets decreased and droplet size distribution narrowed.  
Microcapsules of small size and size distribution were then generated.  
Figure 2-7 shows the schematic illustration of the emulsion method. First, 50 
mL of cyclohexane as organic phase containing 0.9 ml sorbitan trioleate (Span 85) 
was stirred at a certain rotation speed for 2-3 min, and then 10.5 ml of aqueous 
phase containing pH 8.0 McIlvaine buffer (0.2 M Na2HPO4 and 0.1 M citric acid), 
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enzyme (from 1 mg to 50 mg) and 1 ml of poly(ethyleneimine) with a molecular 
weight of 1,300 Da was added to form water-in-oil microdroplets. After 15 min of 
agitation, the emulsion was stabilized, droplets remained a constant size after this 
period. Next 0.5 ml sebacoyl chloride (C10H16Cl2O2) as a crosslinker in 10 ml 
cyclohexane was added to react with poly(ethyleneimine) at the interface of all 
droplets simultaneously and the mixture was agitated for 5 min to mature the 
membranes. The reaction was stopped by diluting with 50 ml cyclohexane. 
Supernatant was discarded. Microcapsules were rinsed with 50 ml of cyclohexane 
to remove any remaining organic residues like hydrolyzed sebacoyl chloride. The 
microcapsules were then transferred to a Buchner filter funnel and rinsed with 
Milli-Q water to remove water soluble residues. Small molecules such as 
hydrolyzed sebacoyl chloride, hydrochloric acid and unreacted poly(ethyleneimine) 
on the surfaces and inside the microcapsule cores were rinsed off.  
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Figure 2-  Schematic illustration of the emulsion method. 
This method can prepare small microcapsules ranging from a few microns to 50 
µm. The properties of produced microcapsules are discussed in Chapter 4. As 
agitation influences mass transfer in a reactor, this mass transfer can be considered 
as a crucial parameter for determining the diameter of microcapsules. In general, the 
diameter of produced microcapsules decreased with increased agitation speed. 
Microcapsules prepared by the emulsion method have a relatively small size yet a 
larger size distribution than those prepared by the vibration nozzle method 
(encapsulator). The size and size distribution of microcapsules prepared by the 
emulsion method is shown in Figure 2-8. 
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Figure 2- Optical micrograph of microcapsules prepared by the emulsion method 
with pitched blade turbine (a); size distribution of microcapsules obtained from 
particle size analyzer (b).  
2.5 Encapsulator microencapsulation method 
The vibration nozzle (or encapsulator) method of microencapsulation is based 
on the laminar jet break-up technique. The Inotech encapsulator has been used for 
cell immobilization with different types of alginates. We reported for the first time 
that PEI microcapsules could likewise be prepared by this encapsulator. 
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Kondo’s [19] US Patent 2 379 817 was issued in 1945 as the initial nozzle-
based microencapsulation technology. This program has led to the development of a 
two-fluid gravity-flow apparatus producing relatively large capsules. 
Immobilization of living cells or biocatalysts in hydrogels is a well-established 
technique in a broad, increasing range of different applications. Sodium alginate is 
the most used polysaccharide as a polymer matrix due to its good biocompatibility 
and its easy gelling reaction [20-23]. Our work is the first to demonstrate the ability 
to permanently encapsulate enzymes in PEI microcapsules with an encapsulator. No 
microencapsulation technique hitherto had permitted the simultaneous production of 
beads with a narrow size distribution, a high production rate, a satisfactory level of 
material utilization under mild and nontoxic conditions, under completely sterile 
conditions and with the ability to scale up [21].  
The vibration nozzle technique can be used to produce monodisperse beads of 
>200 µm in diameter, depending on how the application is scaled up. The break-up 
of laminar jets is well investigated, but most of the analysis end at the point where 
the diameter of the neck decreases under a certain value, since mean diameter of 
microcapsules is about double of nozzle diameter. We tried to break the neck and 
replaced it with a homemade nozzle with a diameter of 10 µm to produce smaller 
microcapsules. However, the produced microcapsules were not as small as expected 
and were lightly aggregated. 
This method was performed with a commercial encapsulation device (Inotech 
IE-50R encapsulator, Figure 2-9 a). The encapsulator was equipped with a 100 µm 
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nozzle (Figure 2-9 c). Figure 2-9 b shows beads generated from a 500 µm nozzle. 
Microdroplets were produced by pumping a 10 mL solution containing pH 8.0 
McIlvaine buffer and 5% (v/v) PEI with MW of 750 kDa (PEI 750) through the 
nozzle while applying vibrations at a given frequency. Formed microdroplets fell 
into a hardening solution containing 50 mL of cyclohexane, 0.7 mL of span 85 and 
0.4 mL of sebacoyl chloride, which was agitated by a magnetic stir bar. The scheme 
of the vibration nozzle method is shown in Figure 2-9 d. 
The homemade nozzle is a glass needle with a nozzle diameter of 10 µm. In 
general, the bead diameter of a Newtonian liquid is about twice the diameter of the 
nozzle. However capsules we obtained from the nozzle of 10 µm were much bigger 
than 20 µm and large microcapsules were attached to several small microcapsules 
(Figure 2-10). As shown in Figure 2-10, microcapsules aggregated and had a large 
size distribution. 
2.6 Scheme of enzyme microcapsules 
The fabrication process for enzyme microcapsules is similar to that of empty 
microcapsules. The only difference is the enzyme-containing aqueous phase with 
PEI. Given that enzyme molecules contain primary amine groups that can react with 
the crosslinker, enzymes after the microencapsulation process can be found 
embedded both in the membranes and within the core (Figure 2-11). A low 
molecular weight of PEI (1.3 kDa) was used for the emulsion method, yet only a 
high molecular weight of PEI (750 kDa) can produce strong, intact and spherical 
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microcapsules using the vibration nozzle method. According to the pore size 
measurement described in Chapter 4, the membranes of microcapsules were semi-
permeable and allowed diffusion of small molecules such as PEI with a molecular 
weight of 1.3 kDa (PEI1.3), but not large molecules such as laccase (67 kDa) and 
PEI with a molecular weight of 750 kDa (PEI 750). Microcapsules prepared by the 
emulsion method only contained enzymes and water molecules after rinsing with 
Milli-Q water since PEI 1.3 molecules were washed off (Figure 2-11 Emulsion 
method). However, large microcapsules prepared with high molecular weight PEI 
by the vibration nozzle method contained PEI 750 as well as enzyme and water 
molecules; only the very small molecules such as hydrochloric acid and hydrolyzed 
sebacoyl chloride could pass through and be rinsed away (Figure 2-11 Vibration 
nozzle method).  
PEI interacts with laccase, and its presence in the core phase decreased the 
enzymatic activity of laccase, which is discussed in Chapter 4. The toxicity of PEI 
increased with increased molecular weight [24, 25], suggesting that PEI 750 is more 
toxic than PEI 1.3. In addition, the yield of the emulsion method is about twice that 
of the vibration nozzle method. In comparison, the emulsion was deemed more 
suitable as an enzyme encapsulation method for our biosensor platform. Given that 
the size of microcapsules influences the immobilization quality, microcapsules 
prepared by the vibration nozzle method were too big to be immobilized into paper 
pulp.  
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Figure 2- Scheme of the encapsulator and vibration nozzle method. Inotech IE-50R 
encapsulator (a); Beads generated from 500 µm nozzle (b); Microdroplets generated from 
100 µm nozzle at optimal condition (c); Scheme of PEI microcapsules formation by 
vibration nozzle method (d). 
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Figure 2- Optical micrograph of microcapsules prepared by an encapsulator 
equipped with a homemade nozzle with a diameter of 10 µm.  
 
Figure 2- Scheme of the enzyme microcapsules formation.  
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2.7 Preparation of paper strips 
In the universal paper-making method, a dilute suspension of wood pulp in 
water is drained through a screen and the interwoven pulp is laid down on the 
screen. Suspended water is removed from the sheet by pressing and drying in order 
to make paper. The paper handsheets were prepared in our lab using simple 
equipments. Hard wood paper pulp from Paprican was used as substrate for the 
preparation of handsheets, including empty paper (without microcapsules, as 
negative control), enzyme paper (containing enzyme microcapsules), BV paper 
(used in BV test, containing microcapsules soaked in BCIN and NBT solution) and 
microcapsule paper (containing empty microcapsules). 
Paper pulp was suspended in water or buffer depending on the experiment, and 
then agitated to form a homogeneous suspension before transferring it to a Buchner 
filtration funnel for quick drainage. Similarly, empty microcapsules or enzyme 
microcapsules suspension in water or buffer were mixed with a homogeneous pulp 
suspension, gently agitated, and then transferred to a Buchner filtration funnel for 
drainage. Wet paper was dried by purging with N2. Dried paper handsheets were cut 
and kept in separated tubes, which were later used for the colorimetric test and 
storage stability test. These paper strips are only for single use and can facilitate 
detection purposes by signaling a color change. Figure 2-12 shows hard wood paper 
pulp before paper-making (a) and papers with or without microcapsules labeled by 
fluorescamine (b, c), in which microcapsules were labeled by fluorescamine; 
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emitting green color under ultraviolet excitation (Figure 2-12 c right hand paper). 
This paper contained microcapsule aggregates, suggesting that capsules were not 
uniformly dispersed in paper pulp before filtration. Generally speaking, with this 
technique it is possible to achieve a better dispersion yet not to obtain 
monodispersed microcapsules. Thus this kind of colorimetric paper strip generates 
uneven intensity, which in practice improves visual ability.  
 
Figure 2- Dry bleached hard wood pulp from Paprican (a) and papers with 
microcapsules labeled by fluorescamine (right side in b and c) and without 
microcapsules (left in b and c).  
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 Chapter 3  Characterization and applications of 
microcapsules obtained by interfacial polycondensation1 
3.1 Abstract 
This review highlights the materials, mechanisms and applications of 
microencapsulation by interfacial polycondensation in different areas. This technology 
entraps active ingredients inside microcapsules/microspheres, having an average diameter 
ranging from nano size to several hundred microns. Polycondensation reactions take place 
at the boundary of two phases to form the shells of microcapsules or matrix microspheres. 
The emulsions can be classified into three types: water-in-oil, oil-in-water, and oil-in-oil. 
According to the hydrophilic-lipophilic property of core phase, different active substances, 
such as proteins, enzymes, insecticides, herbicides, vitamins, catalysts, drugs, essential oils, 
dyes, and phase change materials have been successfully incorporated into different 
microcapsules/microspheres. Based on the shell-forming materials, this technology is 
capable of preparing polyamine, polyurea, polyurethane, polythiourea, polyester, 
polyepoxide, polyacrylamide, and polysiloxane microcapsules. Over the past two decades 
microcapsules prepared by interfacial polycondensation have been widely used in 
                                                 
1 This chapter was published as a review article in Journal of Microencapsulation. 
Yufen Zhang, Dominic Rochefort, Characterization and applications of microcapsules 
obtained by interfacial polycondensation, Journal of Microencapsulation, 2012, 29(7), 636-
649. 
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carbonless paper, cosmetics, pharmacy, agriculture, energy storage/transfer, thermal 
insulation/regulation, and information and magnetic recording.  
Keywords 
 Characterization, Polymers, Permeability, Interfacial polycondensation, Agrochemicals 
3.2 Introduction 
Interfacial polycondensation is founded on the classic Schotten-Baumann reaction 
between an acid chloride and a compound containing an active hydrogen atom [1, 2].  Its 
mathematical model was described by Berezkin [3]. In this paper, microencapsulation by 
interfacial polycondensation includes all reactions where reactants meet at the interface of 
an emulsion and react rapidly. 
During the past two decades, interfacial polycondensation has found increased 
applications due to its high yield, moderate and fast syntheses, and controllable release 
characteristics, which in turn is a straightforward and frequently applied method of 
producing microcapsules. The encapsulation of core substances by interfacial 
polycondensation has been widely used in different fields. However, with the exception of 
one critical review in French published in 2007 [4], there has been no recent review of the 
main reference works on the subject of interfacial polycondensation since Morgan [5] and 
Arshady [6] back in the 1980’s. Since then, many new types of microcapsules were 
synthesized for various applications by different polymers. The present survey provides a 
new general review of various interfacial polycondensation procedures employed for the 
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preparation of microcapsules and microspheres. It outlines the new features of 
characterization and novel materials of shell-forming, and discusses the recent progress in 
different applications.  
Interfacial polycondensation is a traditional and well-understood microencapsulation 
technology, and has become increasingly popular in energy storage/transfer industries as 
well as in many other applications such as pharmaceutics, agriculture and cosmetics. Future 
studies of microencapsulation by interfacial polycondensation will focus on areas, such as 
encapsulation efficiency, activity of entrapped materials, storage stability, functionality and 
cost. 
3.3 Classification, mechanism and characterization 
3.3.1 Classification 
Microcapsules/microspheres can be classified in terms of their morphology and 
microemulsion process.  
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Figure 3-  Scheme of microcapsule formation by interfacial polycondensation. 
Based on their morphology, microcapsules/microspheres can be classified into hollow 
microcapsules [7-9], porous microspheres [10] and matrix microspheres [10, 11].  
 The preparation of microcapsules by interfacial polycondensation involves the 
emulsification process. In terms of the solubility of emulsion droplet as soft template, the 
emulsion can be classified into three types: oil-in-oil [12], oil-in-water [13-15] and water-
in-oil [16-18]. 
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3.3.2 Mechanism 
The basic principles of interfacial polycondensation are explained in previous reviews, 
books, and patents [5, 6, 19-25]. In short, monomers or prepolymers contained in two 
immiscible phases are cross-linked to form microcapsules/microspheres. Figure 3-1 
represents the scheme of microcapsules/microspheres formation. If both the polymer and 
crosslinking agent are soluble in the droplets, microspheres are formed; otherwise, the 
membranes are formed around the microdroplets, namely microcapsules [6]. Interfacial 
polycondensation is a two-step process: the formation of stable microemulsion and 
polycondensation reaction at the interface of an emulsion.  
The performances of microcapsules are largely dictated by the physicochemical 
properties of the materials, thus the microencapsulation system should be selected in terms 
of end applications. Microcapsules with different shell materials and active ingredients 
were investigated for various applications, which are listed in Table 3-1.   
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Table 3- The core and shell phases and applications of microcapsules by interfacial 
polycondensation. 
Shell materials Core materials Diameter /µm Applications  References 
Polyamine: HMDA, 
TDC 
Essential oils, 
Poly(acrylic 
acid) gel, oil 
210,   
0.5-20 
Cosmetics (essential 
oils), Extraction of 
metal cations 
[13, 14, 26-
30]  
Polyamine: PEI, 
TDC 
Enzymes in 
hemoglobin 100 Pharmacy [31] 
Polyamine: SMA, 
polyamines 
Insect sex 
pheromones 50-60 Insecticide  [10] 
Polyamine capsules-
Co(NO3)2•6H2O 
Polyacrylic acid 4-12  Catalysis, magnetic recording [32] 
Polyamine /Polyurea Hemolysate <1-63 Promising blood substitute [33, 34] 
Polyamine: PEI, SC, 
TC, HAD 
Empty, Alginic 
acid 313-865 
New microfluidic 
device, metal extraction [35, 36] 
Polyamide-
Polystyrene Empty  11-83 Morphology study [15] 
PU: IPDI, 
propanetriol Organic liquids 0.17-0.59 Nanoreactor  [37] 
PU and poly(ether 
urethane)  
Essential oil, α-
tocopherol, 
MCR 
0.15-0.5 Drug carrier, cosmetics, pesticide [38-41] 
Poly(ortho ester);  
polyester 
DHEA, BSA, 
agrochemicals 1-500 
Controlled release, 
agriculture [12, 42, 43]
Polyepoxide: EGDE,  
HMDA/DETA) 
VB6 and 
magnetite 10-100 PTFE membrane device [16, 44, 45]
Polysiloxane: OES, 
TEOHS Empty 
<1- 
several Kinetics study [9] 
Polythiourea: 
TDITC, OPD Carbofuran  3 Pharmaceutical [46] 
(Photo-crossinking) 
Polyurea: polymeric 
isocyanate with a 
polyamine 
TCMP; Photo-
initiators; / 
benzalkonium 
chloride; 
limonene oil 
1-125 Agriculture, Pharmacy, information recording [47-50] 
Polyurea: MDI, 
HMDA, HMDI, 
DETA; Polyamine 
CDEMA 3-10 Kinetic study, Agriculture: Herbicides [51-57] 
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PU/polyurea: MDI, 
HPVA. DEG and 
TMP  
Dyes   0.5-30 Cosmetics (lipsticks) [41, 58] 
Polyurea: TDI, 
amines 
Reactive amines; 
Chlorpyrifos, 
DBDPO 
4-36 
Self-healing, agriculture, 
controlled release, 
improve thermal 
stability 
[18, 59, 60]
Polyurea, 
polythiourea and PU 
Hydrophilic 
compounds 
(formamide) 
< 1 Silver nanoparticles [8] 
TDI with EDA 
(Polyurea) / DETA 
(PU);UF; Nylon-6, 
10: HDA, SC ; 
PAPI; UG 
Phase change 
materials, BSA, 
ink, perfume, 
detergent 
1-300 
Energy storage/heat 
transfer, thermal 
regulation, clinics, 
carbonless paper, 
perfume and laundry 
[3, 61-74] 
Alginate/polyacryla
mide dibutyl sebacate 500-1400 
Bioremediation of 
atrazine [75, 76] 
HSA/TPC, 
AC/POPA empty 
10-40, 
96-249 
Morphology and 
microencapsulation 
process study 
[77, 78] 
3.3.3 Characterization 
Size and size distribution 
The measurement of size and size distribution of microcapsules usually conducted on 
the optical microscope, confocal laser scanning microscope (CLSM), scanning electron 
microscope (SEM) and particle size analyzer. 
Landfester [79] reviewed the structures in miniemulsions, typically in which the mean 
diameters of microcapsules/microspheres by interfacial polycondensation are influenced by 
the type of blade, agitation speed and emulsification time [64, 80-83].  Given such 
influences, the mean particle size increased with decreasing agitation speed. The stirrers 
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used were selected according to the properties of the solution, such as viscosity. High 
agitation speed can provide a high break up force to generate small microemulsions. The 
emulsification time should be long enough to reach an equilibrium between coalescence 
and break up forces, leading to a stable droplet size [84], In other parameters such as 
viscosity, the concentration of emulsifier and molecular weight of the core phase can 
likewise influence the mean diameter of microcapsules. Viscosity of the stock solution was 
also critical to capsule formation [85, 86]. For instance, compared to the process of urea-
formaldehyde microcapsules containing dicyclopentadiene with a less viscous solution 
[80], microcapsules made by McIlroy [18] are several times larger at a rotation speed of 
1500 rpm yet nonetheless exhibit a similar size to previous capsules prepared at higher 
speeds; this is likely due to a shear thinning of the continuous phase. Furthermore, it was 
found that the mean particle size increased with increasing the content and molecular 
weight (eicosane > octadecane > hexadecane) of phase change materials at the same 
stirring rate. In addition, the mean particle size decreased with increasing the content of the 
emulsifier [64]. Generally, an emulsifier with lower interfacial tension produces smaller 
microcapsules [87]. Ni et al. [88] found that the diameter of microcapsules decreased as the 
emulsifying time was increased at the initial three minutes, beyond which no appreciable 
changes in the diameter were observed. The increase of content and Mw of core materials 
and the decrease of emulsifier concentration can increase the viscosity of the emulsion, thus 
these changes can lead to similar results. Generally, emulsification is the driven process for 
size and size distribution of microcapsules/microspheres. In that the two-phase fluid has to 
be homogenized, the stirrer must provide a sufficient pumping effect and shear stress to 
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obtain an adequate droplet breakup for the final optimal size.  Study on polyurethane 
microcapsules by Frere et al. [89] shows that diameter of microcapsules increases as 
temperature is increased, but mechanical resistance decreases with increase of diameter. It 
was observed that different types of surfactants and variation in pH and ionic strength of 
the continuous phase affected the diameter of the miniemulsion droplets and the resulting 
microcapsules [37]. 
As for microcapsules prepared with other instruments, the factors influencing the size 
varied with different instruments. Where microcapsules were prepared with PTFE 
membranes such as water-in-oil and oil-in-water emulsification devices, the PTFE 
membrane nominal pore size and permeation pressure of dispersed phase can affect the size 
and size distribution of produced microcapsules [16, 44]. With regard to microcapsules 
prepared with a commercial encapsulation device such as an Inotech Encapsulator, the 
agitation speed doesn’t affect the size of formed microcapsules; the nozzle diameter and 
pump speed of aqueous phase are key factors for the size distribution [17, 90]. This 
technique is based on a laminar jet breakup technique and is capable to produce mono-
dispersed microcapsules at large quantities. Multi-fluid passing through the nozzle was 
broken up by applying a vibration at high frequency. Microdroplets were formed before 
reaching contact with the stirred hardening solution. Therefore, the function of agitation is 
to disperse produced microcapsules. Similarly, Quevedo [35] found that the size of the 
capsule produced by the tubular microfluidic device gradually decreased with increased 
aqueous flow rate and, hence, with increasing Reynolds number. Alternatively, the disperse 
phase flow rate may be slowed in order to decrease the capsule size. Accordingly, the 
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factors that influence the mean diameters differ from different polycondensation systems. 
Mahabadi et al. [91] found that the net effect of two kinetic processes shows an optimal 
shearing time where the smallest particle size can be attained, and this optimal time is a 
function of several primary variables. The depletion of surfactant/stabilizer, especially 
when surfactant concentration was low, resulted in rapid growth of particle size, eventually 
suspension failure. 
Wall thickness 
Many requirements such as wall thickness are strongly dependent on the application of 
the capsules. For this reason, studies regarding to what extent, and by which means the 
thickness of the capsules wall can be controlled are of considerable interest. The wall 
thickness varies from a few nanometers to tens of microns, which is controllable by 
changing some parameters, such as the nature and composition of the two immiscible 
phases, the concentration of the reactants, physico-chemical properties of the encapsulating 
agent, the partition coefficient of each reactant between the two phases, chemical nature 
and concentration of the chain extending agent, type and concentration of the emulsifying 
agent, the swelling or solubility of the microcapsule wall, and the rate of reaction between 
the monomers, reaction time, emulsification time, and molecular weight (MW) of the 
prepolymer. The factors influencing the wall thickness vary for different 
microencapsulation systems. Study on polyamine microcapsules by Danicher et al. found 
that wall thickness strongly depends on the reaction conditions: monomers concentration, 
crosslinking agent fraction and reaction time [83]. Based on the transmission electron 
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microscope (TEM) micrograph Jabbari [53] found the thickness of the wall does not 
increase with  increased reaction time.  Similarly, Poncelet [92] reported that membrane 
formation was primarily affected by the concentration of crosslinking agents, whereas both 
poly(ethyleneimine) (PEI) concentration and  reaction time appeared to have little effect on 
the membrane weight. The membrane weight slightly increased with increased PEI 
concentration and reaction time. Nevertheless, small changes in some parameters can 
definitely change the wall thickness. For example, the wall thickness of diethylene triamine 
microcapsules can be controlled from 20-500 nm [10, 53, 93] to 10 µm [94]. Janssen [94] 
gave the following equation of  wall thickness of the capsules during encapsulation.  2 
 
Measurements of the wall thickness as a function of the reaction time √ݐ for smaller-
sized capsules (300-1000 µm) show very good agreement with this equation. Mainly the 
diffusion rate from microcapsules decreased with increased wall thickness, with the 
exception of the diethylene triamine microcapsules prepared by Janssen [94]. During the 
                                                 
2  dt: wall thickness; d1: thickness of top layer of the capsule wall; D2,DETA: diffusion 
coefficient of DETA through sub layer to the capsule wall; C0,DETA: concentration of DETA 
in aqueous phase; Mw: molecular weight of the average polymer unit; r: reaction ratio 
TDC/DETA; ρpol: density of the polymer; β: volume fraction of polymer in the sub-layber; 
t: time. 
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maturation of capsules wall, the pore size increased with increased wall thickness. Addition 
of diamine to aqueous phase reduces the permeability of the capsules wall and an increase 
of the ratio of the diamine and the triamine concentration also reduces the permeability 
[95]. Measurements of the rate of hydrolysis of encapsulated teraphtaloyl dichloride show 
that no hydrolysis will take place during wall formation, as hydrolysis only takes place in 
the aqueous phase [96]. 
Thermal properties and chemical structures of capsules’ shell 
Since shells of microcapsules produced from interfacial polycondensation were 
composed of new types of materials, which were formed by reactions of minimum two 
monomers or polymer, their compositions and thermal properties were unknown. Some 
properties of capsule shells were determined by the following methods. Thermal properties 
of shells used to be determined by differential scanning calorimetry (DSC) and thermal 
gravimetric analysis (TGA) [17]. Fusion temperature obtained by DSC measurement can 
give some chemical structure information, for example, suggesting the presence of defaults 
in the macromolecular back bone such as irregular bounds of urethane and urea functions 
[97]. TGA curves can provide differences between capsules-forming material and formed 
microcapsules in composition as well as the effect of capsules-forming material 
concentration on capsules composition. Chemical structures were measured by nuclear 
magnetic resonance (NMR), matrix assisted laser desorption ionization-time of flight mass 
spectrometry (MALDI-TOF), Fourier-transform infrared spectroscopy (FTIR) [77, 98, 99]  
and elemental analysis. The main component throughout the capsules’ degradation can be 
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determined via NMR [100]. MALDI-TOF experiments allowed for the investigation of the 
microstructure of polymer membranes, thereby proving the presence of some  functional 
groups in the membranes [97]. Quantitative elemental analysis and X-ray photoelectron 
spectroscopy (XPS) of capsules shells can provide the chemical composition and ratio 
information of capsule-forming materials that participated in the reaction [17, 36, 101].  
Permeability of shells   
The capsules’ wall (or shell) acts as a membrane. Membrane permeability is a crucial 
parameter for hollow microcapsules and matrix microspheres, since they can affect the 
reaction between the encapsulated active compound and outer substrate, or influence the 
release capability of the encapsulated compound. Microencapsulation has two major 
functions, controlled release and enclosing fragile ingredients with a semi-permeable and 
biocompatible membrane that would protect them from an attack, for example, the 
immunoprotection barrier. If membranes of microcapsules have a permeability that is too 
large, entrapped active ingredients would release rapidly from the microcapsule having the 
first function, on the other hand, the membranes of microcapsules having the second 
function can’t protect encapsulated ingredients.  
Permeability can be detected by fluorescent markers (confocal laser scanning 
microscope), pore size analyzers or microscopy (TEM, SEM). Pore size and the charge of 
the shells are the most relevant factors for the permeability. When the shells are net charge, 
pore size is the key factor. An Autosorb-1 automatic surface area and pore size analyzer 
can be used to determine the specific surface area and total volume of the microcapsules’ 
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pore. In the vacuum sorption system, ultrapure nitrogen gas and liquid nitrogen gas were 
used as the adsorbate and coolant. The specific surface area was determined with the 
intrusion and extrusion curves by the multipoint Brunauer-Emmett-Teller (BET) analysis 
[29, 102, 103]. The average pore diameter can be  determined by the Barrett-Joyner-
Halenda (BJH) method [104]. The BJH scheme may be summarized in the following 
formula:  
 
In this formula, vads(xk) is the volume of (liquid) adsorbate c [cm3/g] at relative pressure 
xk (calculated from the value of adsorption expressed in [cm3/g STP] by vads(x) = 
0.0015468 a(x) ), pore volume V is given in [cm3/g], S is the surface area [m2/g] and t is the 
thickness of the adsorbed layer (in appropriate units).3 
The straightforward method for pore size measurement is to cut the microcapsules and 
observe the cross section cuts by TEM or SEM according to the pore size [26, 105, 106]. 
The obtained photos are shown in Figure 3-2. The membrane cut-off also can be performed 
on the CLSM by using different Mw of fluorescent markers [17, 107, 108]. The pore size 
can be controlled by changing some experimental parameters, such as the ratio of 
                                                 
3 x: relative pressure, x=p/ps, ps is saturation pressure; a(x) : adsorbed amount (cc/g at 
STP), STP: standard temperature and pressure (0°C and 0.986 atm) 
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crosslinking monomer/prepolymers, molecular weight of prepolymers, reaction time, 
concentration of chain-extending agent, and maturation time. The charge property of the 
microcapsule’s membrane is another important factor in the permeability. The capsules will 
show charge-controlled permeability when the shells are charged. For example, PEI-SC 
microcapsules having different charge properties at various pHs showed various 
permeability. Shells are positively charged at pH 5. Typical laccase anionic mediators like 
ABTS2- were found to accumulate in the capsule wall and prevented an efficient electron 
transfer with the electrode. PPD is a monovalent cation around pH 5 and is able to 
permeate through the membrane [109]. However, at a higher pH, net charged shells 
allowed the diffusion of fluorescein isothiocyanate labelled poly(ethyleneimine) (PEI-
FITC) [17]. Similar results were found for the multilayer microcapsules [110]. The 
membranes of microcapsules have highly sensitive permeability tuned by probe charge and 
environmentally controlled gating. They can completely reject negatively-charged probes, 
yet attract positively-charged species to form a higher concentration in the capsule interior. 
Montasser et al. [34] found that the permeability of polymeric wall of polyamine/polyurea 
microcapsule is related to its crystallinity and contributes to the growth of nanocapsule 
membrane by the diffusion of the hydrophilic monomers to get stable colloidal 
suspensions. 
Morphology 
Surface morphology is an essential character of microcapsules, which can provide 
useful surface feature information such as thickness, porosity and smoothness for the final 
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application, and effect different reagents and parameters on the formation and dispersion of 
microcapsules. Surface morphology of shells used to be conducted on different 
microscopes, such as optical microscope [99, 102], AFM [109, 111, 112], SEM [30, 57, 
99], TEM [53, 98] and CLSM [102, 113]. Most membranes have a porous structure which 
is controllable by adjusting some parameters. Morphological properties of membranes are 
frequently sensitive to the nature of monomers and solvents [114]. Essawy [15] found that 
an indispensable aspect controlling the whole process at almost any stage and condition is 
the composition of the phases and the distribution as well as the state of all ingredients (not 
merely the reactants) between the phases. Figure 3-3 is a typical image of a membrane 
obtained from SEM [15]. Morphology of the capsules membrane in dependence on the 
amount of shell components while keeping the molar ratio between the TPC and the amine 
components (1,6-hexamethylenediamine + diethylenetriamine)) unchanged (1:2). The 
internal structure of the microcapsules was investigated with TEM by Jabbari [53]. The 
TEM micrograph in Figure 3-4 shows the cross-section of microcapsules at 14 000 
magnification. According to this image, the microcapsules have a micro-reservoir structure 
in which the wall extends well into the core and the active agent is accommodated by the 
micro-reservoirs, distributed uniformly throughout the entire volume of a microcapsule. 
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Figure 3-  (a) and (b) SEM cross-section micrographs and IFME® numerical results of 
(b). (c) 3D reconstruction of the 90 μm thickness central part of the capsule from Confocal 
results (without cutting the sample). Reprinted from publication [106], with permission 
from Elsevier. 
3.4 Applications 
Microcapsules prepared by interfacial polycondensation provide permanent and cross-
linked membranes, such as polyamine, polyurea, polyester, polysiloxane, polyurethane and 
polyepoxide, allowing the entrapment of different active ingredients. This has been used in 
various fields including the paper industry, agriculture, pharmacology, dye, (solar, heat, 
nuclear) energy storage/transfer, thermal regulation/insulation, and information and 
magnetic recording. These are listed in Table 3-1. 
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Figure 3- Morphology of the capsules membrane in dependence on the amount of shell 
components while keeping the molar ratio between the acid dichloride (TPC) and the amine 
components (HMDA+DETA) unchanged (1:2); the amount of shell components varies in 
the order of TPC/amine 0.5/1 (a), 1/2 (b), 2/4(c), 3/6 (d); the bar corresponds to 200 nm (a, 
b, d) and 100 nm (c). Reprinted from publication [15], with permission from the authors. 
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Figure 3- TEM micrograph of the cross-section of microcapsules at ×14 000 
magnification. The shadows around the boundaries of the microcapsules are due to folding 
of the wall at the edges. Thickness of the polymeric film surrounding the microcapsules 
and the polymeric films forming the internal structure of the microcapsules are in the order 
of 25±50 nm, respectively. Reproduced with permission of Informa Healthcare [53]. 
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3.4.1 Microencapsulation of phase change material (PCM) 
Microencapsulated PCM work, as unique thermal energy storage units, have been 
studied by many researchers and developed by companies, such as BASF Corporation for 
building applications and Microtek Laboratories, Inc. for increased energy efficiency and 
thermal regulation.  
Since the 1980s, microencapsulated PCM technique has been widely developed. This 
can enlarge the utility fields of the PCMs, since microencapsulation may protect PCMs 
from reactions to the outside environment. In addition, it can supply the larger heat transfer 
area and controllable changes in storage material volume as the phase change occurs, mask 
highly toxic PCM, make it is easier to handle in practical applications, and allow portable 
energy storage systems. PCMs have the ability to change their state at a certain temperature 
range, and can store and release large amounts of energy during the phase changing process 
[115-117]. Therefore, the benefit of microencapsulated PCMs extend their application use 
in various areas including thermal-regulated fibres, fabrics, coatings and foams [64, 69, 
118-121], thermal insulation [118], heat/thermal energy storage, heat transfer and thermal 
regulation [61-63, 66, 68, 70, 71, 122], solar energy utilization [69, 117, 120] , and building 
materials [120, 121, 123]. For instance, n-octadecane is a well-known PCM providing an 
unacceptable low thermal conductivity despite its desirable properties. This is considered a 
major drawback, thus reducing the rates of thermal storage and release during the heating 
and cooling processes.  The encapsulation of n-octadecane can enhance the heat transfer, 
for this reason it has been extended to the application of outdoor apparel, such as ski wear, 
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hunting clothing, and smart garments with temperature-regulating microclimates [70, 124]. 
Nevertheless, this application should be carefully considered due to its high cost. 
Alternatively, some commercial PCMs, like paraffin waxes for solar heating systems are 
practical and ideal for many applications since these materials are produced in large 
quantities and widely used everywhere.  In addition, phase change temperatures between 
-10 and 80°C are possible to manufacture with microcapsules. 
The continuous increase in the level of greenhouse gas emissions and the rise in fuel 
prices are the main driving forces behind efforts to effectively utilise various sources of 
renewable energy like solar energy. Solar green house is attracting more and more attention 
[117, 120], which can be classified into two categories: The first is to store and utilise solar 
energy for different purposes, for example solar cookers, which was thought to have a great 
potential in hot climate countries. The second is to reflect solar heat that can avoid 
absorption of solar energy resulting in elevated temperature at the shingle’s surroundings, 
thereby contributing to the so-called heat-island effects and increasing the cooling load to 
its surroundings or energy consumption needs for air conditioning [120]. 
3.4.2 Agriculture 
One of the most important applications of microencapsulated ingredients is in the area 
of agriculture, such as microencapsulation of fertilizer [125, 126], herbicides [53, 54, 127], 
pesticides and insecticides [40, 51, 52, 59, 128, 129], insect pheromones and other sex 
attractants [10, 130, 131] and several other agrochemicals [43, 47, 130, 132]. 
Microencapsulation could increase the fertilizer, herbicide and pesticide efficiency at 
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reduced doses due to a controlled release, allowing farmers to apply pesticides and 
herbicides less often and at low initial concentration and toxicity. The membranes formed 
by interfacial polycondensation are stable, permitting a more controlled release, thereupon 
providing the advantage of longer protection to the treated area than microencapsulated 
fertilizer in polysaccharide shells which can be de-cross-linked in some buffer solution 
[133]. 
This is the typical case of drift from the host due to rain or wind when applying 
insecticides, fertilizer, fungicides and herbicides.  Not to mention, volatility is another issue 
for fertilizer, nonetheless suitable microencapsulation could efficiently solve all these 
problems.  
Polyurea microcapsules [47] were used as carriers for the nitrification inhibitor such as 
(trichloromethyl)pyridines, which has a great long term stability in the field environment, 
while maintaining the level of efficacy of non encapsulated inhibitors. This type of 
microcapsule avoids the disadvantage of fast release described in U.S. Patent 4,746,513 
[134], which releases all the nitrapyrin upon contact with moisture, exhibiting the same 
stability and volatility as the free form. Polycondensation encapsulation has been used to 
encapsulate agriculturally-active ingredients, particularly to enhance handling safety and 
storage stability of the active ingredient  through the use of polyurethane rather than 
polyurea microcapsules [135, 136]. The agriculturally-active material by itself is usually 
insoluble in water, or has an unacceptably low solubility in water, and then it’s difficult to 
be applied by spraying. Therefore, Misselbrook [137] treated herbicides, such as, trifluralin 
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by microencapsulation to enhance their combinability with water. This process can be used 
for reducing nitrosamine impurities while microencapsulating agriculturally-active 
materials containing nitrosamines. Insect pheromones as insecticides are attracting more 
attention compared to conventional hard pesticides [40, 52]. Sex pheromones could reduce 
insect populations by disrupting their mating process, and microencapsulation of 
pheromones could control their release and protect them from oxidation.  
3.4.3 Pharmaceutics 
Therapeutic is one of the most important applications for microencapsulation by 
interfacial polycondensation. These potential applications include drug carriers for 
controlled release [38, 39, 46], enzyme artificial cells for clinical trial in hereditary enzyme 
deficiency diseases and other diseases [31, 138], artificial red blood cells for use in urgent 
blood loss [33], medicine release, information recording and reflective index adjustable 
instruments due to the obvious advantages of the photo-crosslinking process. High selective 
regulation can be conveniently achieved by selecting exposure wavelength and photo-
reactive core compounds [48]. Since polymeric nanocapsules from poly(α,β-malic acid)-
grafted nano-silica templates are biocompatible, biodegradable and non-toxic to cells and 
tissues, these nanocapsules conform to green chemistry and are expected to be applied as 
drug carriers [139]. 
As early as 1965, Chang successfully encapsulated cells or tissue fragments, and the 
enclosed materials may be protected from destruction and participation in immunological 
processes [140]. The recent progress in artificial cells has been discussed in his reviews 
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[138, 141]. The earliest routine clinical use of artificial cells is in the form of coated 
activated charcoal for hemoperfusion for use in the removal of drugs, toxins and waste in 
uraemia and liver failure. Encapsulated cells are being studied for the treatment of diabetes 
by encapsulation of transplanted islet cells, liver failure, and kidney failure. In addition, the 
use of encapsulated genetically engineered cells is being investigated for gene therapy 
[138]. Recent advances of polymeric artificial cells in biotechnology, molecular biology, 
nanotechnology and polymer chemistry are now unfolding further exciting possibilities in 
this field [141].  
3.4.4 Cosmetics 
Interfacial polycondensation is one of the classical methods for essential oil 
encapsulation [13, 14, 27]. Lipsticks [58] and fragrance [142, 143] microencapsulation 
have been used extensively. US patent 20070065379 showed many different applications in 
cosmetics. The composition according to the invention can be a composition for caring, 
making up the face/body or hair composition such as shampoo, conditioner, styling 
composition or hair dye [144]. Since essential oils are oil soluble, microencapsulation 
processes are commonly based on the principle of oil-in-water emulsion formulation. 
Microencapsulation could protect essential oils against degradation caused by 
environmental factors. Furthermore it can improve their solubility, end efficiency, mask or 
enhance their taste, turn them into stable compounds and control release [13]. Biatry [145] 
patented thermally stabilizing microcapsules to protect cosmetic or pharmaceutical 
composition against the effects of thermal variation. 
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3.4.5 Self-healing 
One of the most promising applications of microencapsulation is self-healing. Self-
healing composites [146] possess great potential for solving some of the most limiting 
problems of polymeric structural materials: microcracking and hidden damage. Figure 3-5 
illustrates the autonomic healing concept. Healing is accomplished by incorporating a 
microencapsulated healing agent and a catalytic chemical trigger within an epoxy matrix. 
Similarly, amine core microcapsules [18] were prepared by interfacial polymerization of an 
isocyanate and an amine stabilized by an inverse Pickering emulsion, which were isolated, 
dried, and redispersed in epoxy. Preparation of amine-containing microcapsules enables the 
creation of self-healing epoxies where the microencapsulated healing agents contain the 
same chemistry as the bulk matrix. Capsules released the core material upon rupture and 
were able to cure epoxy to form a polymer film. Although the potential benefits are quite 
high, the specific composite described here has some practical limitations on crack-healing 
kinetics and the stability of the catalyst to environmental conditions [146]. 
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Figure 3- The autonomic healing concept. A microencapsulated healing agent is 
embedded in a structural composite matrix containing a catalyst capable of polymerizing 
the healing agent. a. Cracks form in the matrix wherever damage occurs; b. the crack 
ruptures the microcapsules, releasing the healing agent into the crack plane through 
capillary action; c. the healing agent contacts the catalyst, triggering the polymerization that 
bonds the crack faces closed. Reprinted by permission from Macmillan Publishers Ltd: 
[146]. 
3.4.6 Others 
Microcapsules find broad application in the case of carbonless copy paper. Sheets of 
carbonless paper are coated with microencapsulated dye or ink and/or reactive substances. 
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Microcapsules, upon pressure-induced rupture, spill a dye (in colourless form in the 
capsules) and a colour developer that when mixed react to generate a colour. The rupture 
can occur under writing pressure or during printing using dot-matrix or impact printers. 
Many companies such as NCR Corporation, Appleton and Xerox supply this kind of paper. 
Numerous patents are available for carbonless copy paper, also known as pressure-sensitive 
recording papers [147-156]. 
  Metallic particles have been widely studied as they present an interest both for 
fundamental physics and potential applications such as catalysis and magnetic recording 
[32], which can be prepared by using complexing microcapsules obtained by interfacial 
polycondensation.  Laguecir et al. [26, 29, 157] studied the application in the extraction of 
metal ions. Given that polymeric microcapsules are porous, the wall is capable of 
physically absorbing some particles. On the other hand, the metal ions extraction is due to 
the complexion with polymers,  such as PEI,  both in the membrane and in the core [7]. As 
illustrated in Figure 3-1, this type of PEI-SC microcapsules contains non crosslinked PEI, 
being that the PEI molecules are too large to release from the shells. Therefore, PEI exists 
in both membranes and the core of microcapsules. 
Many of interesting applications were disclosed by patents. US patent 20090029140 
describes the process for treating substrate, preferably flexible substrate such as leather, 
leather imitations or polymeric films and textile substrate [158]. Cationic polymer and 
encapsulated materials may be used, for example, in a fabric softener composition [159].  
Poly(vinyl alcohol) microcapsules and phenolic resin were used as wall materials to 
  
66
 
encapsulate biocide comprising an isothiazolone biocide or antifouling agent, which is 
useful in marine antifouling coatings and paints [160].  
3.5 Microencapsulation for paper modification in our group 
Bioactive papers are obtained from the modification of the bulk or the surface of paper 
substrates with biomolecules with the goal of adding functionality to the paper. These 
functionalities may include detection, capture or inactivation of specific targets, such as 
harmful molecules or pathogens. These features of bioactive paper are designed to operate 
without using any sophisticated equipment or apparatus, making the device portable and 
adaptable to various uses and situations.  The concept of bioactive paper thus far has been 
mainly oriented to fulfil specific needs in health, safety and food packaging applications. In 
our group, bioactive papers have been fabricated by the immobilization of different 
microencapsulated enzymes either through coating them onto the paper or by incorporation 
into the paper pulp. The physical processes of obtaining microencapsulation are the 
emulsion and encapsulator method for the same chemical process, namely as interfacial 
polycondensation. PEI microcapsules were prepared by interfacial polycondensation due to 
the benefits of this method, as mentioned in the introduction [17, 109, 113, 161-163].  
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Figure 3- Zeta potential of empty (squares) and laccase (triangles) microcapsules at 
different pHs of the buffer solution. 
Figure 3-6 illustrates the zeta potential of empty and laccase microcapsules prepared by 
the emulsion method at different pHs of the buffer solution. Our results showed that the 
absolute value of zeta potential decreased due to the encapsulation of enzymes, revealing 
that membranes of enzyme microcapsules have different properties with empty 
microcapsules. The dispersion of enzyme microcapsules is poorer than empty microcapsule 
due to the low zeta potential indicated in Figure 3-6, yet their isoelectric point is practically 
overlapping. Zeta potential is a function of the surface charge of the particle. If all the 
microcapsules in suspension have a large negative or positive zeta potential they tend to 
repel each other, hence there is no tendency to flocculate. However, if the microcapsules 
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have low zeta potential values, then there is no force to prevent the particles agglomerating 
and flocculating. As shown in Figure 3-6, the zeta potential can be improved by changing 
the pH of dispersant medium. Thereafter, the dispersion of microcapsules can be adjusted 
according to the preference of the core phase. For example, the optimal pH of 
microencapsulated laccase is 4.5, thus a suitable acidity solution, such as citric acid, can be 
used to wash and disperse produced microcapsules.  
Bioactive papers prepared by the immobilisation of PEI microcapsules presented a 
higher retention of the enzyme on the paper sheets due to the size of the capsules and 
favourable electrostatic interactions between paper and microcapsules [113]. The 
enzymatic activity was also maintained for a longer period of time in the paper compared to 
free laccase, due to the protection from bacteria and proteases offered by the semi-
permeable membrane [164]. The scalable synthesis of microcapsules offered by interfacial 
polycondensation is one of the great benefits of the technique which allows the 
modification of large areas of paper substrates which can be achieved either by coating or 
printing [162, 164]. 
3.6 Conclusion 
Microencapsulation by interfacial polycondensation as a conventional method has been 
extensively studied, and the goal of this paper was to review some of the numerous 
applications of this technique. This approach offers a broad variety of opportunities such as 
protection and masking of fragile active ingredients, facilitation of handling and controlled 
release. The present article provided a literature review of different characterization 
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methods and potential application fields of microcapsules prepared by interfacial 
polycondensation method; it also provided core materials and physical properties of shells. 
Current research is focusing on the development of novel shell and core materials, and 
overcoming its obstacles, which may lead to many new applications. Microencapsulation of 
self-healing materials and PCMs are likewise receiving much attention.  
List of acronyms 
Acronym Full name  Acronym Full name 
ABTS 2,2’-azinobis(3-ethylbenzthiazoline-
6-sulfonate) 
PAPI Polyamine-polyisocyanates 
AC Acid chloride PCM Phase change material 
AFM Atomic force microscopy PEI Polyethyleneimine 
CDEMA 2-chloro-N-(2,6-diethylphenyl)-N-
(methoxy methyl)acetamide 
POPA polyoxyalkylene polyamine 
CLSM Confocal laser scanning microscopy PPD p- phenylenediamine 
DBDPO Decabromodiphenyl ether PTC Phtaloylchloride 
DBS Dibutyl sebacate PTFE Polytetrafluoroethylene 
DEG Diethylene glycol PU Polyurethane 
DETA Diethylene triamine SC Sebacoyl chloride 
DHEA Dehydroepiandrosterone SEM Scanning electron microscopy 
EDA Ethylenediamine SMA Styrene–maleic anhydride 
EGDE Ethyleneglycol diglycidylether TC Trimesoyl chloride 
FITC Fluorescein isothiocyanate TCMP (Trichloromethyl)pyridine 
HAD 1,6-Hexamethylenediamine TDC Terephthaloyl dichloride 
HMDA 1,6-hexamethylenediamine TDI Toluene-2,4-diisocyanate 
HMDI Hexamethylene-1,6-Diisocyanate TDITC Terephthaloyl diisothiocyanate 
HPVA Hydrolyzed polyvinyl alcohol TEM Transmission electron 
microscopy 
HSA Human serum albumin TEOHS Tetradecaethoxyhexasiloxane 
IPDI Isophorone diisocyanate TPC Terephthaloyl chloride 
MCR Monocrotophos TMP Trimethylolpropane 
MDI Diphenylmethane-4,4’-diisocyanate UF Urea-formaldehyde 
OES Oligoethoxysiloxane UG Urea-gluteraldehyde 
OPD o-phenylenediamine   
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 Chapter 4 Comparison of emulsion and vibration nozzle 
methods for microencapsulation of laccase and glucose 
oxidase by interfacial reticulation of poly(ethyleneimine)4 
 
4.1 Abstract  
Microcapsules for enzyme immobilization were successfully fabricated via interfacial 
cross-linking of poly(ethyleneimine) (PEI). A method based on laminar jet break-up 
technique using a commercial instrument developed to produce alginate beads is reported 
for the first time for production of PEI microcapsules. The diameter, wall thickness and 
pore size of membranes were obtained from confocal laser scanning microscopy (CLSM) 
by labelling PEI and proteins. The composition of membranes was analyzed by elemental 
analysis. Larger microcapsules (ca. 200 µm diameter) were obtained with the encapsulation 
device. In comparison, the emulsion method produced smaller capsules (ca. 20 µm 
diameter) but with a wider size distribution. Encapsulation efficiency for both methods was 
analyzed by bincinchoninic acid (BCA™) and fluorescence assays, yielding efficiencies of 
94±2% and 83±3% for the emulsion method and encapsulation device, respectively. 
                                                 
4 This chapter was published as a paper in Journal of Microencapsulation. 
Yufen Zhang, Dominic Rochefort, Comparison of emulsion and vibration nozzle 
methods for microencapsulation of laccase and glucose oxidase by interfacial reticulation 
of poly(ethyleneimine), Journal of Microencapsulation, 27(8), 2010, P703-713. 
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Glucose oxidase from Aspergillus Niger (GOx) and Laccase from Trametes Versicolor 
(TvL) were encapsulated by both microencapsulation methods and their activities were 
compared.  
4.2 Introduction  
  Enzyme immobilization continues to hold significant promises for a broad range of 
applications. Biosensor is one of the most active research areas in technique development 
for enzyme immobilization since major improvements in the actual techniques on 
biosensors will lead to their greater application in the future.[1-3] Recent developments in 
biosensors also show the need in applying enzyme immobilization techniques on 
unconventional supports like plastics and papers. The impetus for such orientation is the 
application of biosensors to a larger public and to regions with difficult or inexistent access 
to advanced measurement technologies. As a result, we and others have carried out 
research on bioactive papers and paper-based biosensors.[4-8] Paper is already widely 
distributed and found uses in numerous hygiene, personal and packaging products, offering 
an unequalled potential to broaden the application of biosensors. Modifying papers with 
enzymes have applications in monitoring of glucose or protein levels in urine[6], assessing 
water quality and packaging to improve preservation[9, 10]. These appealing applications 
require novel enzyme immobilization techniques that will address the problem of enzyme 
stability while being compatible with current paper making processes for large-scale 
production. 
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We have oriented our effort towards developing an enzyme immobilization based on 
microencapsulation which consists of entrapment of biomolecules in the core of hollow 
spheres made by a semi-permeable membrane, thus providing a chemically and 
mechanically robust system. Once prepared, the capsules can be easily incorporated into or 
onto paper sheets by simple mixing with pulp or by deposition on the surface of the 
sheet.[4] Microcapsules can also be coated or printed on paper to make it compatible with 
current high-end papermaking technologies. In this paper PEI is studied as a wall material 
to produce microcapsules containing hydrophilic cores. PEI is a cationic polymer 
commercially available in a broad range of molecular weights (200–800,000 Da) with 
different degrees of branching.[11, 12] The good biocompatibility of PEI already makes it 
appealing for many applications in biotechnology. It is one of the most frequently used 
polycations for the condensation of DNA[11-13] and for entrapment of biocatalysts and 
drugs due to its compatibility with most enzymes, cells and natural compounds.[14] PEI 
microcapsules can be prepared efficiently from the fast interfacial condensation of the 
polymer with a diacid chloride. During the cross-linking reaction, the primary and 
secondary amines on the highly-branched PEI react with the acid group at each end of the 
sebacoyl (decanedioyl) chloride through nucleophilic substitution reaction to covalently 
linking the chains together. The first and the crucial step in PEI microcapsules preparation 
is the formation of stable microdroplets of the aqueous phase containing the polymer. This 
is normally achieved by emulsifying a PEI solution (aqueous phase) in an organic solvent 
prior to the addition of the cross-linking agent. The broad range of microdroplet diameters 
obtained from such emulsion methods results in microcapsules with a large size 
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distribution. In order to achieve a better control on the microcapsule formation and to 
reduce their size distribution, we have adapted a commercial encapsulation device used for 
cell encapsulation in alginate beads for the formation of PEI microcapsules by interfacial 
reticulation.[15, 16]  
The present article will focus on the comparison of both microencapsulation methods 
and the characterization of microcapsules. The factors that can impact size, membrane 
thickness and composition of microcapsules will be described. PEIs of three different 
molecular weights were used to prepare microcapsules by these two approaches to study 
the differences in properties of the capsules with respect to permeation across the 
membrane.  
4.3 Materials and methods 
4.3.1. Materials 
Sebacoyl chloride (SC), cyclohexane, Span 85, Sulforhodamine 101 acid chloride 
(Texas red) and fluorescein isothiocyanate (FITC), bovine serum albumin (BSA), TvL (EC 
1.10.3.2), GOx (E.C. 1.1.3.4) and QuantiPro BCA (bicinchoninic acid) assay kit were 
purchased from Sigma-Aldrich. Salts used for buffer preparation were purchased from 
A&C American Chemicals Ltd and MilliQ water (18 MΩ·cm) was used in the preparation 
of all solutions. All three PEI aqueous solutions (50 wt. %) with the average molecular 
weights (MW) of 1 300, 2 000 and 750 000 Da were purchased from Sigma Aldrich and 
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used as received. For convenience, these different PEI will be referred to as PEI1300, 
PEI2000 and PEI750k, respectively. 
4.3.2. Preparation methods of PEI microcapsules    
Two methods were used to prepare microcapsules via interfacial polycondensation of 
PEI. In the mechanical emulsion method, a microemulsion of 10ml McIlvaine buffer 
(aqueous phase, pH 8.0) containing PEI (4.8 % v/v) and 1% v/v of Span 85 was achieved in 
50ml cyclohexane (continuous phase) for 15min with a 4cm of 4 blade axial impeller 
stirrer. SC was then added to the emulsion to crosslink PEI at the interface of hydrophilic 
microdroplets, which was conducted in a 250ml beaker. This is a updated method based on 
the first description of PEI-SC microcapsules reported by Poncelet et al.[17] Enzyme and 
BSA encapsulation was obtained by dissolving the proteins in the aqueous phase prior to its 
emulsification in the organic phase. 
The second technique (which will be herein referred to by the name encapsulator) is 
based on the laminar jet break-up technique and is performed with a commercial 
encapsulation device (Inotech IE-50R Encapsulator). A detailed description of the 
instrument and its use for the production of alginate beads can be found in references [15, 
16]. A typical batch of capsules was prepared with this technique by pumping a solution 
(10 ml) of McIlvaine buffer (pH 8.0) with 5% v/v of PEI through the nozzle while applying 
a vibration at high frequency. The aqueous microdroplets formed at the nozzle were then 
collected in a stirred reaction vessel containing 50 ml of cyclohexane with 1% v/v Span85 
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as an emulsifier and 0.8% SC as the cross-linker. The capsules obtained were incubated for 
5 minutes in the organic phase to mature the membrane before stopping the reaction by 
dilution with 50 ml of cyclohexane. The suspension was allowed to settle for 1 minute and 
the supernatant was discarded. Microcapsules were rinsed twice with 100 ml cyclohexane 
to remove unreacted organics and surfactants, transferred in filter funnel and thoroughly 
rinsed again with MilliQ water. Figure 4-1 presents a scheme describing microcapsule 
formation by both methods. 
 
Figure 4- Schematic diagrams of microcapsule formation with the encapsulation device 
(A) and by the emulsion method (B). 
4.3.3. Characterization of microcapsules 
A direct, microscopic approach was used to determine the wall thickness of 
microcapsules. PEI samples with different MW were first labelled with the fluorescent tag 
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FITC and then dialysed using a filtration membrane (2 kDa MW cut-off) to remove any 
unreacted fluorophores. Labelled PEI samples were then used to prepare microcapsules as 
detailed above and the resulting fluorescent microcapsules were studied by Confocal Laser 
Scanning Microscopy using a Leica TCP SP5. The diameter of isolated microcapsules and 
their wall thickness were measured from the micrographs and histograms recorded at the 
centre of the capsules. As this technique only provides diameter for isolated microcapsules, 
a particle size analyzer (Horiba Partica LA-950) based on laser diffraction is also used to 
evaluate the average particle size and size distribution of thousands of microcapsules.  
 The determination of the ratio between PEI and crosslinker SC in the microcapsules 
membranes was achieved by elemental analysis [18] and thermogravimetric analysis 
(TGA). EA was carried out in an elemental analysis instrument from Fisons Instruments 
SPA, Model EA1108. TGA measurements were made on a thermogravimetric analyzer, 
Universal V3.5B from TA Instruments, using a scanning rate of 10°C/min and curves were 
recorded within a temperature range of 25-600°C. All analyses were performed under a 
nitrogen-gas atmosphere in platinum crucibles. The freshly-prepared microcapsule samples 
were first dried at room temperature and then left at 60°C for 8 h in a vacuum oven. 
Alternatively, for the samples made from PEI1300 and PEI2000, water was removed by 
lyophilisation. The samples were fast frozen in acetone-dry ice bath prior to be dried with 
VirTis frezemobile 25EL sentry 2.0 lyophilizer, and the condenser was set to -86°C. In 
elemental analysis, carbon and nitrogen contents in the reagents and the membranes were 
obtained, and then the ratios between nitrogen and carbon elements in the reagents and the 
  
100
 
membranes were used to calculate the final results which were further confirmed by TGA 
analysis. 
 The porosity of PEI microcapsules was determined under wet conditions with the 
capsules suspended in a buffer solution. The molecular weight cut-offs of PEI membranes 
were estimated by their ability to diffuse across the capsule wall, which was determined by 
confocal microscopy. To do so, PEI (1 300 or 2 000 Da) and Laccase (66 000 Da) were 
used as MW beacons and labelled with FITC in 0.1 M carbonate buffer (pH 9) at 4°C in the 
dark for 6 h. The FITC-PEI solutions were then dialysed with regenerated cellulose 
membranes (Spectrum Laboratories, cut-off 1kDa) against 250 ml of MilliQ water for 7 
days (water was changed twice a day) in the dark at 4°C to remove any uncoupled FITC. 
Laccase was also tagged with FITC in water at 4°C in the dark for 4h, but in this case, 
unbound FITC was removed by gel chromatography.[19] In order to distinguish the above 
MW beacons from the microcapsules, their membranes were labelled with a different 
fluorescent tag. The microcapsules were reacted with Texas-red (sulforhodamine 101 acid 
chloride) in pH 9 Tris-Cl buffer at 2°C in the dark for 4 h and with a labelling ratio of 2% 
wdye/wcapsules.[19] Unbound or hydrolyzed Texas-red was removed by plenty of rinsing 
water, until the dye became undetectable in the water. The Texas-red tagged microcapsules 
were then suspended in a solution of each MW beacons and left at 4°C for 16 h to allow 
equilibration between the inner (core) aqueous phase of the microcapsules and the 
surrounding solution. Samples were then removed from the MW beacon solutions and 
confocal microscopy was used to examine the capsules. 
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Entrapment efficiency of both encapsulation techniques was measured with the BSA 
protein since it has a MW similar to that of TvL. During BSA encapsulation, solution from 
both the reaction vessel and rinsing solutions were collected for protein content assay using 
QuantiPro BCA assay. Prior to this, free PEI in the core which interferes with the 
measurement was removed by a 30 kDa MW cut-off membrane. The use of high molecular 
weight (750 kDa) PEI made it difficult to separate the unencapsulated proteins from a 
solution containing the large polymer. Therefore, a different assay was used for the 
efficiency of the encapsulator method, in which BSA was conjugated with FITC prior to its 
encapsulation and the solutions were measured by fluorescent signal using a 
spectrofluorometer (Infinite 200).  
4.4 Results and Discussion 
4.4.1 Microencapsulation with an encapsulation device    
Microcapsules of high quality can be produced by interfacial condensation of HMW 
PEI using the encapsulation instrument described in section 4.2.2. This encapsulator is 
commercialized for the scalable production of alginate beads for living cells 
immobilization. [15] Here we applied this instrument to generate microdroplets from an 
aqueous solution of PEI instead of alginate to prepare hollow microcapsules. To do so, the 
calcium hardening solution was replaced by a cyclohexane phase containing a cross-linking 
agent to achieve interfacial polycondensation with PEI. In comparison with the emulsion 
method (Section 4.2.2.), the encapsulation device offers more flexibility on the size of the 
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microdroplets by adjusting the nozzle and its parameters. Since these instrumental 
parameters are dependent on the viscosity and surface tension of the shell forming phase 
(here aqueous PEI solution), the same polymer and concentration are used in a sequence of 
experiments to determine the effect of these instrumental parameters. Bead formation is 
achieved by breaking up the laminar jet created at the nozzle of the instrument with a 
mechanical vibration applied to the fluid.[16] In general, the nozzle diameter has the 
strongest influence on the microcapsule size given that the beads formed with this 
technique have a diameter approximately twice of the nozzle diameter. When the 
instrument was equipped with a 100 µm nozzle, flow rate of aqueous phase was found to be 
the most important parameter affecting the size of microcapsules. The diameter of 
microdroplets is affected to a negligible extent by the frequency of the vibration. Amplitude 
of the vibration waveform and magnitude of the electrostatic charge did not affect the mean 
diameter of produced microcapsules. Only a narrow range of parameters allow formation of 
spherical and stable microcapsules but, generally, mean diameter of microcapsules will be 
affected by about ±20% by varying pump speed. Figure 4-2 A for instance presents the 
impact of flow rate on the mean diameter of capsules. The size of the microcapsules 
decreased as the flow speed increased. Flow rates above 4.4 ml.min-1 produced many 
particles in addition to the microcapsules and those were mostly of irregular, non-spherical 
shape. This can be explained by the pressure that builds up in the nozzle and disrupts the 
continuous flow of PEI solution. Low MW PEI (1 300 and 2 000 Da) solutions present a 
lower viscosity, therefore allowing higher flow rates (up to 5.6 ml.min-1) to pass through, 
resulted in microcapsules with smaller mean diameters (108 µm as seen in Figure 4-2 B). A 
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smaller viscosity increases the optimal frequency of the vibration waveform required to 
break the laminar flow in monodispersed microdroplets, which in turn reduces the diameter 
of the droplets. However, microcapsules made from LMW PEI had spherical shapes before 
washing, but were destroyed partially after washing. The concentration of cross-linker SC 
in the cyclohexane phase affects the microcapsule formation by achieving a higher degree 
of reticulation which results in thicker membranes. This effect of cross-linker concentration 
on the capsule formation by the encapsulation device is similar to what have already been 
observed with an emulsion-based method.[17] To evaluate this effect in our system, we 
varied the cross-linker concentration from 0.2 to 1.6 v/v %. While a low concentration 
yielded fragile capsules due to their thinner membrane, a high concentration increased the 
agglomeration of the microcapsules. The surfactant stabilizes the aqueous microdroplets in 
the cyclohexane, therefore preventing their agglomeration during the cross-linking reaction 
and membrane formation. We have determined that the concentration range of 1 to 2 v/v % 
is the most suitable for microcapsule formation with the encapsulation device.  
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Figure 4- Effect of the flow rate at the nozzle of the encapsulation device on the 
microcapsules mean diameter (A) and optical micrograph of irregular microcapsules 
obtained at high flow rates (B). 
Other parameters can be adjusted on the encapsulation device to improve microdroplet 
formation and dispersion but were found to have only very limited effect on the size of the 
microcapsules. The frequency and amplitude of the vibration waveform must be adjusted to 
provide uniform chains of well-dispersed microdroplets. In addition, a ring-shaped 
electrode (see Figure 4-1) allows electrostatic charging the microdroplets and the voltage 
applied on this electrode can be adjusted to improve dispersion. All these parameters were 
varied independently and the values selected to produce microcapsules with the lowest size 
distribution, less agglomeration and highest stability are listed in Table 4-1. The coefficient 
variation (CV) of produced microcapsules can go down to 18% under optimal parameters. 
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Table 4- Optimal reagent ratios and instrumental parameters for preparation of PEI 
microcapsules with the encapsulation device. 
PEI 
concentration 
S.C. 
concentration 
Emulsifier 
concentration
Voltage 
/kv 
Frequency 
/Hz 
Flow rate/ 
ml.min-1 
5% (v/v) 0.4%-1.0% (v/v) 1% (v/v) 0.9-1.8 800-3000 2.6-3.4 
 
4.4.2 Characterisation of microcapsules 
4.4.2.1. Size and size distribution 
Microscopy was used to compare the size, size distribution and aspect of microcapsules 
prepared by the two methods. Figure 4-3 shows microcapsules made by the emulsion 
method (A and B) and by the encapsulator (C and D). As optical microscopy provided only 
limited information on the small capsules obtained by emulsion due to their size, images A 
and B were obtained from fluorescence micrographs (CLSM). As expected, the emulsion 
method yielded small capsules (5 to 50 μm diameter) with a very broad size distribution. 
The mean diameter of microcapsules could be varied from 15 to 40µm by adjusting the 
impeller rotation speed from 775 to 2130 rpm. Figure 4-3A shows most of the smaller 
microcapsules tend to aggregate more than the larger ones due to surface tension effects. 
PEI with a low molecular weight (1 300 Da) is preferably used to produce microcapsules 
with the emulsion method (Figure 4-3A and B) since those obtained with high molecular 
weight PEI (750 kDa) using the same method are strongly aggregated and showed an 
irregular shape. Low molecular weight PEI is insoluble in cyclohexane [20] but the longer 
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chains of high molecular weight PEI, on the other hand, might protrude from the interface 
to some extent or reach a neighbouring microdroplet. Using HMW PEI can however be 
advantageous for the preparation of larger capsules by allowing the formation of thicker 
and stronger membrane walls. Figure 4-3C and D present images obtained by optical 
microscopy that are representative of the microcapsules prepared by the encapsulator 
method described in the experimental section. The microcapsules seen in Figure 4-3 were 
prepared from high (C) and low (D) MW PEI. One can first notice that the capsules are 
much larger than those presented in A and B, with an average diameter of 210 μm and with 
a smaller size distribution. Adjusting the parameters described in Section 4.3.1 provided 
capsules with mean diameters ranging from 180 to 260 μm. Using this method, high MW 
PEI produced well-dispersed capsules that maintained a spherical shape. On the contrary, 
when LMW PEI is used, the capsules appeared fragile and collapsed after a short period of 
time (Figure 4-3D). HMW PEI capsules present stronger walls than their LMW 
counterparts due to the denser network of reticulated PEI achieved by much longer polymer 
chains (2 vs. 750 kDa).  
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Figure 4- Micrographs of typical microcapsules prepared by the emulsion method (A 
and B) and by the encapsulation device (C (PEI750k) and D (PEI1300)). The micrographs 
A and B were obtained by CLSM using FITC-modified PEI.  
Vibration nozzle method can produce larger microcapsules than emulsion method 
(Figure 4-4) but with a narrower size distribution. As shown in Figure 4-4, the mean 
diameter of microcapsules prepared by emulsion method at rotation speed of 1140 rpm is 
about 25 µm while the mean diameter of microcapsules prepared by vibration nozzle 
method are much larger: about 202 µm at pump speed of 3.8 ml.min-1. 
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Figure 4- Size distribution of microcapsule prepared by emulsion method (dashed line) 
and vibration nozzle method (solid line). The data was obtained from particle size analyzer 
based on laser diffraction (Horiba). 
4.4.2.2. Wall thickness 
Several techniques, including surface plasmon resonance spectroscopy [21, 22], 
ellipsometry [23], differential scanning calorimetry [24], atomic force microscopy [25, 26], 
transmission electron microscopy [25] and CLSM [26], have been used to determine the 
wall thickness of several types of microcapsules. Here, the process of determining 
microcapsules membrane thickness was carried out by CLSM, using FITC-modified PEI in 
the preparation of the capsules. The wall thickness is easily measured from the histograms 
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of the cross-section of the microcapsules (Figure 4-5 A and B). This technique is however 
only relevant to the microcapsules prepared from low MW PEI (1 300 and 2 000 Da) as the 
labelled PEI which did not participate in the membrane formation was removed from the 
inner core of the capsules during the washing step of the preparation procedure. The 
microcapsules prepared with the encapsulation device from high MW PEI presented a 
uniform fluorescent signal throughout all of their cross-section (Figure 4-5 C), making the 
membrane thickness difficult to evaluate. The uniform fluorescent signal was due to the 
remaining labelled PEI which could not be removed from the core of the capsules during 
the washing step because of its large size (molecular weight of 750 kDa). Breaking the 
microcapsules allowed high MW PEI to be released from the capsules and the remaining 
signal was solely attributed to the membrane (Figure 4-5 D). The wall thickness of capsules 
made from high MW PEI by the encapsulator method at a flow rate of 3.2 ml.min-1 was 
about 4±2 µm. In comparison, the wall thickness of capsules made from PEI1300 and 
PEI2000, using the mechanical method at 1640 rpm, were only about 1.5±0.8 and 2±0.9 
µm, respectively. As expected, increasing the PEI MW resulted in microcapsules with 
thicker membranes for a given amount of cross-linker because of the polycondensation of 
longer polymer chains. The mean thickness of the membranes increased with the 
concentration of cross-linker by allowing more PEI chains to participate in membrane wall 
formation. Increasing the concentration of crosslinker from 0.4% to 1.1% resulted in an 
increase of membrane thickness from 1.0 to 2.0µm. However, at cross-linker 
concentrations above 1.2 v/v%, the microcapsules presented irregular surfaces and most of 
them agglomerated.  
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Figure 4- (A and B) Fluorescence intensity histograms calculated from the 
corresponding confocal micrographs of microcapsules (insets) prepared with FITC-tagged 
PEI (2 000 Da) using the emulsion method (A) and the encapsulation device (B). Images in 
C and D are micrographs obtained for microcapsules prepared by the encapsulation device 
with high MW PEI (750 kDa). Image in D shows how broken microcapsules are emptied of 
the fluorescent polymer. 
4.4.2.3. Membrane composition 
  Wet microcapsules contained approximately 96.8% water, which was analyzed by 
lyophilisation of wet microcapsules. The moisture environment in the microcapsules could 
keep the native structure of microencapsulated enzymes. 
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  The results of the elemental analysis presented in Table 4-2 were obtained from 
microcapsules prepared by both methods using various concentrations of the SC cross-
linker with a fixed amount of PEI. The ratios between PEI and SC were then calculated 
from the relative proportions of carbon and nitrogen which changes upon reticulation 
because SC does not contain any N atoms. The carbon and nitrogen content of PEI 
measured by EA are given in the bottom lines of Table 4-2. One can readily notice from 
Table 4-2 that increasing the concentration of SC from 0.33 to 0.83% resulted in 
insignificant changes in the membrane composition for both methods and with both 
molecular weights of PEI. This is in agreement with our observation that membrane wall 
thickness slightly increases with the cross-linker concentration. Table 4-2 also shows that 
microcapsules formed by PEI with a MW of 2 000 Da present a slightly higher proportion 
of the polymer in their membranes which can be explained by the reduced pore size 
obtained with longer polymer chains. Smaller pore size resulted in a lower diffusion rate of 
unreacted polymer which was trapped in the membranes and therefore increased the ratio 
of PEI found in the capsules. This is further exemplified by the higher amount of PEI found 
in the membranes of microcapsules formed with the encapsulator with 2 kDa PEI which 
present thicker membranes than those obtained from the emulsion method. As a result of 
this PEI entrapment effect, the membranes of microcapsules made with 750 kDa PEI could 
not be analysed by EA because most of the polymer was retained inside of their core 
(Figure 4-5 C), resulting in an overestimation of the membrane content in polymer. 
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Table 4- Results from the elemental analysis of the microcapsule membranes 
composition prepared by the emulsion method and the encapsulation device. 
Method PEI MW
(Da) 
Cross-linker 
(v/v %) 
% N found %C found Calculated 
PEI:SC ratio 
 
Emulsion 
method 
 
1300 
0.33 18.1 53.1 56.2 : 43.8 
0.50 17.1 50.7 55.7 : 44.3 
0.83 17.2 51.6 55.3 : 44.7 
 
2000 
0.33 18.2 50.7 59.9 : 40.1 
0.50 18.2 51.0 59.9 : 40.1 
0.83 17.8 51.4 58.1 : 41.9 
 
 
Encapsulation 
device 
 
1300 
0.33 17.9 55.4 56.7 : 43.3 
0.50 18.7 54.5 56.7 : 43.3 
0.83 18.7 54.5 53.5 : 46.5 
 
2000 
0.33 19.9 52.9 66.6 : 33.4 
0.50 20.6 52.4 65.9 : 34.1 
0.83 20.8 52.4 63.1 : 36.9 
 1300 - 30.2 49.8 - 
2000 - 29.6 49.6 - 
 
Figure 4-6 represents the TGA curves obtained for microcapsules prepared from 2 kDa 
PEI with three different concentrations of SC. The solid line represents PEI alone to verify 
the incidence of the cross-linking reaction on the TGA curves. One can notice a 50°C shift 
toward higher temperature for the first weight loss around 100°C which corresponded to 
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water evaporation. PEI and microcapsules are highly hydrophilic and can take up moisture 
from air. This moisture requires more time and energy to leave the microcapsules where it 
is incorporated within the membrane wall. The effect of cross-linking was also evidenced 
by the apparition of a slope between 400°C and 475°C that was not present on the curve for 
PEI and which represented the decomposition of functional groups created during the 
reaction between the diacid chloride and the polymer. Similarly to Table 4-2, higher 
amounts of cross-linker did not affect significantly the chemical composition of the 
microcapsule membranes. 
 
Figure 4- TGA curves of microcapsules prepared by the mechanical method with 2000 
Da PEI and various concentration of cross-linking agent (v/v % values are listed in the 
legend). The solid line was obtained for the PEI polymer alone. Inset is the amplification of 
the apparition from membrane decomposition slopes between 375°C and 500°C.  All 
experiments were conducted at a heating rate of 10 °C/min in a N2 environment. 
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4.4.2.4. Membrane cut-off 
Porosity is a factor of great importance in microencapsulation. Since our goal is to 
develop an efficient enzyme immobilization platform for biosensors, the microcapsules 
must have the right porosity to avoid enzyme leaching while allowing a quick diffusion of 
the substrate and reaction products. Thermoporometry, a technique based on DSC 
measurements, has been successfully used to evaluate the porosity of alginate hydrogel 
beads.[27, 28] Its use to determine the porosity of the thin membrane of hollow-core 
microcapsules filled with water however remains to be demonstrated. We therefore relied 
on a simple method based on confocal fluorescent microscopy to evaluate the diffusion of 
molecules of various molecular weights into the microcapsules and measured the MW cut-
off. In this method, the membrane of the microcapsules was modified with a red-emitting 
fluorophore (Texas red) while the molecular weight beacons were tagged with a green-
emitting label (FITC). Solutions of three different MW beacons (PEI1300, PEI2000 and 
laccase from T. versicolor 66 kDa) were incubated with the tagged microcapsules for 16 h. 
The appearance of a green signal either in the core or in the membrane of the capsules was 
then used to establish the membrane MW cut-off (see scheme in Figure 4-7 D). 
The confocal micrographs shown in Figure 4-7 are for microcapsules prepared with PEI 
of 2 kDa (red signal) either by the emulsion method (images A and C) or the encapsulation 
device (image B). The green signal of the MW PEI1300 and PEI2000 presented in the core 
of the capsules (Figure 4-7 A and B) showed that PEI could diffuse through the membranes 
of capsules prepared by both methods. Figure 4-7 C shows however that laccase enzyme 
  
115
 
was too large to permeate through the membrane and its signal was found only on their 
membrane wall. Consequently, microcapsules prepared by either of the two methods 
provided an efficient retention of the enzyme while allowing the diffusion of substrates 
with molecular weights below 2 kDa. Most substrates of interest for our biosensors fall in 
this category with MWs of a few hundreds of Daltons. The porosity analysis can be refined 
by calculating the radius of hydration of the molecules used to carry out the microscopy 
experiment. PEI is a globular molecule for which the rH values can be calculated from the 
molecular weight. The radii of the PEI molecules used in this study were calculated from 
the equation rH = 0.068 MW0.39 [29] and the hydrodynamic radius of PEI (2 kDa) was 1.3 
nm. In addition, the dimensions of laccase were determined to be 65×55×45 Å3, for an 
approximate diameter of 5 nm.[30] The MW cut-off of capsules membranes in their fully 
hydrated form was therefore found between 2.6 and 5 nm.  
PEI-SC microcapsules are quite strong, they can be rehydrated for many times, keeping 
the same morphology. Although small changes in porosity after they were dried and 
rehydrated are possible, the end application requires only for small molecules to diffuse 
(substrate) and their access to the core should not be modified after drying and rewetting. 
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Figure 4- Confocal micrographs showing the combined signals of microcapsules 
membranes (red) and of different molecular weight markers (green). Microcapsules were 
prepared either with the emulsion method (A and C) or with the encapsulation device (B). 
The molecular weight markers labelled with FITC were PEI1300 (A), PEI2000 (B) and 
laccase from T.versicolor (C). The scheme in D shows a diagram explaining the 
experiment.  
4.4.2.5. Encapsulation efficiency 
The encapsulation efficiency is herein defined as the percentage of proteins actually 
contained in the microcapsules relative to the amount initially used in the aqueous phase. 
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To evaluate the efficiency, a solution of the BSA protein was used in the preparation of 
microcapsules and the free BSA concentrations (i.e. that of the proteins that were not 
entrapped in the capsules) of all liquid phases, including those used to wash the 
microcapsules, were measured. This method therefore provided the amount of proteins that 
were tightly entrapped in the capsules as some located on the outer surface of the capsule 
membrane could be leached easily.[31] The emulsion method presented a higher efficiency 
(94±2%) compared to the method based on the encapsulation device (83±3%). For the 
same amount of reagents, emulsion method can produce more than double mass of 
microcapsules than encapsulator method, since microdroplets produced by emulsion 
method are much smaller. On the other hand, LMW PEI has low toxicity. Then emulsion 
method has better encapsulation efficiency than encapsulator method.  
4.4.3 Enzyme microcapsules 
Figure 4-8 represents the pH profile for the activity of free and encapsulated glucose 
oxidase obtained for the oxidation of glucose. The optimal pH of microencapsulated GOx 
showed a shift of 0.5 pH unit towards lower value comparing with free GOx. The proton 
exchange properties of PEI resulted in a membrane pH slightly different to the solution pH, 
affecting the enzyme activity in the microcapsules. The profile shows a broadening of the 
curve near maximal activity that was to be expected for an enzyme immobilized in a 
polymeric matrix. 
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Figure 4- pH dependency of glucose oxidation by GOx either free in solution (squares) 
or in PEI microcapsules (circles). Glucose oxidation was monitored by oxygen 
consumption in McIlvaine buffers at 25°C. 
The enzymatic activities of GOx and TvL microcapsules were found to be strongly 
dependent on the microencapsulation procedure as well as on the nature of the enzyme. The 
activity of TvL microcapsules prepared by emulsion method was 6.2 times higher than 
those prepared by encapsulator method, whereas the activity of GOx microcapsules 
prepared by emulsion method was only 2.4 times higher compared to the encapsulator 
method. Regarding the effect of the encapsulation method, the encapsulation device had 
lower encapsulation efficiency but the enzymatic activity losses were mainly due to the 
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higher toxicity of HMW PEI towards the enzymes compared to lower MW polymer. In 
addition, the thicker membranes produced with HMW PEI limited the substrate diffusion, 
resulting in lower enzymatic activity. HMW PEI also tended to be trapped inside the cores 
and could not be washed off easily due to its large size. Enzyme microcapsules prepared by 
encapsulator method therefore had a lower activity than those obtained with the emulsion 
method which yields better microcapsules with LMW PEI. The differences observed 
between the activities of microencapsulated laccase and glucose oxidase should be 
explained by a different enzyme-polymer interaction. Laccase appeared to be more 
sensitive to the presence of PEI than glucose oxidase. A detailed study of the PEI-enzyme 
interactions will be the topic of a forthcoming publication. 
4.5 Conclusions  
  A commercial encapsulation device for the production of beads was used for the first 
time to prepare microcapsules from the interfacial reticulation of PEI. We have provided a 
methodological description of the formation and a characterization of PEI microcapsules 
prepared by an emulsion method and with the encapsulation device. Microcapsules can be 
prepared in mild conditions with high entrapment efficiencies under optimal instrumental 
parameters and optimal reagents ratios. The vibration nozzle technique produced 
microcapsules with a narrow size distribution with diameters of about 200µm. The 
characterization of microcapsules shows that the chemical reactions involved in the 
reticulation by the two methods are similar. PEI with large molecular weight must however 
be used to obtain stable microcapsules using the encapsulation device. In terms of the 
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characteristics of microcapsules, such as diameter, wall thickness, pore size, 
biocompatibility and entrapment efficiency, microcapsules prepared by emulsion method 
have better properties to entrap enzymes. Moreover, the smaller size of the microcapsules 
prepared by the emulsion method makes them more appropriate for an immobilization on 
paper using a conventional thin layer coating. Mechanical strength is an important factor 
for coating application, and is currently being investigated. The activity analysis of 
microencapsulated enzymes and the effect of the microencapsulation procedure on their 
structure will be discussed elsewhere.  
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 Chapter 5  Activity, conformation and thermal 
stability of laccase and glucose oxidase in 
poly(ethyleneimine) microcapsules for immobilization in 
paper 5 
 
5.1 Abstract 
In this paper we report on the microencapsulation of glucose oxidase from Aspergillus 
niger (GOx) and laccase from Trametes versicolor (TvL) with the goal of immobilizing 
these enzymes in paper substrates to develop biosensors and bioreactors. Despite having 
high encapsulation efficiency, the technique caused a severe decrease (up to 65%) in the 
specific activities of both enzymes once microencapsulated. Encapsulated TvL presented 
lower KM and Vmax values compared to free laccase in solution, but the KM for GOx did not 
change after microencapsulation. TvL was found to interact strongly with 
poly(ethyleneimine) (PEI) in a manner similar to that expected from an uncompetitive 
inhibition mechanism, and fluorescence and circular dichroism spectroscopy demonstrated 
                                                 
5 This chapter was published as an article in Process Biochemistry. 
Yufen Zhang, Dominic Rochefort, Activity, conformation and thermal stability of laccase 
and glucose oxidase in poly(ethyleneimine) microcapsules for immobilization in paper, 
Process Biochemistry, 46(6), 2011, P993-1000. 
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that significant alteration of the enzyme's conformation occurs in the presence of PEI, an 
effect of the cationic polymer that was not observed with GOx. Microencapsulation 
improved the thermal stability of GOx at temperatures up to 60°C due to stabilization of its 
active conformation but reduced the thermal stability of laccase because of the increased 
coordination between PEI and copper atoms in the enzyme's active site. Preliminary GOx 
bioactive paper was fabricated, which could be potentially used as food packaging paper.  
Keywords 
Bioactive paper, enzyme, conformation, microencapsulation, stability, immobilization 
5.2 Introduction 
Enzymatically-modified paper strips show great promises as inexpensive, portable and 
widely distributed biosensors. Several examples of bioactive papers were produced either 
through physical adsorption of the biorecognition elements [1] or by printing sol-gel-
derived bioinks on the paper [2]. In our lab, bioactive paper is prepared by incorporating 
poly(ethyleneimine) microcapsules containing  enzymes into paper pulp, which we 
demonstrated to be an efficient and scalable method to retain biomolecules in paper sheets 
[3]. Microencapsulation consists of the entrapment of a species within beads or shells often 
made by a polymer. Many strategies have been developed to encapsulate enzymes [4] that 
could potentially be of interest to immobilize enzymes on paper substrates. These 
techniques include layer-by-layer wall formation, ionotropic gelification, and interfacial 
polycondensation of a polymer [5-10]. The major challenge of microencapsulation 
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technique is to maintain the enzymatic activity of entrapped enzymes. Liu [11] reported 
that immobilized GOx in alginate/chitosan microspheres maintained around 90% of the 
original activity after lyophilization and storage at -20oC for a month. However, 
encapsulated protein molecules can be released from the pores of Ca-alginate gel beads 
which appeared to collapse after lyophilization due to the highly porous gel network. In 
addition, high porosity of CaAlg gel beads also allows chitosan to diffuse deeply into the 
gel core and possibly causes desorption of GOx. Alginate/chitosan microspheres [11-13] 
have also been used to immobilize enzymes and since this technique does not involve any 
chemical crosslinking process, immobilized enzymes maintained high activity. Despite 
these advantages, the microspheres prepared by this method usually have a relatively large 
diameter and loaded protein can be released easily from the pores of gel beads. 
PEI is often found in use in binding, immobilization and entrapment [14-23]. However, 
many authors reported a decrease of enzymatic activity in PEI-based immobilization 
systems. Matella et al. [24] for example studied the immobilized enzyme system using 
poly(ethyleneimine), glutaraldehyde (GA), and cotton cloth and reported an approximately 
50% to 90% of enzyme inactivation with the combination of PEI and GA. The enzymatic 
activity losses after immobilization were attributed to unfavorable interactions between 
proteins and polyelectrolytes that could result from van der Waals forces, dipolar or 
hydrogen bonding, electrostatics forces, and hydrophobic dehydration [25, 26].  The 
conformational changes resulting from these interactions, together with the limited 
diffusion of enzymes immobilized in dense polymeric networks, may all be are held 
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responsible for the reduction of enzymatic activity during microencapsulation and 
determining the exact cause of enzymatic activity loss from the encapsulation processes is 
therefore a key step in the development of our immobilization platform based on 
microencapsulation. 
Some strategies to immobilize biocatalysts on various supports using PEI are discussed 
in a review article from Bahulekar et al.[27] In a previous publication, [28] we have 
compared two simple and efficient enzyme microencapsulation methods based on 
interfacial polymerization of PEI and evaluated the microcapsules' properties by several 
characterization methods. The intent of the current paper is to investigate the enzymatic 
activity of free and encapsulated enzymes since enzyme activity loss occurred during the 
microencapsulation process by interfacial polycondensation of PEI has never been 
reported. Takashi et al. [29] used polyamide microcapsules prepared by interfacial 
polycondensation to entrap trypsin (I) and found that KM and Vmax values were 
considerably higher for free trypsin in solution than for immobilized trypsin. As far as the 
authors are aware of, there are only very limited reports on biological encapsulation using 
interfacial polymerization method, even when this method provides a tight control on 
microcapsules mean diameter in a fast preparation. In addition, no report on the specific 
interactions between microencapsulated enzymes and membranes of PEI microcapsules can 
be found in the literature. Here, PEI microcapsules were prepared by a microemulsion 
method and used to entrap two different enzymes (GOx and TvL), with a high entrapment 
efficiency. The activities of both enzymes were investigated throughout the various steps of 
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the encapsulation procedure to provide an explanation of the loss in enzymatic activity 
observed.  
5.3 Materials and methods 
Materials   
Polyethyleneimine (PEI, Mw = 1300 Da; 50 wt% soln. in water), sebacoyl chloride 
(SC), cyclohexane (CH), Span 85, bovine serum albumin (BSA), TvL (EC 1.10.3.2, ca. 
10% protein content, 22.4 U.mg-1), p-phenylenediamine (PPD), D-(+)-glucose, 
fluorescamine and QuantiPro BCA (bicinchoninic acid) Assay kit were purchased from 
Sigma-Aldrich. Other salts used for buffer preparation were purchased from A&C 
American Chemicals Ltd. Glucose oxidase from Aspergillus niger (GOx, E.C. 1.1.3.4, 
specific activity @25 oC >110 U.mg-1) was obtained from Amersco, water was purified 
with a Milli-Q purification system to a specific resistance of at least 18 MΩ·cm-1.  
Enzyme microcapsules 
Enzyme microcapsules were prepared by a microemulsion technique adapted from that 
of Poncelet et al.[30] and described in details in a previous publication [28]. In short, 
various weights of enzymes (laccase: 1 to 50 mg, glucose oxidase: 5 to 60 mg) between 1 
and 50 mg (see Table 5-1), were dissolved in a McIlvaine buffer (0.2 M Na2HPO4 and 0.1 
M citric acid) solution (10 mL) containing PEI (4.6% v/v). This aqueous phase was 
emulsified in cyclohexane for 15 min prior to the addition of the cross-linking agent 
sebacoyl chloride. The microcapsules obtained were firstly rinsed with cyclohexane and 
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subsequently with Milli-Q water to remove unbound PEI molecules.  PEI microcapsules 
can be prepared efficiently from the fast interfacial condensation of the polymer with a 
diacid chloride [28], and the reaction leading to membrane formation is shown in Figure 5-
1.The loading of laccase in the microcapsules was calculated from the amount of laccase 
used in the preparation (see above) multiplied by an encapsulation efficiency factor of 0.94 
which was determined evaluated earlier [28].   
Measurement of enzymatic activity              
The activities of TvL and GOx were determined from the rate of oxygen consumption 
by the enzymes in the presence of its substrate (o- or p-phenylenediamine (OPD or PPD) 
for TvL and glucose for GOx) rather than by conventional spectroscopic methods which 
provided unreliable absorbance readings for turbid suspensions of microcapsules. Oxygen 
consumption measurements of free laccase in solution were achieved by adding an aliquot 
of the enzyme solution in a buffer (total volume = 3 ml) in the chamber of an oxygen cell 
(Rank Brothers Ltd.) and by following the decrease in O2% over time upon addition of the 
substrate to the cell.  
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Figure 5- Scheme of the cross-linking reaction during encapsulation showing several 
possible linkages between PEI chains. 
A similar procedure was followed with microcapsules except that a weighted amount of 
capsules was introduced in the cell chamber. To obtain a sufficient amount of enzyme for 
the measurement while maintaining substrate saturation conditions, the amount of 
microcapsules to be introduced in the cell was determined to provide a value of 0.1 U/ml 
(the amount was calculated using the initial laccase loading in the capsules (Table 5-1)). In 
all cases, the full scale of the instrument was calibrated prior to the measurement by 
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purging the buffer solution with N2 (0%) and by saturating the solution with air (100%) 
afterwards. The measurement chamber of the instrument was kept at 25°C for all 
experiments using a water jacket and the initial rate of any given reaction was then 
obtained from the slope of the graph. The substrates selected for TvL activity 
measurements were o- or p-phenylenediamine (OPD or PPD) which are either neutral or 
slightly cationic in the pH range required to sustain activity.  
Fluorescence spectroscopy Assay 
A Perkin Elmer Luminescence spectrometer LS50-B was used to investigate the 
conformation of both TvL and GOx in the presence of PEI at room temperature. The 
excitation wavelength was set at 280 nm and the emission spectrum was recorded from 295 
to 400 nm for both enzymes. Fluorescence measurements were carried out in 0.1 M acetate 
buffer at a pH of 5 in a quartz cuvette of 10 mm length path. All emission spectra presented 
were obtained by averaging 20 individual scans. 
Circular dichroism (CD) 
CD spectra of TvL and GOx in the absence and presence of PEI were recorded on a 
Chirascan (Applied Photophysics) instrument using a 500 µm light path cuvette at room 
temperature. Both enzymes were dissolved in a McIlvaine buffer at a protein concentration 
of 1 mg/mL. All spectra presented were corrected by subtracting from the baseline which 
was recorded with the buffer, for pure enzyme spectra, or with PEI dissolved in buffer 
solution for all other spectra. 
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Table 5- Decrease in laccase activity observed after the microencapsulation procedure. 
The activity was measured by the oxygen consumption method in the presence of 4.4 mM 
of substrate PPD in 50 mM McIlvaine buffer (pH 5) at 25°C. 
Enzyme Condition TvL amount 
loaded in 
microcapsules 
(mg) 
Mass of 
microcapsules 
used for 
activity 
measurement 
(mg) 
Total 
laccase 
amount 
in O2 
cell 
(µg) 
Specific 
activity 
(%O2/s·g 
of 
laccase) 
Residual 
activity 
vs. free 
laccase 
(%) 
TvL 
Free 
(solution)  - 15 5.7 100 
Encapsulated 
(suspension) 
1.0 405 20 1.8 32 
5.8 74 20 2.1 37 
9.9 45 21 1.9 33 
25.9 16 19 1.8 32 
49.7 10 23 1.5 26 
5.4 Results 
5.4.1 Enzymatic activity of microencapsulated enzymes 
   The effects of the microencapsulation procedure on the activities of TvL and GOx 
were evaluated by comparing the mass-specific activity of free and encapsulated enzymes 
using the O2 consumption method described in measurement of enzymatic activity. Table 
5-1 shows the comparison of the enzymatic activities (presented in %O2 consumed in the 3 
ml cell per second) between a solution of free laccase (15 µg) and suspensions of TvL 
microcapsules with each sample containing ca. 20 µg. To ensure that the mass transport of 
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O2 to the enzyme across the walls and aggregates was not limiting, we incorporated 
different amounts of capsules that were prepared with various quantities of TvL. A proper 
comparison of the activities was achieved by adjusting the amounts of microcapsules used 
for the activity measurements to obtain a fixed mass of TvL in the O2 cell. The average 
residual activity of TvL once encapsulated, calculated from the results presented in Table 
5-1, was 33%. A similar value, 35%, was obtained for glucose oxidase. 
Further assessment of the effect of microcapsules on the enzymes was achieved by 
kinetic measurements. We have already demonstrated that a decrease in Vmax and KM 
occurred in microencapsulated TvL using either o- or p-phenylenediamine substrates [3, 
31]. What we have observed here  with the enzyme GOx and using glucose as a substrate is 
a decrease in Vmax but a KM that remained virtually unchanged (see Figure 5-2) In Figure 5-
2, the data points were fitted to a hyperbola function to estimate Vmax at infinite glucose 
concentration and to calculate KM at Vmax/2. The microencapsulation of GOx resulted in a 
small variation of KM, from 19 (free) to 14 mM (encapsulated). In comparison, the KM for 
TvL decreased by 84% upon encapsulation [3], suggesting that the PEI membrane affected 
the TvL’s affinity for its substrate to a greater extent than it did for GOx.  
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Figure 5- Michaelis-Menten behavior for the oxidation of glucose by free (squares) and 
microencapsulated (triangles) glucose oxidase. All initial rates were measured with an 
oxygen cell in a McIlvaine buffer at pH 5 and were expressed as the decrease in O2 % 
content per second.  3.3 U GOx (107 mg microcapsules) in 3 ml of buffer solution was 
used for each measurement at 25°C; immobilized enzyme: 30.7 U GOx per gram 
microcapsules. 
The thermal stabilities of TvL and GOx were studied by incubating a solution or a 
suspension of the free and encapsulated enzymes at 60°C for different periods of time. The 
samples were then rapidly cooled to room temperature and their activities measured in the 
O2 cell at 25°C. Figure 5-3 presents the effect of the incubation at 60°C on the activities of 
GOx (A) and TvL (B). A drastic decrease of over 90% occurred for microencapsulated TvL 
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in less than 12 minutes. Oppositely, GOx presented a higher thermal stability when 
incorporated in microcapsules than the free enzymes, with the encapsulated GOx having a 
half-life time higher by a factor of 4 than that of free GOx. The inclusion of GOx in the 
membrane of the microcapsules could be responsible for this increased thermal stability by 
restricting the freedom of this large molecule (150 kDa) to undergo thermally-induced 
conformational changes or by preventing the dissociation of the enzyme subunits. 
As described in Section 5.2.2, our microencapsulation procedure involves the use of 
several chemicals (cyclohexane, sebacoyl chloride, PEI and surfactants) that might affect 
the enzyme activities. To determine if any of these chemicals could be held responsible for 
the losses observed, the enzymatic activities of TvL and GOx were monitored along the 
different steps of the microencapsulation procedure. Table 5-2 presents the normalized 
activities (100% as free enzyme buffer at optimal conditions) of both enzymes measured 
immediately after each critical step of the procedure. PEI directly affects TvL’s activity (a 
78% decrease) while GOx’s activity remained virtually the same. The interaction between 
TvL and PEI was hence investigated further. 
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Figure 5- Heat inactivation curves obtained by measuring the activity of GOx (A) and 
TvL (B) after an incubation of a solution of the free (squares) and microencapsulated 
(circles) enzymes at 60°C. All solutions were cooled prior to activity measurement in the 
oxygen cell at 25°C. 
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Table 5- Monitoring of TvL’s and GOx’s activities by the oxygen consumption method, 
during the various steps of the microencapsulation procedure. 
Enzyme Condition Activity (%O2/s) 
Relative activity 
(%) 
TvL  
(0.012U/ml) 
Buffer 0.266 100 
Buffer + 0.04 mM PEI 0.059 22 
Buffer, after emulsification in 
cyclohexane 0.262 98 
GOx  
(5 U/ml) 
Buffer 0.578 100 
Buffer + 0.04 mM PEI 0.578 100 
Buffer, after emulsification in 
cyclohexane 0.575 99 
 
To evaluate the activity inhibition on free, non-encapsulated TvL by PEI, kinetic 
measurements were carried out using o-phenylenediamine (OPD) as the substrate. In this 
case, TvL-catalyzed OPD oxidation was monitored over time with a UV-Vis 
spectrophotometer (λmax = 450 nm) in the presence of various concentrations of the 
suspected inhibitor PEI. Figure 5-4 shows the Lineweaver-Burk plots obtained for OPD 
oxidation with PEI concentrations ranging from 0 to 0.135 mM. The analysis of the curves, 
presented in the legend of Figure 5-4, shows a decrease in both KM and Vmax, suggesting a 
noncompetitive inhibitory mechanism. These decreased values were also obtained for the 
encapsulated enzymes (see above and [3, 31]) although in the latter the reduced Vmax could 
be attributed to the hindered diffusion of the substrates across the microcapsules' 
membrane. The apparent noncompetitive inhibition suggested by the kinetic measurements 
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cannot however rule out the possibility of conformational changes occurring in the 
enzymes' structure in the presence of PEI. This possible cause of the decreased TvL’s 
activity by PEI was therefore evaluated by fluorescence and circular dichroism 
measurements. Figure 5-5 shows the intrinsic fluorescence emission of tryptophan residues 
contained in the TvL's (A) and GOx's (B) structures. The emission scan of native TvL 
presents a maximal intensity at 350 nm. Upon addition of PEI, this peak decreased in 
intensity and shifted towards higher wavelengths due to the exposition of tryptophan 
residues to a different environment, suggesting a change in the enzyme's conformation. The 
fluorescent signal of GOx remained virtually unchanged in the presence of PEI, which is 
expected since GOx maintained its activity in the presence of PEI (Table 5-2). The 
photographs included as insets in Figure 5-5 were taken before (left vial) and after (right 
vial) the addition of PEI to the concentrated solutions of TvL or glucose oxidase. TvL 
solutions usually present a light green-blue color due to the Type 1 copper atom located in 
its active site. In the presence of PEI, the green-blue color turned to yellow, indicating a 
possible interaction of the polymer with either the active site's Cu or the amino acids in its 
vicinity. Additional information on the structural changes was gathered from circular 
dichroism experiments. Figure 5-6 represents the CD spectra of TvL (A) and GOx (B) with 
and without PEI. The band observed at the 220-240 nm of the spectra is attributed to the β-
sheets arrangements in the enzymes' secondary structure. The 30% decrease in band 
intensity for the TvL enzyme clearly shows a disruption in the β-sheets induced by the 
polymer.  
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Figure 5- Lineweaver-Burk plot for the OPD oxidation by laccase in presence of PEI at 
different concentrations. Initial rates (Absorbance/s) for the reaction were measured at 450 
nm in 50 mM  McIlvaine buffer at pH 5 at 25°C. 
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Figure 5- Intrinsic fluorescence emission spectrum of laccase (A) and glucose oxidase 
(B) in the presence (dotted line) and absence of PEI (solid line). The spectrum obtained for 
a solution of PEI in buffer is showed for comparison in A (dash-dot). Excitation 
wavelength was set to 280 nm in both experiments. The photographs in insets of the spectra 
were taken for a concentrated solution of the enzyme (left) and immediately after addition 
of PEI (right). 
A 
B 
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Figure 5- CD spectra showing the disruption of β-sheets arrangements in laccase (A) in 
presence of PEI. The spectra in B show no alterations for glucose oxidase by PEI. 
5.4.2 Preliminary results on bioactive paper 
The bioactive paper was fabricated by incorporating microcapsules of GOx in an 
aqueous suspension of bleached hardwood pulp. The paper sheets, in which the 
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microcapsules were uniformly distributed, were obtained by filtration of the suspension 
over a filter paper with a funnel and were allowed to dry at room temperature overnight 
prior to the measurements. Figure 5-7 (A) shows an image obtained with a wide field 
fluorescence microscope of a paper that was modified with GOx microcapsules. For the 
purpose of the measurement, the enzyme was fluorescently-labeled with fluorescamine 
prior to its encapsulation.  Although some small aggregates can be found in the fibers, the 
distribution of microcapsules is relatively uniform. Figure 5-7 (B) shows the pictures of a 
paper strip modified with GOx microcapsules taken at different times after the addition of a 
solution of 0.5 M glucose and 0.5M KI. The color of the strip changed from yellow to dark 
brown due to the oxidation of I- to I2 in presence of the H2O2 produced by the GOx-
catalyzed oxidation of glucose in the presence of oxygen. Applying the reagents to a paper 
modified with microcapsules that does not contain any enzyme did not produce any color 
change (Figure 5-7 C), showing that encapsulated GOx is active in the paper and it is the 
enzyme that is responsible for the color change. 
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Figure 5- (A) Fluorescence micrograph of a 3 mm2 section of a bioactive paper 
prepared by the incorporation of GOx-containing microcapsules in paper pulp suspension. 
The microcapsules were tagged by fluorescamine to obtain fluorescent signal.  (B) and (C) 
are photographs of a paper prepared with GOx-microcapsules or non enzymatic 
microcapsules, respectively, and on which a solution containing 0.5 M glucose and 0.5 M 
KI was added.  
5.5 Discussions 
Microencapsulation of enzymes by interfacial reticulation of PEI resulted in the 
inclusion of the encapsulated proteins within the membrane of the capsules [32] as a result 
of the pH-dependent electrostatic interactions occurring between the polymer and the 
proteins. Incorporation of pH indicators in the aqueous phase during the encapsulation 
procedure revealed an initial pH of 11 (phenolphthalein) due to the basic nature of PEI. At 
pH 11, PEI is neutral but TvL and glucose oxidase are negatively charged (pIs of 4 and 4.5, 
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respectively). During the cross-linking reaction, sebacoyl chloride reacts by its end groups 
with the secondary and primary amino groups on the PEI Figure 5-1), releasing protons that 
decrease the pH of the aqueous phase to a final value between 6 and 8 (methyl red and 
phenolphthalein indicators). At neutral pH, PEI bears a positive charge (15-20% of amino 
groups are charged) [33] causing the negatively-charged proteins to interact with the 
polymer. Once the enzymes are brought in contact with the membrane in formation, cross-
linking reaction can occur between the proteins' amino groups and those on PEI by the acid 
moieties at the ends of sebacoyl chloride, resulting in their irreversible immobilization 
within the membrane. 
Inclusion of TvL and GOx in PEI microcapsules' membrane induces changes in their 
reactivity as it was pointed out by the reaction kinetic measurements. The maximum rate 
(Vmax) of free enzymes was much higher than that of encapsulated ones, since the 
membrane of microcapsules reduced the substrate diffusion rate, some of enzyme 
molecules were crosslinked into membranes, and hydrophilic character of membranes of 
microcapsules can reduce the oxygen concentration inside of microcapsules. Diffusion of 
substrate into, and product out of, the capsules is achieved by the concentration gradient. 
The decrease in activity (Vmax, app) may be explained by a rapid depletion of substrate in the 
environment immediately surrounding the enzyme, which is confined within the pores of 
the capsules. Since there is some diffusion restriction, the apparent activity would appear to 
be lower than it really is at the active site of the enzyme, since a macroscopic measurement 
is made in the bulk solution. A significant decrease in apparent Michaelis constant was 
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observed for TvL (400 to 65 mM, PPD oxidation [3]) while that of GOx remained the same 
(19 to 14 mM, glucose oxidation).  An increase in enzyme-substrate affinity, suggested by 
the lower KM, upon the inclusion of TvL in the membrane is possible and enzymes have 
been reported with lower KM,app in polymer films [34] and microcapsules [35]. Results from 
fluorescence and CD measurements pointed out that PEI affects laccase closely to its active 
site which can be used to explain the decrease in KM value for encapsulated laccase. GOx 
however does not see its structure modified by PEI and KM stays unchanged upon 
encapsulation. Therefore, we conclude that, for both enzymes, Vmax decreases in 
microcapsules due to diffusion restriction and substrate depletion. Laccase, which is most 
sensitive to PEI, has its active site altered in the presence of the polymer resulting in a 
better access of the substrate, hence a lower KM value (not observed with GOx). This 
difference provides an indication that the interactions between the enzyme and the polymer, 
and therefore the explanation of the activity losses, might be dependent on the nature of the 
enzyme rather than simply due to their inclusion in a polymeric membrane. Another 
indication is provided by the very different results obtained from heat inactivation 
measurements of both enzymes. We have observed an increase in the thermal stability of 
microencapsulated GOx that can be explained by the stabilization of the enzyme's structure 
within the membrane since cross-linking between the polymer and GOx must have 
occurred during the capsule membrane formation. An increased heat-resistance for GOx in 
polyurea microcapsules prepared by interfacial polymerization has previously been 
reported by Komori et al.[36] Conversely, microencapsulated TvL was more prone to heat 
inactivation than free TvL (Figure 5-3). This opposite behavior can only be explained by 
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the existence of detrimental interactions occurring between the PEI membrane and the TvL. 
In order to minimize these interactions, lyophilized microcapsules were subjected to the 
same heat treatment at 60°C. In the absence of water, microencapsulated TvL maintained 
its activity and no losses were observed within the first 15 minutes of incubation (vs. 90% 
activity decrease in solution). Under dry conditions, the polymer and the enzyme were not 
able to interact. 
We therefore identified three possible explanations of the severe reduction in enzymatic 
activity of PEI encapsulated enzymes and that might help rationalize the lower KM 
observed or the differences in heat inactivation: protein losses, enzyme inhibition by 
reagents, and conformational changes. We have showed in a previous publication [28] that 
high encapsulation efficiency (96%) was achieved with the procedure, ruling out the 
possibility of the loss of large quantities of enzyme to the organic phase or during the 
washing steps of the preparation. Inhibition of TvL by PEI, on the other hand, was clearly 
demonstrated in Figure 5-4 where the LB curves suggested an uncompetitive inhibition 
behavior. The fluorescence and circular dichroism experiments determined that this 
apparent inhibition was in fact due to conformational changes in the TvL’s structure. The 
chemical composition of PEI contains 16% nitrogen, of which 20% are primary amines, 
which are known to be able to coordinate with proteins [37]. If such interactions lead 
inevitably to a disruption of the enzyme structure, the changes observed with TvL would be 
expected to occur also in glucose oxidase. As showed above, the addition of PEI did not 
exert significant effects on GOx’s conformation and the enzyme maintained its activity in 
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the presence of the polymer. It is noteworthy to mention that some researchers [38, 39] 
reported that higher amounts of PEI reduced the stability of GOx.  To explain this 
discrepancy between the behaviors of TvL and GOx, we turned towards the possible 
complexion of the copper atoms from the TvL’s active site and PEI. A sufficiently 
concentrated TvL solution would present a light green-blue color due to light absorption by 
the Type 1 copper at around 600nm (see inset of Figure 5-5). The rapid change to a yellow 
color with the presence of PEI was a strong indication that PEI interacted directly with the 
active site. PEI molecules are strong copper-chelating agent because of their secondary and 
tertiary amino groups [40], thus they could break or distort some ligands connected with 
coppers in the TvL’s active site. In addition, the ion pairing between oppositely charged 
molecules could also exert a modest influence on the enzyme’s stability [26]. PEI might 
also cause distortions of optimum bond lengths and bond angles with a tightly packed 
interior of enzyme which are determinant for the catalytic activity. This effect of PEI is 
demonstrated by its ability to inactivate complex biological agents. An N-acetylated 
version of PEI was reported by Haldar et al. as an efficient antiviral and antimicrobial agent 
[41]. The authors proposed that the virucidal action originates from the ability of PEI to 
interact with proteins and thus achieve in membrane disruption. We do not believe that 
such interactions between PEI and protein can be held responsible for the loss in the 
activity of encapsulated TvL since no modification to GOx’s structure took place in the 
presence of PEI. In addition to our observations, Bolivar et al. reported on the successful 
use of PEI to stabilize the quaternary structure of the enzyme glutamate dehydrogenase 
[42], The authors coated the enzyme with PEI which was afterwards cross-linked with 
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glutaraldehyde to obtain a composite that exhibited significantly higher thermal stability in 
solution than that of the unmodified enzyme. We have also observed an increased thermal 
stability for GOx when incorporated in the membrane of PEI microcapsules. We therefore 
conclude that the metal ion chelating ability of PEI, rather than unfavorable interactions 
with the enzyme peptidic backbone, was responsible for the loss in TvL’s activity. Such 
chelating events caused a disruption of the β-sheets in the vicinity of the TvL’s active site 
and occurred in order to accommodate the large polymer. This disruption was clearly 
demonstrated by circular dichroism spectroscopy and was amplified at higher temperatures. 
A strategy based on template-assisted layer-by-layer microencapsulation is currently 
undergoing in our lab as a mean to prevent TvL from interacting with the PEI membrane 
with the goal of decreasing the loss in activity. 
Since the physical incorporation of GOx microcapsules into paper pulp did not affect its 
enzymatic activity, GOx paper strips maintain the same activity as GOx microcapsules. As 
discussed above, the reduction of enzymatic activity of microencapsulated GOx is mainly 
due to the diffusion restriction, some of GOx molecules crosslinked in the membranes can 
also reduce its activity, thus microencapsulation only reduces its reaction speed with its 
substrate. GOx paper can potentially be used as food packaging products to improve shelf 
life by scavenging oxygen that might penetrate the physical barrier.  
5.6 Conclusions  
   The current work aimed at comparing the enzymatic activity of free and 
microencapsulated TvL and glucose oxidase to determine the factors causing the loss of 
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enzymatic activity during the interfacial polycondensation of PEI. The reduction of 
enzymatic activity after microencapsulation was explained by multiple factors. In general, 
diffusion through these closed shells with pore size <5 nm is a slower process compared 
with free enzymes in solution. For encapsulated GOx, the diffusion limitation is the key 
factor that led to the reduction of enzymatic activity since no interactions between GOx and 
PEI were observed. Some other factors, such as reduction of the amount of oxygen inside 
microcapsules (substrate depletion) can also reduce it activity. PEI, however, affected the 
conformation of TvL and decreased its enzymatic activity.  Microencapsulation improved 
thermal stability of GOx, but decreased the thermal stability of TvL, since the coordination 
between the copper center in TvL and nitrogen atoms in PEI molecules was increased at 
higher temperatures. Preliminary colorimetric bioactive paper strips were prepared by 
incorporating microencapsulated enzymes into the paper pulp. Depending on the properties 
of microcapsules, enzyme microcapsules can be immobilized in paper by different ways 
including coating, sizing and printing. Although the present works only focused on TvL 
and GOx, we believe that a similar approach is applicable to other enzymes, and it could be 
used to develop different functional and valuable bioactive paper. 
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 Chapter 6 Fast and effective bioactive paper for self-
diagnosis of bacterial vaginosis6 
6.1 Abstract 
In this article, sensitive colorimetric bioactive paper was fabricated to determine 
sialidase–related diseases like bacterial vaginosis (BV) in a one-step and dry format 
spot assay with fast response and good storage stability. The paper was prepared by 
three simple steps. The first step involves preparation of poly(ethyleneimine) (PEI) 
microcapsules, the second step is to incubate positively charged microcapsules in 
negatively charged 5-bromo-4-chloro-3-indolyl-a-D-N-acetylneuraminic acid (BCIN) 
solution, an color enhancer nitro blue tetrazolium (NBT), and in the third step, paper 
was fabricated by incorporating incubated microcapsules into paper pulp. This paper 
changes color from white to dark purple in the presence of sialidase in as little as 6 
minutes, and color could be enhanced with increased length of reaction time. In this 
reaction system, BCIN was the substrate for sialidase, NBT was the color enhancer, and 
PEI microcapsules acted as catalyst. The loading efficiency of BCIN was about 22.2%, 
and filtered BCIN solution could be reused for the next fabrication.  
Keywords 
Neuraminidase; Microcapsules; Bioactive Paper strip; Bioactive paper; 
Colorimetric biosensor 
                                                 
6 This Chapter will be submitted to Lab on a chip as a paper. 
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6.2 Introduction 
Bacteria vaginosis (BV) is the most common vaginal infection in women of child-
bearing age. Normal vaginal flora consisting of hydrogen peroxide-producing 
lactobacilli are replaced by Gardnerella vaginalis, Mycoplasma hominis, Mobiluncus 
species, which are anaerobic gram-negative rods in women with BV [1]. BV is strongly 
associated with gynecologic and obstetric complications including an increased risk for 
salpingitis, endometritis, pelvic inflammatory disease (PID), chorioamnionitis, 
premature rupture of membrane, and pre-term birth. BV is also associated with higher 
susceptibility to sexually transmitted pathogens, including HIV [2].  A number of 
studies have shown BV to be associated with elevated sialidase (also known as 
neuraminidase) activity, which is an abnormal condition of the vaginal ecosystem 
caused by a flora shift from the lactobacillus species present in normal conditions to 
overgrowth of a variety of aerobic and anaerobic vaginal bacteria, including 
Gardnerella vaginalis, Bacteroides, Prevotella, Mobilincus and Mycoplasma species 
[3].  
Many kinds of BV tests exist, The Amsel criteria [1, 4-9] are the gold standard 
currently, which require the presence of at least three of four clinical signs set forth by 
Amsel et al:  (i) Presence of abnormal vaginal discharge; (ii) Elevated vaginal pH 
(>4.5); (iii) Positive amine odor; (iv) Presence of clue cells on Gram stain or saline 
preparation of vaginal secretions. The Nugent Gram stain criteria [5, 7, 10-12] measure 
specific gram-stained bacterial morphotypes. This method is to use a Gram stained 
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evaluation of vaginal smears with the Nugent criteria or score [12]: colorimetric pH 
test: 72% and 67%; Papanicolaou smear: 72% and 79%. [13] Consequently, organisms 
that do not Gram stain, such as ureaplasmas and mycoplasmas, are not measured [7]. 
Some other detection methods, such as the Whiff test [7, 14-17], and the Ison and Hay’s 
criteria, [18] were also developed. However, these conventional methods for diagnosing 
BV rely on an expert assessment and laboratory tests. The Nugent and Amsel criteria 
are considered as the most effective assessment for BV, but they are slow and 
accordingly dependent on specialist interpretation and laboratory equipment [19]. 
There has long been a need for a rapid, uncomplicated diagnostic test for BV. Since 
high levels of sialidase activity have been found in women with BV, colorimetric 
detection based on the detection of sialidase is becoming a promising method. But only 
the BVBlue assay [19-22] has been commercialized, it has a fast response (approx. 10 
min), but it is not portable since it is a two-step liquid-phase chromogenic solution test 
kit. The active component for BVBlue assay is IBX-4041, which refers to the invention 
of US patent 2003/0162240 A1. The color reaction includes two steps. The optimal pH 
for the first hydrolysis step is 5.5-6, and the second color development step requires pH 
of ≥9. It is based on detection of the enzyme sialidase produced by pathogenic vaginal 
bacteria, and should be performed in a physician’s office or a lab. This means patients 
cannot self-test at home. Since 2000, BCIN has been used as the substrate of sialidase 
for the detection of BV by Wiggins. [23] This method was first developed by some 
other authors, such as Reukov et al. [24] who immobilized BCIN onto nanocoated 
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fibers. The portable biosensor shows very slow response, takes at least 2 h to light up, 
and BCIN loading efficiency is only about 18%. The reactions for all of above assays 
were shown in Eq. 6-1 A. Sialidase in specimen catalyzed hydrolysis reaction of BCIN 
and produced light yellow color indoxyl isomers at pH 5.5-6, produced isomers were 
oxidized at higher pH 9 to generate visible blue color. 
The method was described in US Patent 7591978 B2 [2, 3] is a dry format assay. 
Same substrate BCIN was assembled onto a sheet device with color enhancer of nitro 
blue tetrazolium (NBT) and some other compounds, while it gives response within a 
reasonable time, the device assembly method and detection step are complicated and 
expensive. Innovation of this method is the addition of color enhancer NBT, which 
decreases total reaction time. The reactions were illustrated in Eq. 6-1 B. First step is 
the same as previous publications such as Wiggin’s and Reukov’s, hydrolysis reaction 
of BCIN catalyzes by sialidase at pH 5.5-6 to produce indoxyl isomers; indoxyl isomers 
are oxidized in the presence of NBT at pH 9 to generate dark purple precipitate. It can 
detect liquid flow as a lateral flow assay and running buffer solution is necessary for the 
sample preparation. Moreover, the assembly method is not compatible with industrial 
fabrication. Furthermore, storage stability, which is a very important factor in potential 
applications, was not discussed.  
Here, we report a method of bioactive paper fabrication method for the detection of 
sialidase, which could be applied to BV diagnosis by women. PEI microcapsules 
soaked in BCIN and NBT solution were incorporated into paper pulp for the fabrication 
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of bioactive paper. The paper can be used for the detection of sialidase-related diseases 
like BV. This kind of BV paper strips were resulted efficient in permitting to obtain a 
fast evaluation of the risk of pathologies related to the presence of sialidase with good 
storage stability.  There is no sample preparation step and detection is as fast as 6 min, 
suspected patients can test by themselves before visiting a physician’ office. Such 
bioactive paper strip was expected to be used not only by women on a day-to-day basis, 
but also by a physician as a fast determination. 
6.3 Materials and methods 
Materials 
BCIN was purchased from Toronto Research Chemicals Inc. NBT, PEI (50 wt% 
soln. in water, MW: 1300), sebacoyl chloride, cyclohexane, Span 85, and 
neuraminidase from Clostridium perfringens (C. Welchii, TypeV) were purchased from 
Sigma-Aldrich. Salts used for buffer preparation were purchased from A&C American 
Chemicals Ltd and MilliQ water (18 MΩ·cm) was used in the preparation of all 
solutions.  
6.3.1 Preparation of microcapsules 
PEI microcapsules were prepared by the mechanical method via interfacial 
polycondensation. The detailed method has been described by our group [25].  Briefly 
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hydrophilic microdroplets of McIlvaine buffered PEI and Span 85 in cyclohexane 
(continuous phase) were crosslinked by sebacoyl chloride to form microcapsules.  
6.3.2 Fabrication of bioactive paper 
Neuraminidase (Sialidase, acetyl-neuraminyl hydrolase) can catalyze the hydrolysis 
of α2-3, α2-6, and α2-8 linked N-acetyl-neuraminic acid residues from glycol-proteins 
and oligosaccharides. BCIN is a known chromogenic substrate of neuraminidase [23], 
but the two-step color reaction requires different optimal pH. So it is not possible to 
make a one-step assay. Tetrazolium salts are known as highly sensitive color indicators 
in combination with 5-bromo-4 chloro-3-indolyl-phosphate for the detection of nucleic 
acid, protein, or glycoconjugates and are very common oxidizers in staining 
applications [26-29]. NBT was used here to oxidize the intermediate (halogenated 
indoxyl) of sialidase-catalyzed hydrolysis of BCIN and form dark purple product [3]. 
Then neuraminidase substrate was comprised by BCIN, NBT and PEI microcapsules 
for the fabrication of bioactive paper. 
Four kinds of paper were fabricated with paper pulp. The materials used for their 
fabrication are listed in Table 6-1. A 0.01 M pH 6 phosphate buffer was used in paper 
fabrication. Samples were obtained in sheet at a ca. 95% consistency and without any 
retention agent used. Prior to handsheet formation, hard wood kraft pulp were 
suspended in water or buffer using a blade mixer for 16 h. Mixed suspensions were 
transferred to the top of Whatman No. 4 filter paper with pore size 20-25 μm in a 
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Buchner filter funnel with diameter of 7 cm. In papers 1 and 2, microcapsules were 
soaked in BCIN and NBT solutions for 30 min, and then mixed with paper pulp. 
Microcapsules only were socked in BCIN solution for the preparation of paper 3. Paper 
4 did not contain microcapsules; only the paper pulp was mixed with BCIN and NBT 
solutions. In all 4 cases, the microcapsules and paper pulp used for paper preparation 
were wet. The paper after filtration was dried by purging with nitrogen gas. Since filter 
solutions of papers 1-4 contained enough BCIN and NBT, which can be reused to soak 
new batch of microcapsules to fabricate new paper strips.  
Table 6- Materials used for the preparation of four kinds of paper 
Paper Pulp /g 
Microcapsules 
 / g 
BCIN/ 
×10-7 mole NBT/ ×10
-7 mole 
1 1 1 3.1 7.1 
2 1 1 3.1 3.6 
3 1 1 3.1 0 
4 1 0 3.1 7.1 
5 1 0 in 6.88×10-8 mole BCIN + 1.58×10-7 mole NBT 
 
In order to visualize the function of PEI microcapsules, paper 5 was fabricated. 
Paper pulp was suspended in pH 6 buffer solution and the paper was prepared by 
filtration. Wet paper was dried by purging with nitrogen. This pure paper was soaked in 
BCIN and NBT solutions and dried again by nitrogen gas. Paper 5 contained the same 
amount of BCIN and NBT as calculated from paper 1(see Tables 6-1and 6-2).  
The reaction taking place on the papers 1 and 2 required two steps. The first step 
was hydrolysis of BCIN catalyzed by sialidase in the specimen, and the second step is 
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the oxidation of indoxyl isomers from hydrolysis reaction with redox indicator NBT in 
the presence of PEI microcapsules formed a dark purple colored products. Secondary 
amine groups on PEI membranes acted as a catalyst in the second step of the reaction 
(Eq. 6-1 C). Unlike the description in previous publications, this both steps could be 
performed at the same pH value.  
For the determination of paper activity, a very small amount (2-20 µl) of diluted 
neuraminidase was directly added to small piece of paper, and then paper strips were 
scanned at different times (from time 0 to 36 h) and mean grey values of scanned 
images were taken by Photoshop. Mean color intensities of different images were 
calculated by mean grey values (Mean color intensity = 256-mean grey value). 
  Neuraminidase was dissolved in 0.01M pH 6 phosphate buffer, since the optimal 
pH for its catalyzed hydrolysis reaction is pH 5.5-6. Normally, the vagina is slightly 
acidic with pH of 3.8-4.2, but it was elevated for the patients with bacterial vaginosis, 
so the elevated vaginal flora is close to this pH value. 
6.3.3 Loading efficiency of BCIN 
BCIN loading efficiency was evaluated using a UV-Vis spectrophotometer. Since 
BCIN has high UV absorbance at 280 nm, a standard curve was made by plotting assay 
data to determine the concentration of BCIN. The assay was performed with various 
known concentrations of  BCIN by plotting concentration on the X axis and absorbance 
on the Y axis. And then the absorbance of filter solution for bioactive paper preparation 
was measured by UV-Vis spectrophotometer. The loading efficiency was obtained from 
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comparison of BCIN concentration in the filter solution and original solution before 
paper preparation. 
6.4 Results and discussion  
6.4.1 Microcapsules in bioactive paper 
PEI microcapsules [25] for the entrapment of large enzyme molecules were used 
here to soak up small molecules for the preparation of sialidase-sensitive paper. Photos 
of the microcapsules are shown in Figure 6-1(a) (wet microcapsules viewed with a 
optical microscope) and Figure 6-1(b) (dried microcapsules using a scanning electron 
microscope (SEM)). Dried microcapsules could be rehydrated many times. Figure 6-
1(c) represents fabricated paper containing microcapsules, in which microcapsules and 
their aggregrates were fixed in the kraft hard wood paper pulp. 
6.4.2 Different kinds of paper 
Since PEI-SC microcapsules are positively charged and BCIN is negatively charged 
at pH 6, BCIN can absorb onto the surface of microcapsules due to the electrostatic 
interaction. Membranes of microcapsules are porous, which allows absorption of small 
molecules like BCIN. In addition, the pore size of the membranes allows the diffusion 
of small molecules [25], thus BCIN and NBT molecules can diffuse across the 
membranes and remained in the core of microcapsules and absorbed onto outer 
membranes of microcapsules due to electrostatic interaction. Microcapsules with mean 
  
168
 
size of 20 μm and their aggregrates can be fixed into paper with pore size ranging from 
0.01-10 μm.  Therefore, papers 1 and 2 can retain BCIN and NBT molecules due to 
existence of PEI microcapsules.  On the other hand, both paper pulp and BCIN are 
negatively charged at pH 6 and the size of BCIN and NBT molecules are much smaller 
than the pore size of paper (0.01-10 μm). Therefore,  paper 4 without microcapsules lost 
its BCIN and NBT after filtration, and thus it did not show any color response to 
neuraminidase (Fig. 6-2).  
 
Figure 6- Microcapsules in wet (1(a)) and dried (1(b)) format and microcapsules in 
paper (1(c)). The wet microcapsules (1(a)) and microcapsules in paper (1(c)) were obtained 
from optical microscope; the dried format micrograph was obtained by SEM, and copper 
was used as the support. 
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Figure 6-. The color reaction of four kinds of paper in the presence of sialidase. Paper 1 
and 2 gave fast and significant color response in the presence of sialidase, which indicates 
the hydrolysis of BCIN and oxidation reaction of the intermediate accelerated by 
alkalization of NBT. Paper 3 showed a little bit of blue color after 2 hours, and was easy to 
recognize the color at 36 hours, which indicated the hydrolysis of BCIN in the presence of 
sialidase at pH 6. Paper 4 did not give any color response, which indicated there was no 
BCIN and NBT remaining in the paper. 
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Microcapsules were used for the fabrication of paper 3, so the substrate BCIN 
remained in it. The reaction mechanism is shown in Equation 6-1A. Since this is a one-
step spot assay, only sialidase solution in pH 6 buffer was added to the paper strips. The 
second reaction step in Eq. 6-1A was very slow.  The color changes of paper 3 after 
adding neuraminidase are shown in Figure 6-2, where the paper did not give a visible 
color within 100 min; only the photo at 36 h showed a little bit of green color.  Since 
the second color development step requires higher pH and the intermediate 
(halogenated indoxyl) from the first hydrolysis step took a longer time to be oxidized at 
pH 6, so the color response is very slow. In addition, the amount of BCIN used here 
was very small (2.83 × 10-5 mg/mm2), so the color appearing on paper 3 was very weak.  
Both papers 1 and 2 gave fast and visible response to samples, but paper 1 was 
darker (Figure 6-2 and 6-4) and displayed higher color intensity (Figure 6-5) than paper 
2. Table 6-1 shows that double the amount of NBT was used to prepare paper 1. The 
reaction scheme on paper 1 and 2 was illustrated in Eqs. 6-1A and 6-1C. There is no 
need to change buffer pH. Indoxyl from the first step of 1A was oxidized by NBT under 
the same condition, which was catalyzed by the amine-containing membranes of PEI 
microcapsules. For the same amount of intermediate (halogenated indoxyl), its oxidized 
dimer (indigo dye) was enhanced by double amount of oxidizer of NBT. Paper 1 gave a 
noticeable response at 6 min, which is faster than the patent reported by Dwir et al. [3] 
They reported no optimal pH was found under which the overall reaction to yield the 
indigo dye proceeds fast enough to give a signal in less than 10 min. And their reported 
optimal pHs for two steps were 5.5-6 and ≥ 9 respectively, which was shown in Eqs. 6-
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1A and 6-1B. The components of paper 1 per centimeter paper are listed in Table 6-2, 
BCIN used in paper 1 strips with the size of 2 mm×5 mm was much less than it in 
assembled card in Dwir’s patent [3] with width of 4 mm (2.83×10-4 mg in our strip vs. 
3.53×10-2 mg in Dwir’s patent), but response was faster than it, since this colorimetric 
reaction was catalyzed by PEI microcapsules (Eq. 6-1 C). Figure 6-3 shows the activity 
of paper 1 and 5 by adding of the same amount of neuraminidase. For the hydrolysis of 
BCIN, both papers did not have a significant difference, but paper 1 was getting darker 
than paper 5 (as expected by Eqs. 6-1A and 6-1B at pH 6) after 10 min, and showed 
remarkably darker color with increased length of reaction time. The same amount of 
BCIN and NBT were loaded onto both papers, but paper 1 contained microcapsules and 
paper 5 was prepared only by paper pulp. It was found that papers 1 and 5 displayed 
different color intensities in the presence of the same amount of sialidase (Figure 6-3), 
which indicated that the combination of  microcapsules efficiently accelerated this color 
reaction. In practice, paper 1 has better visibility than paper 5 due to its uneven 
intensity generated by PEI microcapsules and their aggregrates containing high 
concentrations of BCIN and NBT. Paper 5 displayed uniform color, since it did not 
contain microcapsules, By comparison with all kinds of paper strips prepared, paper 1 
showed the fastest response and most intense color.  
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Equation 6-. Reaction mechanism of chromogenic substrate of sialidase. Equation 
6-1A: BCIN was hydrolyzed in the presence of sialidase at pH 5.5-6 to produce 
indoxyl, and then indoxyl isomers were oxidized to blue color indigo dye at higher pH 
(pH > 9); Equation 6-1B: indoxyl (hydrolyzed monomer) was oxidized in the presence 
of NBT at higher pH (pH > 9) to form a dark purple precipitate; Equation 6-1C: The 
redox reaction of indoxyl and NBT was catalyzed by secondary amino groups (on the 
membranes of PEI microcapsules) at the same pH.  
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Figure 6- The color change of paper 1 and 5 with different length of reaction time in the 
presence of 15 µl (0.937 UN) sialidase. Paper 1 was measured after 2 months of 
preparation, and has faster and intense response than paper 5 (1 day) due to the 
incorporation of microcapsules.  
NBT in papers 1 and 2 could react with the microcapsules to form a little bit of pink 
product at room temperature, which was shown in Figure 6-2 (papers 1 and 2 at 36 
hours). But it was much slower than the enzymatic reaction. Therefore, it does not 
really affect detection of sialidase. The rest part on paper 3 and 4 did not change to pink 
after 36 hours, since NBT was not used for the fabrication of paper 3, and paper 4 did 
not contain microcapsules, so NBT was not retained in the paper after filtration.  
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Table 6-.  Paper 1 components per square centimeter of paper. 
Microcapsules 
g/cm2  paper 
Wet pulp 
g/cm2 paper 
BCIN 
mol/cm2 paper 
NBT 
mol/cm2 paper 
Loading 
efficiency 
0.144 0.144 2.24×10-8 5.10×10-8 Assume 100% 
0.144 0.144 5.28×10-9 NA Measured, 22.2% 
6.4.3 The same paper with different amounts of sialidase 
Papers 1 and 2 changed their color with different lengths of reaction time in the 
presence of various amount of sialidase (Figure 6-4). Paper 1 was measured after 55 
days of preparation, and had a little bit faster response than paper 2 (12 days) due to the 
high amount of NBT. Papers 1 and 2 showed noticeable color change by adding of 2 µl 
(0.125UN) sialidase and a visible dark purple color appeared in the presence of 5 µl 
(0.312UN) sialidase. With the addition of 10 µl (0.625 UN) sialidase, both papers 
displayed significant dark purple color change. 
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Figure 6- The color change of papers 1 and 2 with different lengths of reaction time in 
the presence of various amount of sialidase (2 μl, 5 μl, 10 μl, 15 μl). Paper 1 was measured 
after 55 days of preparation, and had faster response than paper 2 (12 days) due to the high 
amount of NBT. Both paper strips can give visible dark purple color response in the 
presence of 5 µl (0.312 UN) sialidase. The noticeable color was developed as fast as 6 min. 
Figure 6-5 showed the intensity comparison of paper 1 and 2 in the presence of 5 µl 
and 10 µl sialidase at different time length, which clearly indicated paper 1 have higher 
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color intensity than paper 2 due to higher amount of color enhancer NBT. Paper 1 can 
give visible color in 6 min, which is faster than paper 2 (15 min). 
 
Figure 6- Mean color intensity of paper 1 and 2 in the presence of sialidase at different 
time length. 
6.4.4 Loading efficiency of BCIN  
The standard curve of BCIN is shown in Figure 6-6. The loading efficiency of 
BCIN was calculated to be 22.2%.  
To date, paper 1 was kept for 13 months at -18°C and it still works well. A putative 
explanation for this is that PEI microcapsules can prolong the storage stability of BCIN.  
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Figure 6- Standard graph of BCIN. The measurements were conducted by UV-Vis 
absorbance at wavelength of 280 nm. Original concentration of BCIN was used in paper 
preparation was 3.1×10-7 mol.mL-1 in 0.05M phosphate buffer. And other solutions were 
obtained from different dilutions.  
6.5 Conclusions 
A colorimetric biosensor for the detection of neuraminidase was successfully 
fabricated through incorporating PEI microcapsules containing BCIN and NBT into 
paper pulp. The portable paper strips could be easily stored at -18°C, since BCIN is 
sensitive to temperature. Paper strips kept the same activity over a minimum of 12 
months. This colorimetric spot assay did not require any sample preparation step, and 
low amounts of sample (less than 10 µl) can be directly added to small pieces of the 
bioactive paper. The noticeable response time was in as little as 6 min, and the dark 
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purple color can be developed by increasing the reaction time. NBT and microcapsules 
enhanced the paper color by accelerating the second step of the reaction of BCIN and 
sialidase, which made it possible to have trace amounts of BCIN in paper but generate 
significant color response in the presence of sialidase. In practice, there is no expertise 
requirement for this simple one-step test, thus it could be used by women in the privacy 
of their home. Since the paper fabrication step is compatible with industrial application, 
this method could be potentially commercialized. Some further studies, such as paper 
response to different types of sialidase and real specimens from patients are envisioned 
in future work. 
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 Chapter 7 Antibody sensitized microcapsules for the 
detection and deactivation of pathogens 
7.1 Introduction 
Antibody immobilization has become one of the most favorable approaches owing 
to its potential applications in biosensors for pathogen, fungus and virus detection [1-5], 
medical diagnostics [6-9], environmental monitoring [10, 11] and the food industry [12, 
13]. Microencapsulation as a traditional immobilization method is now being applied in 
the preparation of immunosensors and biosensors by entrapment of biorecognition 
elements.  
Antibody microcapsules can serve as a basis for immunosensor or biosensor-based 
analytical platforms in the detection of pathogens and their associated toxins by 
incorporating monoclonal, polyclonal or recombinant antibodies. Furthermore, 
microencapsulation has been studied as a means of avoiding interference from maternal 
antibodies; due to its protective capsules, microencapsulated reovirus can bypass 
suckled, neutralizing maternal antibodies that inhibit the active immunization of 
neonates [14]. Nonetheless, the most practical applications of microencapsulation 
protect antibodies against neutralization rather than viruses. Wallaces [15, 16] described 
a magnetic microencapsulated antibody displacement assay, in which semi-permeable 
nylon microcapsules were used to entrap antibodies for the detection of thyroxin in 
clinical practice. The addition of magnetic cellulose at the end of the incubation step 
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speeded up the sedimentation process producing a more stable pellet containing 
magnetic antibody-entrapped microcapsules. Vascular endothelium (VE)-cadherin-
secreting hybridoma cells were also immobilized in alginate-agarose microcapsules to 
inhibit angiogenesis [8]. Hybridoma cells were protected within the biocompatible and 
semi-permeable membranes that permitted the exit of anti-VE-cadherin monoclonal 
antibodies but not the entry of cellular immune mediators. 1B5 hybridoma cells were 
grown within poly-L-lysine-coated alginate and agarose beads and secreted anti-VE-
cadherin antibodies for 9 days of culture. The observed anti-angiogenic effect was 
antibody concentration-related, demonstrating a controlled drug delivery system. US 
patent 4483928 [17] reported a  similar simple method to selectively measure the 
antigen of lymphocytes using a cell-mediated immunity approach where  microcapsules 
are sensitized with the antibody to the antigen of lymphocyte. This simple strategy 
based on cell-mediated immunity comprises the quantification of microcapsules 
sensitized with antibodies against an antigen of lymphocyte and sheep red cells that are 
optically distinguishable from the antibody sensitized microcapsules. 
Apart from antibody microcapsules, antigenic microcapsules were also used in 
clinical evaluations. Kobayashi [18] has performed passive agglutination tests using 
chemically stable polyurethane microcapsules sensitized with various antigens. A 
quantitative passive agglutination test of antibodies specific to Treponema Pallidum for 
the detection of serodiagnosis of syphilis was carried out with microcapsules instead of 
conventional sheep erythrocytes. The microcapsules used in this kind of study required 
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the following features: an absence of antigenic substance on the particle surface to 
avoid non-specific reactions, good chemical stability, the possibility of mass production 
with uniform quality and the modification of particle characteristics such as particle 
size, specific gravity and surface properties according to the purpose of the test. 
Based on the success of prior studies, we attempted to encapsulate antibodies by 
PEI microcapsules. Given that the membranes of PEI microcapsules contain nitrogen, 
activated antibodies were likewise being conjugated to its membranes. The aim of this 
work was to develop a pathogen detection/deactivation platform. As we know 
encapsulated GOx can produce hydrogen peroxide in the presence of glucose, which 
can kill pathogens close to membranes, so GOx microcapsules have killing capacity. 
Since concentration of hydrogen peroxide produced from GOx microcapsules is low, 
we conjugate antibody to the membranes of microcapsules that can capture pathogens 
to improve their killing capacity. On the contrary, empty microcapsules do not have this 
killing ability, since they do not produce hydrogen peroxide.  
7.2 Materials and methods 
7.2.1 Materials 
Empty PEI microcapsules and GOx microcapsules were previously synthesized 
[19], Rabbit polyclonal antibody, goat polyclonal to Escherchia Coli (ab25823), goat 
polyclonal to Escherchia Coli (Horseradish peroxidase). (ab69185), rabbit anti-goat 
IgG (labeled by FITC), and Rabbit F(ab’)2 fragment to goat lgG (ab47846) were 
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purchased from Abcam Inc. Immunoglobulin G (from human plasma) was purchased 
from Athen Research and Technology. Sodium (metal) periodate (NaIO4), sodium 
cyanoborohydride (NaBH3CN), sodium sulfite (Na2SO3), ethanolamine 
(HO(CH2)2NH2), poly(ethyleneimine) (Mw: 1300 Da), sebacoyl chloride, and glucose 
oxidase from Aspergillus Niger were purchased from Sigma-Aldrich. Miller’s LB Broth 
used for propagation and maintenance of E.Coli, DifoTM Granulated Agar and 
Filterplate for rapid ELISA were purchased from Whatman Inc. 
7.2.2 Methods 
7.2.2.1  Antibody microencapsulation  
Antibody microencapsulation followed the same protocol as for enzyme 
microcapsules. Microdroplets from the aqueous phase containing Immunoglobulin G 
from human plasma labeled by Texas-red and poly(ethyleneimine) labeled by FITC 
were crosslinked with sebacoyl chloride at the interface of microemulsion. The 
resulting microcapsules were first rinsed with cyclohexane to remove hydrophobic 
species followed by plenty of Milli-Q water to remove hydrophilic residues. 
7.2.2.2  Conjugation of antibody to membranes of microcapsules  
This assay refers to the antibody-enzyme conjugates introduced by Hermanson [21]. 
In that the membranes of microcapsules contain amine groups like enzyme molecules, 
activated antibodies can be conjugated to its membranes. Many immunoglobulin 
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molecules are glycoproteins that can be periodate-oxidized to contain reactive aldehyde 
residues. Polyclonal IgG molecules often contain carbohydrate in the Fc portion of the 
molecule. This was removed from antigen binding sites to allow conjugation to take 
place through the polysaccharide chains without compromising its activities [21]. 
Antibody-microcapsule conjugation by reductive amination was accomplished by the 
oxidation of antibody and subsequent crosslinking to the amine-containing outer 
membranes. In this study empty microcapsules and GOx microcapsules were 
conjugated to goat anti-E.coli antibodies. The procedure of antibody conjugation to the 
empty and GOx microcapsules is given in Annex 1.  
7.2.2.3  Confirmation of antibody-microcapsule conjugation 
In order to confirm the conjugation between goat anti-E.Coli antibodies and 
microcapsules, three different assays were applied. The first assay used was confocal 
laser scanning microscope (CLSM). Ab-conjugated microcapsules were first blocked 
by skimmed milk to avoid unspecific binding and then incubated in secondary FITC-
antibodies. If the primary antibodies (conjugated to microcapsules) were successfully 
conjugated to microcapsules and their binding sites were still active, the secondary 
FITC-labeled antibodies could be observed on the membranes of microcapsules by 
CLSM. The protocol is described in Annex 2.  
The second assay was a traditional ELISA (see Annex 3). If the goat anti-E.Coli 
antibodies were well conjugated to microcapsules, they would bind to their antigens 
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(E.Coli) and the bound antigens could be detected by secondary antibody-HRP which 
would give off a blue color in the presence of 3, 3’, 5, 5’ –Tetramethylbenzidine (TMB) 
for ELISA. In practice, conventional ELISA for antibody-microcapsules presented 
challenges when binding the microcapsule-antibody conjugates to the microplates. The 
antibody-modified microcapsules tended to detach from the plate due to their large size 
and duo to the formation of microcapsule aggregates.  
The third assay was a rapid ELISA (Annex 4). Rapid ELISA overcame the 
problems of conventional ELISA by using vacuum filtration of the microcapsules in the 
filter plate assay, avoiding the washing step and reducing the amount of time required. 
7.2.2.4  Enzymatic activity of GOx microcapsules-antibody 
Enzymatic activity measurements were conducted with an oxygen electrode (Rank 
Brothers Ltd.). Since the unconjugated GOx microcapsules and those conjugated with 
goat anti-E.Coli antibodies were suspended in buffer, membranes of microcapsules are 
solid. It was impossible to measure their absorbance with a traditional UV-Vis 
spectrophotometer. Given that GOx’s reactions with glucose have consumed oxygen, 
their activities were measured in an oxygen cell chamber (3 ml total volume) with an 
oxygen electrode from Rank Brothers, which is sensitive to oxygen concentration. The 
oxygen consumption speed was considered as the relative enzymatic activities. 
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7.2.2.5  The performance of GOx microcapsules conjugated with antibody 
Colony count estimation provides an inexpensive and user-friendly protocol for 
quantitative and qualitative bacterial pathogen detection and is routinely employed in 
the development of hazard analysis and critical control point (HACCP) systems in the 
food industry and in the establishment of risk assessment [22, 23]. 
In that glucose oxidase microcapsules can produce hydrogen peroxide (H2O2) in the 
presence of glucose, Goat anti-E.Coli antibodies conjugated to glucose oxidase 
microcapsules could capture E.Coli thereby killed by the hydrogen peroxide released. 
Thus, glucose oxidase microcapsules conjugated with antibodies would have the 
highest killing capacity. Empty microcapsules might absorb some E.Coli cells due to its 
porosity (less than 5 nm), since they are unable to produce hydrogen peroxide. Their 
killing capacity would be much lower than that of glucose oxidase microcapsules. 
Different microcapsules’ suspensions were incubated with E.Coli cells to determine 
their killing capacity. 
Various concentrations of capsule suspensions were diluted to 10-3 and 10-4 of 
original concentrations. 50 µl of each suspension of capsules in PBS 7.4 was added to 
50 µl of E.Coli culture (2×107 cells/ml) along with 15 µl of Glucose (1 M) and was 
incubated for 30 minutes at 37°C. The suspensions were diluted by PBS 7.4 to 10-3 or 
10-4 of original concentrations and incubated in a Petri dish at 37°C overnight for 
colony counting. 
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7.3 Results and discussion 
7.3.1 Activity of conjugated GOx microcapsules 
Figure 7-1 shows the relative activities of GOx microcapsules and those of antibody 
conjugated GOx microcapsules. In Figure 7-1, a sharp slop means high activity. 
Antibody conjugated GOx microcapsules retained only 64% of its enzymatic activity. 
During the conjugation process, encapsulated GOx came into contact with many harsh 
chemicals such as sodium periodate, sodium cyanoborohydride, sodium sulfite and 
ethanolamine. Although the membranes of microcapsules offered some protection to 
the encapsulated GOx, they were nonetheless porous; if the process took too long, some 
activities would have been diminished.  
 
Figure 7- Plots of oxygen consumption speed as a function of enzymatic activity of 
GOx microcapsules (a) and Ab-GOx microcapsules (b), showing the relative activity. 
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7.3.2 CLSM study of antibody-microcapsule conjugation 
CLSM suggests aggregation of both types of microcapsules, singe microcapsules 
could not be captured due to weak signal. Empty microcapsules without conjugation 
did not give a FITC signal or showed very weak green color. Figure 7-2, a is 
fluorescent image of b (transmitted light) illustrates the big aggregate of microcapsules 
giving off a weak fluorescence. The weak signal was probably due to unspecific 
adsorption of microcapsules’ membranes to secondary antibodies. On the contrary, 
antibody-microcapsule- conjugates gave much stronger signals around the membranes 
because of the specific binding between antibody-microcapsules and secondary 
antibodies labeled with FITC. Figure 7-2 c shows a fluorescent image of microcapsules 
d, and image d was taken under transmitted light.  
7.3.3 Conventional and rapid ELISA 
The length of E.Coli was approximately 2 µm, but the pore size of the membrane of 
microcapsules was larger. Microcapsules could not be completely removed from the 
plate, thus rendering a strong background problematic. The issue was further 
complicated by the fact that porous GOx microcapsules could  absorb E.Coli cells and 
the absorbed cells could bind goat anti-E.Coli antibodies (HRP), whereby the GOx 
microcapsules without antibody would also bind secondary antibody and give 
absorbance. However, GOx microcapsules conjugated with antibodies could bind more 
E.Coli and give a stronger absorbance.  For conventional ELISA, GOx capsules-Ab 
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(0.242) showed higher absorbance than GOx capsules (0.124) using same kind of 
ashless paper with pore size 2.5 µm. 
 
Figure 7- Confocal micrographs of Goat anti-E.Coli antibody-microcapsules (c, d) and 
empty microcapsules (a, b) incubated in rabbit anti-goat IgG, F(ab’)2 fragment. 
GOx microcapsule-antibody conjugates did not show a significant difference in 
absorbance compared to that of GOx microcapsules alone in rapid ELISA (Figure 7-3). 
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According to our tests on different filter papers, glass fibers as well as binding-free glass 
were not suitable for rapid ELISA due to strong absorbance. 
7.3.4 Killing assay  
Fifteen microliter of glucose solution was added to 50 µl of a GOx capsule suspension 
in PBS pH 7.4 and 50 µl of E.Coli culture (2×107 cells/ml) and the mixture was allowed to 
react for 30 min at 37°C. GOx was diluted to different concentrations and the results are 
shown in Table 7-1. Colony-forming unit for each dilutions were compared to buffer 
incubation as positive control to get their killing capacities. The killing capacity of GOx 
microcapsules was 100% (colony-forming unit is 0) at concentration of 0.167 mg.ml-1. At 
concentration of 0.0013 mg.ml-1, microcapsules still exhibit more than 50% killing 
capacity. Since the microcapsules’ suspension was not quite uniform in small volumes, 
different measurements might present some deviations. 
The killing capacities of GOx microcapsules and GOx microcapsule-antibody 
conjugates were compared (Table 7-2). GOx microcapsules-Ab showed a slightly higher 
killing capacity than solely that of GOx microcapsules, suggesting that the killing capacity 
mainly derived from hydrogen peroxide produced by glucose oxidase. The performance of 
microcapsule-antibody conjugates was better with lower concentrations of microcapsules. 
At low concentrations of microcapsules, the antibodies effectively captured suspended 
E.Coli and thus the killing capacity of glucose oxidase with the microcapsules was 
improved.  
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Figure 7- Rapid ELISA result for GOx microcapsules and GOx microcapsules-Ab. 
Table 7- Killing capacity of GOx microcapsules with various dilutions 
Concentration of GOx/mg.ml-1 Dilution CFU/100 µl Killing/ % 
0.167 10
-3 0 100 
10-4 0 100 
0.0833 10
-3 6 99.2 
10-4 1 97.4 
0.0417 10
-3 10 98.6 
10-4 0 100 
0.0208 10
-3 28 96.4 
10-4 6 84.2 
0.0104 10
-3 57 92.1 
10-4 7 81.6 
0.0109 10
-3 81 88.9 
10-4 16 57.9 
0.0026 10
-3 179 75.4 
10-4 17 55.3 
0.0013 10
-3 266 63.4 
10-4 19 50 
N.C. (PBS) 
10-3 726 
 10-4 38 
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Table 7- Killing capacity of GOx microcapsules and GOx microcapsules-Ab 
Concentration of microcapsules/mg.ml-1 Dilution CFU/100 µl Killing/ % 
1.3×10-3 
GOx capsules 
10-3 130 63.9 
10-4 16 42.8 
GOx capsules-Ab 
10-3 116 67.8 
10-4 17 39.3 
6.5×10-4 
GOx capsules 
10-3 171 52.5 
10-4 16 42.8 
GOx capsules-Ab 
10-3 144 60 
10-4 17 39.3 
3.3×10-4 
GOx capsules 
10-3 177 50.8 
10-4 21 25 
GOx capsules-Ab 
10-3 180 50 
10-4 25 10.7 
1.6×10-4 
GOx capsules 
10-3 198 45 
10-4 24 14.3 
GOx capsules-Ab 
10-3 255 29.2 
10-4 25 10.7 
N.C. (PBS)  
10-3 360 
 10-4 28 
7.3.5 Microencapsulation of Immunoglobulin G from human plasma 
IgG (from human plasma) labeled by Texas-red was encapsulated in PEI 
microcapsules tagged by FITC. The location of the encapsulated IgG upon 
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microencapsulation is illustrated in Figure 7-4. The green signal shown in (a) 
corresponds to the FITC-tagged membranes, the red signal in (b) is the core phase 
labeled by Texas-red and finally (c) is the overlay image of the membrane and the core. 
Most of the IgG was crosslinked in the membranes or bound to the internal walls of 
microcapsules; several were encapsulated within the core. The IgG can be protected by 
biocompatible and semi-permeable membranes that permit the exit of small molecules. 
Antibodies were encapsulated into PEI microcapsules and the encapsulated 
antibodies were located in the cores or fixed into the membranes of microcapsules. 
Antibodies were also conjugated to the outer membranes of microcapsules by reductive 
amination. After conjugation, GOx microcapsules had lost 36% of enzymatic activity 
due to the interaction with harsh chemicals used during the conjugation process. Our 
studies with CLSM, ELISA and E.coli killing assay demonstrate that goat-anti-E.Coli 
antibodies were successfully conjugated to the microcapsules. Nevertheless, the 
concentrations of antibodies are low and thus the binding performance of the 
antibodies was weak. Both GOx microcapsules and GOx microcapsule-antibody 
conjugates had killing capacities as GOx produced hydrogen peroxide in the presence 
of glucose. Results suggest that the killing capacity of GOx microcapsule-antibody 
conjugates was almost the same as that of GOx microcapsules at a relative high 
concentration of the microcapsules’ suspension, though it had a slightly higher killing 
capacity at a lower concentration of suspension. This was explained as a more efficient 
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capture of E.coli by the antibody on the outer membranes enabling higher killing 
capacity of glucose oxidase within microcapsules. 
 
Figure 7- Multi-panel view of confocal images of IgG microcapsules. PEI membrane-
FITC signal (a), IgG human plasma of core phase-Texas-red signal (b), the overlay image 
of the core and the membrane of microcapsules (c). 
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 Chapter 8 Conclusions and future work 
8.1 Conclusions 
We have successfully fabricated PEI microcapsules by the emulsion method and the 
vibration nozzle method and have compared both methods. A method based on laminar 
jet break-up technique using a commercial instrument developed to produce alginate 
beads is reported for the first time for production of PEI microcapsules. Optimal 
parameters for both methods were studied and manufactured microcapsules were 
characterized. Some enzymes such as TvL and GOx were encapsulated by both 
methods. By comparison, the emulsion method was chosen for enzyme 
microencapsulation due to its higher encapsulation efficiency, higher productivity, 
lower toxicity and controllable sizes and size distribution. Depending on the properties 
of microcapsules, enzyme microcapsules can be immobilized in paper by different ways 
including coating, sizing and printing. 
We firstly demonstrated the interaction between PEI and laccase. The enzymatic 
activities of free and encapsulated enzymes were compared, and the factors affecting 
enzyme activities were discussed. A simple mixing assay, a fluorescence assay, a 
circular dichroism assay and kinetic studies were carried out for interaction 
measurements. The results revealed that TvL can interact with the PEI molecules; 
TvL’s conformation was changed and its activity was decreased by the interaction 
between Cu in enzyme’s active sites and amino groups in PEI molecules. However, no 
interaction was found between GOx and PEI molecules or all the interactions 
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contributions were eliminated. Therefore, we determined that PEI does not change 
activity of the GOx. The decrease in GOx’s activity after microencapsulation was due 
to the closed shells with pore size less than 5 nm. Some other factors, such as reduction 
of the amount of oxygen inside microcapsules (substrate depletion) can also reduce it 
activity. 
Two kinds of bioactive paper fabrication platform based on microencapsulation 
were built up either through incorporating microencapsulated enzymes into paper pulp 
or incorporating empty PEI microcapsules socked in BCIN and NBT into paper pulp in 
the making. Both methods are scalable. We successfully fabricated two types of 
colorimetric bioactive paper strips named GOx paper and BV paper, which are 
inexpensive, sensitive and one-step spot assays. GOx paper containing GOx 
microcapsules changes color in the presence of glucose and KI, which can be 
potentially used for food packaging paper to improve shell life of food by scavenging 
oxygen that might penetrate the physical barrier.  
 The BV paper strip displays a dark-purple color in the presence of neuraminidase. 
Numerous studies have shown that bacterial vaginosis is associated with elevated 
sialidase. This colorimetric biosensor can detect the presence of sialidase for the 
diagnosis of bacteria vaginosis. The detection is as soon as 6 min. comparing to other 
techniques, BV paper strip is affordable, fast response, one-step spot assay with good 
storage stability, which was not discussed in previous publications. Comparing with 
commercial BVBlue test kit and Dwir’s patent, this paper strip did not require to 
change buffer during detection and has better visibility. Patients can self-test at home 
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by BV paper strip before visiting a physician’s office. Present BV paper strip was only 
tested by specific neuraminidase instead of real specimen, further study is required. 
Preliminary antibody sensitized microcapsules were prepared by two approaches: 
the conventional encapsulation method like enzyme microencapsulation and the 
conjugation of the antibodies to outer membranes of microcapsules. The overall 
difference in performance of the two was that antibody was crosslinked in the 
membranes or inside of microcapsules’ cores by encapsulation method and may lose 
some of activity duo to diffusion restriction structure changes in membranes. This study 
is only ground work, but some protocols were set up for this project. 
8.2 Future work 
8.2.1 Exploring different applications for PEI microcapsules 
PEI microcapsules are sturdy and can be fabricated under mild conditions within 
short time period at low cost. Their characterization can be adjusted by changing a few 
experimental parameters, and have been well studied in previous work, demonstrating 
their potential in many applications. 
Encapsulation protects antibodies from being neutralized during their detection and 
deactivation of pathogens. The challenge at this point is to maintain the activities of 
antibodies. PEI-SC microencapsulation is a matured technology in our group, but PEI 
microcapsules were mainly used for enzyme microencapsulation. Therefore, stability 
studies should be performed to determine the suitable parameters for antibody 
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microencapsulation. Structure of an antibody is related to its immune function, which 
might be affected by microencapsulation, since some molecules were crosslinked into 
membrane and antigen binding sites might be changed. Microcapsules must be 
biocompatible and semi-permeable, allowing the exit of antigens but not entry of 
antibodies. This can be accomplished by attaching antibodies on the surface of enzyme 
microcapsules by methods like conjugation to maintain their activity. 
We have successfully fabricated colorimetric biosensors, for example, the glucose 
oxidase bioactive paper. In the future study, we could encapsulate other kinds of 
enzymes that response to different substrates. Microencapsulation protects vulnerable 
biological molecules from unwanted environmental factors for the fabrication of 
colorimetric biosensors.  
PEI microcapsules are not soluble in water, which permits the absorption of 
impurities due to porous membranes, and they can be potentially used for water 
purification. 
PEI microcapsules are biocompatible. The pore sizes of their membranes can be 
controlled by adjusting some reaction parameters during the fabrication process. The 
flexibility in their pore sizes allows in controlled release for chemicals. 
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8.2.2 Different microencapsulation methods have to be applied for different active 
agents.  
Due to the interaction of amine groups in PEI with laccase either active site’s 
copper or amino groups in its vicinity, laccase lost activity to a large extent after 
microencapsulation. Some other microencapsulation methods such as the use of various 
kinds of alginate beads, layer-by-layer technology, extrusion, spray drying, 
coacervation and so-gel process can be tested to improve activity of microencapsulated 
enzyme. 
8.2.3 Optimization of paper-making method 
Currently, bioactive paper is fabricated by filtration of paper pulp suspension 
containing enzyme microcapsules or empty microcapsules socked in active agents 
through Buchner funnel. The fabrication process can be optimized by changing some 
parameters such as the water and microcapsule contents in pulp suspension. The 
fabrication procedure is industrially compatible with paper-making process and can be 
up-scaled. Furthermore, the paper-drying process also can be optimized to improve the 
enzyme activity, some methods like lyophilization can be tried to dry sensitive paper 
that can maintain its activity. For example the BV paper strip contain BCIN that is light 
and temperature sensitive and the whole paper-making process must be protected from 
light under controlled temperature, followed by drying by lyophilization. In a large 
scale setting, different methods such as instant ultrahigh temperature, air-drying or 
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nitrogen-drying can be evaluated. Other methods of bioactive paper making such as 
coating or printing of microencapsulated active ingredients can be tried. 
The most expensive agent used for BV paper strip is BCIN, which acts as substrate. 
Although Nitro blue tetrazolium (NBT) is an inexpensive agent, for large scale 
application, replacement with enhancers of even lower cost like other indigo dyes might 
be preferred. The ratio between BCIN and NBT should be optimized to improve 
sensitivity and minimize the cost. 
As we reported, the BV paper is sensitive to neuraminidase from Clostridium 
perfringens (C. Welchii, TypeV). However, measurements on real specimens require 
the use of proper positive and negative controls or a pre-determined BCIN 
concentration that can detect sialidase and give a correct signal.  
Collaboration with hospitals to facilitate access to real specimens is needed and a 
comparison of BV paper with traditional methods, such as Amsel criteria, Nugent 
score, Whiff test. Amsel criteria are the gold standard for the diagnosis of bacterial 
vaginosis. At least three of four criteria should be confirmed diagnosis. A characteristic 
fishy odor on wet mount is considered a positive whiff test and is suggestive of 
bacterial vaginosis [1]. 
The BV paper has only been tested with neuraminidase from Clostridium 
perfringens (C. Welchii, TypeV). The sensitivity of BV paper to different 
neuraminidases for example NEU3 should be assessed in future works.  
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Annexes 
Annex  . The procedure of antibody conjugation to microcapsules. 
Step 1 Antibody oxidation by reductive amination: 
1. 20 µl Goat anti-E.Coli is diluted to 2 ml by 0.01M PBS in 2 ml eppendorf tube; 
2. Add 100 µl NaIO4 of 0.1 M, and react 20 min; 
3. Add 1.74 mg of Na2SO3; 
4. Centrifuge solution by MWCO10,000, and recover by pH 9.6 of 0.2 M carbonated 
buffer. 
Step 2 Conjugation of oxidized antibody to the membranes of microcapsules: 
1. Weight 2 g capsules rinsed by pH 9.6 of carbonated buffer, and add 4 mL pH 9.6 
buffer and oxidized antibody; react for 2h; 
2.  Add 40 µl NaBH3CN, react for 30 min; 
3.  Add 200 µl NH2CH2CH2OH, react for 30 min; 
4.  Filtrate and rinse them by pH 7 of 0.01 M PBS. 
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Annex  . Confocal laser scanning microscope (CLSM) for the detection 
of conjugation. 
a) Prepare 2% (w/v) commercial skimmed milk powder solution in water, and filter to 
remove particle; 
b) Incubate antibody conjugated capsules in 1.5 ml of milk solution in 2 ml eppendorf 
microcentrifuge tube for 1h; 
c) Rinse microcapsules. Remove all the supernatant, then rinse with PBS buffer and 
repeat centrifuge and supernatant removal step for 3 times. 
d) Incubate antibody-capsules in 0.05 µg/ml secondary antibody of rabbit anti-goat IgG, 
F(ab’)2 fragment coupled to FITC in PBS for 1h; 
e) Remove unbound secondary rabbit anti-goat IgG, F(ab’)2 fragment coupled to FITC 
from microcapsules by rinsing step described in step c for 5 rinsing cycles; 
f) Carry out steps b-e with empty microcapsules; 
g) Make sure there is no unspecific adsorption of secondary antibody on the capsules; 
h) Observe them by CLSM . 
 
  
  
III
 
Annex  . Conventional ELISA for the detection of conjugation. 
Conventional ELISA is performed in plastic microplates. 
a) 100 µl of E.Coli: DH5α is coated to 96-well plate, and incubate overnight at 4°C; 
b) Rinse plate with 200 µl PBS for 5 times; 
c) Block active sites of plate with 200 µl of 4% skim milk for 3 hours; 
d) Rinse plate by 240 µl PBST (with 0.05% Tween 20) for 5 times; 
e) Add 200 µl primary antibody-HRP and orbital shake for 1 hour; 
f) Rinse with PBST for 5 times; 
g) Add 100 µl secondary antibody-HRP and shake for 1 hour; 
h) Wash them by PBST for 5 times; 
i) Add 100 µl of TMB for ELISA and wait for blue color; 
j) Stop them by H2SO4 (40 ml concentrated H2SO4 in 360 ml water), blue color will 
turn to yellow; 
k) Read plate at 450 nm on microplate manager (Model 680) from Bio-Rad 
Laboratories, Inc. 
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Annex  . Rapid ELISA for the detection of conjugation. 
a) Rinse filtration membranes, and stick on the silicon membrane. Cover removable top; 
b) Add 200 µl PBS for 2 min to incubate membranes; 
c) Add 100 µl 0.33 mg.ml-1 microcapsules for 5 min; 
d) Blocking active sites by 200µl of superblock® blocking buffer in TBS for 15 min; 
e) Wash by 200 µl PBST for three times, drain by vacuum; 
f) Add 100 µl of 108 cells.ml-1 DH5α (107 cells); 
g) Wash twice by 200 µl PBST and drain by vacuum; 
h) Add 100 µl goat anti-E.Coli-HRP with dilution of 1/200 (8.5×10-5), and incubated 
for 15 min. Drain by vacuum; 
i) Add 100 µl of TMB for ELISA, and then wait for the color development; 
j) Stop by H2SO4 (40 ml H2SO4 + 360 ml H2O). 
k) Negative control: microcapsules were instead of PBS. 
 
